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Abkürzungsverzeichnis 
 
ΔΨm  Potential der inneren Mitochondrienmembran 
[Ca2+]i  freie intrazelluläre Ca2+-Konzentration 
ACA  N-(p-amylcinnamoyl)anthranilic, TRPM2-Inhibitor 
ADP  Adenosindiphosphat 
ADPR  Adenosindiphosphat-Ribose 
ATP  Adenosintriphosphat 
Bcl-2  „B-cell lymphoma 2“, anti-apoptotisches Protein 
BK  “Big conductance potassium channel“ 
Ca2+  Calciumion 
CaMKII “Ca2+/Calmodulin-dependent protein kinase II“ 
cdc2  “Cell division cycle protein 2 homolog“  
cdc25b „Cell division cycle 25b“ 
CXCR4 CXC-Motiv-Chemokinrezeptor 4 
DNA  „Desoxyribonucleic acid“ 
EdU   5-Ethynyl-2’-Deoxyuridine 
ER  Endoplasmatisches Retikulum 
fluo-3  Fluoreszensfarbstoff für Ca2+ 
Fura-2 ratiometrischer Fluoreszenzfarbstoff für freies Ca2+  
Gy  Gray, pro Masse absorbierte Energie 
h  Stunde 
H2O2  Wasserstoffperoxid 
IDH1  Isocitratdehydrogenase  
IK  “Intermediate conductance potassium channel“ 
IP3  Inositol-3-Phosphat 
IP3R  Inositol-3-Phosphat-Rezeptor 
IR  “Ionizing radiation“ 
K+  Kaliumion 
Kv3.4   “Potassium voltage-gated channel, Shaw-related subfamily, member 4” 
Mg2+  Magnesiumion 
MitoSOX  Superoxid-sensitiver Farbstoff 
mM  Millimolar 
MPF  “mitosis promoting factor“ 
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mRNA Messenger RNA 
MSI1  “Musashi“, mRNA-Bindeprotein 
Na+  Natriumion 
NCX  Na+/Ca2+-Austauscher 
NMDG+ N-Methyl-D-glucamin, nicht membrangängiger Na+-Ersatzstoff 
p53  humanes Tumorsuppressorprotein 
PARP  Poly-ADP-Ribose-Polymerase 
pH  potentia hydrogenii, Maßzahl für die Wasserstoffionenkonzentration 
PI3K  Phosphoinositid-Kinase 3 
PIP2  Phosphatidylinositoldiphosphat 
PLA2  Phospholipase A2 
PMCA “Plasma membrane calcium  ATPase” 
ROC  “Rezeptor-operated channels” 
ROS  „reactive oxygen species“ 
RT-PCR Reverse Transkriptase-Polymerase-Kettenreaktion 
RYR  Ryanodin-Rezeptor 
SERCA “Sarcoplasmic/endoplasmic reticulum calcium ATPase” 
SH2  “Src-homology 2“ 
siRNA  “small interfering RNA” 
SMOC “Second messenger-operated channels” 
SOC  “Store-operated channels” 
SPCA  “Secretory pathway calcium ATPase” 
TMRE  Tetramethylrhodamin Etylester  
TRP  “Transient receptor potential” 
TRPA  ANTKTM1-Unterfamilie der TRP-Kanäle 
TRPC  klassische Unterfamilie der TRP-Kanäle 
TRPM  Melastatain-Unterfamilie der TRP-Kanäle 
TRPML Mucolipin-Unterfamilie der TRP-Kanäle  
TRPP  Polycystin-Unterfamilie der TRP-Kanäle 
TRPV  Vanilloid-Rezeptor-Unterfamilie der TRP-Kanäle 
VOC  “Voltage-operated channels“ 
 7 
Zusammenfassung 
 
Die Strahlentherapie stellt eine der wichtigsten Säulen dar, auf die sich die moderne 
Behandlung von Krebserkrankungen stützt. Die Resistenz der Tumorzellen 
gegenüber dieser Behandlung stellt hierbei trotz immer fortschrittlicherer 
Behandlungsstrategien ein großes Problem dar. Insbesondere die durch Bestrahlung 
veränderte Regulation des zellulären Ca2+-Signalosoms scheint hier von großer 
Bedeutung zu sein. Ca2+-Signale werden unter anderem von in der Plasmamembran 
lokalisierten Kationenkanälen generiert. Dabei konnte bereits mehrfach gezeigt 
werden, dass Kationenkanäle der Melastatin-Familie (TRPM) insbesondere die 
Resistenz und Malignizität von Tumoren beeinflussen, weshalb sie immer weiter in 
den Fokus der Krebsforschung rücken. Welche Rolle zwei ausgewählten Mitgliedern 
der TRPM-Familie bei der Radioresistenz maligner Tumore zukommt und wie sich 
diese Erkenntnis auf eine Strahlentherapie auswirken könnte, wurde in dieser Arbeit 
näher analysiert.  
Im ersten Teil dieser Arbeit wurde die Interaktion von TRPM2 mit dem anti-
apoptotischen Protein Bcl-2 in T-Zell Leukämiezellen untersucht. Insbesondere Bcl-2 
ist nachweislich an der Therapieresistenz verschiedener Tumorentitäten beteiligt. Um 
dieses Zusammenspiel näher zu charakterisieren, wurden Jurkat Zellen mit 
ionisierender Strahlung behandelt und anschließend der Zellzyklus sowie das 
TRPM2-vermittelte Ca2+-Signaling analysiert. Hierbei konnte gezeigt werden, dass 
Bestrahlung vor allem in Bcl-2 überexprimierenden Zellen einen Ca2+-Einstrom 
induzierte, der nach pharmakologischer Inhibition von TRPM2 stark vermindert war. 
In Kontrollzellen führte dieser erhöhte Ca2+-Einstrom zur Produktion von reaktiven 
Sauerstoffspezies. Bcl-2 überexprimierende Jurkat Zellen waren jedoch in der Lage, 
im Gegensatz zu Kontrollzellen, diese letale Ca2+-Dosis zu tolerieren. Weiter führte 
der TRPM2-vermittelte Einstrom zu einem G2/M-Arrest, der durch Inhibition der 
TRPM2-Kanäle verhindert wurde, was zu einer erhöhten Apoptoserate führte.  
Im zweiten Teil dieser Arbeit wurde die Strahlenresistenz von Glioblastomen 
untersucht. Im Gegensatz zu benignem Hirngewebe ist der Kälterezeptor TRPM8 im 
Glioblastom stark überexprimiert. Der retrospektive Vergleich von mRNA-Daten 
zeigte, dass eine erhöhte Expression von TRPM8 im low-grade Gliom mit einer 
geringeren Lebenserwartung korreliert. In nachfolgenden in vitro Experimenten 
konnte diese Erkenntnis bestätigt werden: Eine siRNA-vermittelte Inhibition von 
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TRPM8 führte zu einem geringeren klonogenen Überleben. Die Kombination von 
Bestrahlung und Inhibition zeigte weiter sowohl eine erhöhte Caspasen-Aktivität als 
auch eine gestörte Proliferation.  
Zusammenfassend legen diese Ergebnisse nahe, dass die beiden Kanäle TRPM2 
und TRPM8 in den untersuchten Tumorentitäten eine wichtige Rolle in der 
Radioresistenz spielen. Weiter zeigen die Untersuchungen, dass diese beiden 
Kationenkanäle als mögliche Targets, einzeln oder in Kombination, zukünftiger 
Behandlungen in Frage kommen und somit neue Strategien in der Krebstherapie 
eröffnet werden. 
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Summary 
 
Radiotherapy plays a major role in modern cancer treatment. Despite steadily 
improving therapy strategies the resistance of cancer cells against ionizing radiation 
often results in therapy failure. In particular, the altered regulation of the cellular Ca2+ 
signalosome seems to be of great importance. Amongst others, Ca2+ signals are 
generated by cation channels localized in the plasma membrane. In this context 
special TRP cation channels are getting more and more into the focus of oncologists. 
It has been shown that TRP channels from the melastatin family play an important 
role especially in the resistance and the malignancy of tumors. This work focuses on 
two members of the melastatin family and their role in radioresistance of malignant 
tumors. 
The first part of this work analyzes the interaction between TRPM2 and the anti-
apoptotic protein Bcl-2 in T-cell leukemia. Notably, Bcl-2 has been shown to be 
involved in the therapy resistance of different tumors. To characterize this interaction 
in more detail, Jurkat cells were treated with ionizing radiation. Thereafter, the cell 
cycle as well as TRPM2-mediated Ca2+ signals were analyzed. Especially in Bcl-2 
overexpressing cells, irradiation induced a Ca2+ influx which was decreased after 
pharmacological inhibition of TRPM2. In control cells, this increased Ca2+ influx 
resulted in production of reactive oxygen species (ROS). In contrast, Bcl-2 
overexpressing Jurkat cells were able to tolerate this increased channel activity 
without risking a hazardous ROS production and Ca2+ overload. Further, this 
TRPM2-mediated Ca2+ influx led to a G2/M arrest which was overriden by inhibition of 
TRPM2 resulting in apoptotic cell death. 
The second part of this work addressed the radioresistance of glioblastoma cells. 
Contrary to benign brain tissue the cold receptor TRPM8 of the melastatin family is 
highly expressed in glioma. The retrospective analysis of mRNA data revealed that 
an increased expression of TRPM8 in low grade glioma correlates with poor 
prognosis. In subsequent in vitro experiments these findings could be confirmed. 
TRPM8 knock-down led to a decreased clonogenic survival in human glioblastoma 
cell lines. Moreover, the combination of irradiation and TRPM8 inhibition resulted in 
both, a higher caspase activity and an impaired cell cycle regulation of glioblastoma 
cells. 
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Together, these results suggest an important role of TRPM2 and TRPM8 in the 
radioresistance of leukemia and glioblastoma cells. Therefore, TRPM8 and TRPM2 
might represent promising targets of future anti-cancer therapy. 
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Einleitung 
 
Ionenkanäle in der Krebstherapie  
 
Vieles deutet darauf hin, dass der Transport von Ionen über biologische Membranen 
eine wesentlich größere Rolle in der Medizin spielt als bisher angenommen. So sind 
Ionenkanäle nicht nur, wie in der klassischen Physiologie beschrieben, am 
epithelialen Transport von geladenen Teilchen oder an der Erregung von Muskel- 
und Nervenzellen beteiligt. Vielmehr nehmen sie Einfluss auf nahezu alle 
zellbiologischen Prozesse (Huber et al. 2013). In den letzten zwei Jahrzehnten 
rückten Ionenkanäle zudem immer weiter in den Fokus der Krebsforschung, da sie 
direkt an der neoplastischen Transformation, der malignen Progression, der 
Gewebsinfiltration sowie der Metastasierung beteiligt sind (Huber 2013). Neben den 
Schritten der Karzinogenese stehen Ionenkanäle auch in Zusammenhang mit der 
Resistenzentwicklung von Tumorzellen gegenüber gängigen Therapiemethoden. Die 
Strahlentherapie stellt eine dieser Methoden dar, auf die sich die moderne 
Krebstherapie stützt. Neben dieser Art der Tumorbehandlung zählen auch die 
chirurgische Resektion des Tumors, die Chemotherapie sowie neuerdings die 
Immuntherapie zu den gängigen Behandlungsmethoden. Umso wichtiger ist es 
daher, die Entwicklung von Resistenzen gegen eine oder mehrere dieser 
Therapieformen zu verhindern. Bemerkenswerterweise wurde im Jahr 2010 gezeigt, 
dass Ionenkanäle bei allen sogenannten „Hallmarks of Cancer“ eine bedeutende 
Rolle spielen (Prevarskaya et al. 2010). Insbesondere die veränderte Regulation des 
Ca2+-Signalosoms scheint hier von essentieller Bedeutung zu sein (Stewart et al. 
2014).  
 
 
Tumor-assoziierte Veränderungen des Ca2+-Signalosoms 
 
Um elementare Funktionen in der Zelle korrekt auszuführen, sind präzise zeitlich und 
räumlich koordinierte Ca2+-Signale zwingend notwendig. Neben der Zellteilung, der 
Migration und der Transkription wird unter anderem auch der Zelltod durch Ca2+ 
reguliert (Steinhardt and Alderton 1988; Berridge et al. 2000; Berridge et al. 2003; 
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Taylor et al. 2008). Ca2+ dient in der Zelle als Signalmolekül und hat hier eine 
Vielzahl an potentiellen Bindungspartnern, unter anderem Calmodulin. 
 
Änderungen in der freien intrazellulären Ca2+-Konzentration [Ca2+]i können hierbei 
sehr vielfältig sein. Diese reichen von genau lokalisierten Ca2+-Peaks, die räumlich 
und zeitlich begrenzt sind, bis hin zu einzelnen Ca2+-Wellen oder -Oszillationen 
(Berridge et al. 2003; Parkash and Asotra 2010). Durch die „Dekodierung“ dieser 
komplexen Änderungen ist die Zelle in der Lage, viele verschiedene Ca2+-Signale zu 
interpretieren und spezifische zelluläre Prozesse zu steuern (Berridge et al. 2000; 
Berridge et al. 2003).  
 
Im Ruhezustand herrscht ein Gleichgewicht zwischen [Ca2+]i, die im Bereich von 
etwa 50-100 nM liegt, und der deutlich höheren extrazellulären Ca2+-Konzentration 
[Ca2+]e, welche ungefähr 10.000 mal so hoch ist. Dieser Gradient wird mit Hilfe von 
Ca2+-pumpen, Na+/Ca2+-Antiporteren und speziellen Ca2+-Bindeproteinen 
aufrechterhalten (Berridge et al. 2000; Berridge et al. 2003). 
 
Die Stabilisierung dieses Gleichgewichtes wird auch Ca2+-Homöostase genannt. 
Hierzu bedarf es Prozesse, welche sowohl das Ansteigen der [Ca2+]i verhindern, als 
auch dem zu starken Konzentrationsabfall entgegenwirken (Abb. 1). Die vier 
wichtigsten Transportmechanismen, die einer [Ca2+]i-Erhöhung entgegenwirken sind 
die Plasmamembran-Ca2+-ATPase (PMCA), der Na+/Ca2+-Austauscher (NCX), die 
Ca2+-Pumpe des sarkoplasmatischen und endoplasmatischen Retikulums (SERCA) 
und der mitochondriale Uniporter (Volpe et al. 1990; Blaustein and Lederer 1999; 
Hussain and Inesi 1999). Dem gegenüber steht die Erhöhung der [Ca2+]i durch die 
Freisetzung von Ca2+ aus den internen Speichern und dem Einstrom aus dem 
Extrazellularraum über die Plasmamembran. Verantwortlich hierfür sind 
verschiedene Ionenkanäle, die aufgrund ihrer Aktivierungsmechanismen in 
unterschiedliche Gruppen eingeteilt werden können: Die Liganden-abhängigen Ca2+-
Kanäle wie der Inositol-1,4,5-Trisphosphat (IP3)-Rezeptor bzw. der Ryanodin (RY)-
Rezeptor sorgen für einen schnellen Anstieg der [Ca2+]i-Konzentration über die Ca2+-
Freisetzung aus den internen Speichern. Darüber hinaus gibt es die Ca2+-
permeablen Ionenkanäle in der Plasmamembran, die 
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Abbildung 1 
Schematische Darstellung der Hauptmechanismen zur Aufrechterhaltung des intrazellulären 
Ca2+-Gleichgewichtes. Membranständige Kanäle, zu denen neben den spannungs-, speicher- und 
ligandengesteuerten Kanälen (SOC, VOC, ROC, SMOC) auch die TRP-Kanäle zählen, sind 
maßgeblich an der langsamen Erhöhung des intrazellulären Ca2+ über die Membran beteiligt. Der IP3-
Rezeptor (IP3R), ebenso wie der Ryanoid-Rezeptor (RYR), regulieren die schnelle Freisetzung von 
Ca2+ aus dem Endoplasmatischen Retikulum (ER). Um die Ca2+-Konzentration zu verringern, gibt es 
verschiedene ATPasen die das Ca2+ sowohl in den Extrazellularraum (PMCA) als auch in Organellen 
wie den Golgi (SPCA) oder das ER (SERCA) transportieren. Weitere Mechanismen sind der 
mitochondriale Uniporter, der die Ca2+-Aufnahme in die Mitochondrien gewährleistet, und der 
Na+/Ca2+-Austauscher, welcher im Austausch für ein aus der Zelle transportiertes Ca2+-Ion drei Na+-
Ionen in die Zelle einschleust. 
 
 
unterteilt werden in Speicher-regulierte Ca2+-Kanäle (store-operated-channels, 
SOCs), spannungsgesteuerte Ca2+-Kanäle (voltage-operated-channels, VOCs), 
rezeptorgesteuerte Ca2+-Kanäle (receptor-operated-channels, ROCs) und Kanäle, 
die über intrazelluläre Botenstoffe aktiviert werden (second-messenger-operated-
channels, SMOCs) (Craven and Zagotta 2006; Watanabe et al. 2008). Die Familie 
der TRP-Kanäle zählt zur letzten Gruppe Ca2+-permeabler Kanäle, die anhand ihrer 
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Aktivierung nur schwer einzuteilen sind. TRP-Kanäle stehen auch im Fokus dieser 
Arbeit steht. Diese Kanäle reagieren sensitiv auf Reize wie Temperatur, Osmolarität, 
pH-Wert und andere physiologische Veränderungen der Umgebung (Harteneck et al. 
2000; Nilius and Voets 2004; Tominaga and Caterina 2004; Vennekens et al. 2008; 
Gees et al. 2010; Wu et al. 2010; Vay et al. 2012) 
 
 
TRP-Kanäle 
 
Die Transient Receptor Potential (TRP) Kationenkanal Superfamilie besteht aus 
einer Reihe spannungsabhängiger und Ca2+-permeabler Kanäle, die ein weites 
Spektrum an zellulären Funktionen besitzen. Neben ihrer Aufgabe als 
multifunktionale Sensoren spielen sie auch eine wichtige Rolle bei der 
Zellkontraktilität, der Zellteilung und der Apoptose. Bisher wurden in Säugetieren 28 
verschiedene Kanäle beschrieben, die ubiquitär exprimiert sind und ihrerseits in 
sechs Familien unterteilt werden: TRPC (classic/canonical), TRPV (vanilloid), TRPM 
(melastatin), TRPP (polycystein), TRPML (mucolipin) und TRPA (ankyrin) (Clapham 
et al. 2005; Montell 2005; Nilius and Owsianik 2011). Alle TRP-Kanäle besitzen eine 
ähnliche Grundstruktur, welche mit der von spannungsaktivierten K+-Kanälen 
vergleichbar ist. Sie besteht aus sechs Transmembrandomänen (S1-S6), die um eine 
Porenregion (S5-S6) angeordnet sind. Die Kanäle sind meist als Homo- 
beziehungsweise Heterotetramere angeordnet, wobei sich die C- und N-Termini stets 
intrazellulär befinden (Gaudet 2008; 2009; Wu et al. 2010). Die Länge und Funktion 
der zytoplasmatischen Regionen variiert dabei stark zwischen den einzelnen 
Familien. Während Mitglieder der TRPC und TRPV Familie drei bis vier intrazelluläre 
Ankyrin-Repeat-Domänen besitzen, sind es bei TRPA1 bis zu 14 Repeats am N-
Terminus. In den anderen Familien sind diese Domänen nicht vorhanden. Eine 
Gemeinsamkeit der TRPC-, TRPM- und TRPV-Kanäle ist die sogenannte TRP-
Domäne. Sie ist ein aus 25 Aminosäuren bestehender, konservierter Abschnitt am C-
Terminus, beginnend mit einer TRP-Box, welche unter anderem als Bindestelle für 
das Membran-Phospholipid PI(4,5)P2 dient (Rohacs and Nilius 2007; Nilius and 
Szallasi 2014). Weitere Interaktionsstellen konnten auch in anderen TRP-Kanälen 
funktionell nachgewiesen werden. So wurden bisher mehrere 
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Phosphorylierungsstellen für die Proteinkinasen A und C identifiziert, ebenso wie 
eine SH2-Erkennungssequenz der PI3-Kinase (Watanabe et al. 2008). 
 
An der Regulierung der intrazellulären Ca2+-Konzentration sind alle TRP-Kanäle auf 
unterschiedliche Arten beteiligt. Sie können direkt als Ca2+-Kanäle in der 
Plasmamembran und den Organellen fungieren oder indirekt die Membranspannung 
verändern, so dass die Aktivität anderer Kanäle beziehungsweise das 
elektrochemische Gefälle für Ca2+ moduliert wird. Bis auf TRPM4 und TRPM5, die 
nur für monovalente Kationen durchlässig sind, besitzen alle anderen TRP Kanäle 
eine Ca2+-Permeabilität. Sie unterscheiden sich lediglich in ihrer Permselektivitäts-
Rangfolge für bestimmte Kationen. So sind TRPV5 und TRPV6 hochpermeabel für 
Ca2+, TRPM6 und TRPM7 hochpermeabel für Mg2+ und TRPV1 sowie TRPML1 und 
TRPP3 hochpermeabel für H+-Ionen (Nilius et al. 2007). 
 
 
TRPM-Familie 
 
Die Melastatin Familie der TRP-Kanäle umfasst acht Mitglieder, die aufgrund von 
Sequenzhomologien in vier Untergruppen eingeteilt werden. TRPM1/3, TRPM4/5, 
TRPM6/7 und TRPM2/8, wobei Letztere nur eine geringe Ähnlichkeit in ihren 
Sequenzen aufweisen (Harteneck 2005). Benannt ist die Familie nach dem ersten 
beschriebenen Mitglied TRPM1, welches als Tumorsupressor (Melastatin) im 
Zusammenhang mit metastasierenden Melanomen identifiziert wurde (Duncan et al. 
1998; Hunter et al. 1998). Drei Mitglieder dieser Familie sind Träger eines 
funktionellen Enzyms an ihrer Carboxyl-Gruppe: TRPM2 besitzt eine NUDT9-
Homologie-Region mit Adenosindiphosphat-Ribose(ADPR)-Pyrophosphatase-
Aktivität und TRPM6 sowie TRPM7 eine funktionelle Serin/Threonin-Kinase (Clark et 
al. 2008). Alle Mitglieder der TRPM-Familie werden mit unterschiedlichen 
Erkrankungen, wie zum Beispiel Amyotrophe Lateralsklerose, in Verbindung 
gebracht. Dies wurde entweder in funktionellen Studien in der Maus oder durch 
humangenetische Analysen gezeigt (Hara et al. 2002; Clapham 2003; Naziroglu et 
al. 2007; Nilius et al. 2007; Naziroglu and Luckhoff 2008). 
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Die Mitglieder TRPM2 und TRPM8 der Melastatin Familie 
 
In dieser Dissertation liegt der Fokus auf den Mitgliedern TRPM2 und TRPM8 aus 
der Melastatin Familie. TRPM2, ehemals bekannt als TRPC2 und LTRPC2 wurde 
erstmals 1998 beschrieben (Nagamine et al. 1998) und später in die Familie der 
TRPM-Kanäle eingeordnet. Die Aktivierung von TRPM2 erfolgt unter anderem durch 
reaktive Sauerstoffspezies (ROS). Zu diesen zählen die Superoxidanionen (O2●-), 
Wasserstoffperoxid (H2O2) und andere Sauerstoffradikale, welche als intrazelluläre 
Messenger in Prozessen wie der mitogenen Signalweiterleitung, Genexpression und 
Regulierung der Zellteilung fungieren (Naziroglu 2007). Eine verstärkte Produktion 
von ROS, beziehungsweise die Inhibition des enzymatischen und nicht-
enzymatischen Abbaus dergleichen, kann zu einer Schädigung der Zellen bis hin 
zum Zelltod führen (Halliwell 2006). Oxidativer Stress - im Experiment mit H2O2 
simuliert - induziert TRPM2-Ströme und erhöht so [Ca2+]i in mit TRPM2 transfizierten 
Zellen (Naziroglu and Luckhoff 2008), β-Zellen (Inamura et al. 2003), neutrophilen 
Granulozyten (Heiner et al. 2003) und U937 Monozyten (Perraud et al. 2001). 
Erhöhtes [Ca2+]i wiederum steigert die Anfälligkeit für den programmierten Zelltod, so 
dass von einer proapoptotischen Funktion der TRPM2-Kanäle auszugehen ist. 
 
TRPM8 ist ein Ca2+-permeabler Kationenkanal der Melastatin Familie, der durch 
Membrandepolarisation, Kälte und kältesimulierende Stoffe wie Menthol oder Icilin 
aktiviert und unter anderem durch die Ca2+-unabhängige Phospholipase A2 (iPLA2) 
reguliert wird. Die Endprodukte der enzymatischen Spaltung von Membranlipiden, 
sogenannte Lysophospholipide (Lysophosphatidylcholin, Lysophosphatidylinositol 
und Lysophosphatidylserin), stabilisieren die Offen-Konformation von TRPM8 
(Vanden Abeele et al. 2006). Diese erhöhte Offenwahrscheinlichkeit wird dadurch 
erreicht, dass die Temperaturschwelle zur Aktivierung von TRPM8 dahingehend 
erhöht wird, dass der Kanal bereits bei regulärer Körpertemperatur aktiv ist. Die 
Modulation durch Lysophospholipide liefert somit einen physiologischen 
Mechanismus, den Kanal bei normaler Körpertemperatur zu aktivieren (Andersson et 
al. 2007). Mehrfach ungesättigte Fettsäuren, wie zum Beispiel die Arachidonsäure, 
sind in der Lage, TRPM8 in Gegenwart von Kälte, Menthol oder Icilin zu hemmen 
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(Bavencoffe et al. 2011). Neben ungesättigten Fettsäuren kann die Aktivität von 
TRPM8 durch eine Proteinkinase A-abhängige Phosphorylierung von Serin-9 und 
Threonin-17 inhibiert werden (Bavencoffe et al. 2010). Zusätzlich wurde beschrieben, 
dass zwei Spleißvarianten von TRPM8 (short TRPM8 α und short TRPM8 β) die 
geschlossene Konformation von TRPM8 stabilisieren und dadurch die 
Kältesensibilität sowie die Aktivität vermindern (Bidaux et al. 2012). 
 
 
TRPM2 in Leukämie 
 
TRPM2 wird, wie oben bereits beschrieben, durch den kanalvermittelten Ca2+-
Einstrom und die daraus resultierende Erhöhung von [Ca2+]i in Verbindung mit dem 
programmierten Zelltod gebracht und wird deshalb auch als „Todeskanal“ 
bezeichnet. Dies wurde durch heterologe Expressionsstudien von TRPM2 in 
humanen embryonalen Nierenzellen und A172 Glioblastomzellen bestätigt, die zu 
einem durch oxidativen Stress verursachten Zelltod führten (Fonfria et al. 2004; Ishii 
et al. 2007). TRPM2 wird in mehreren Tumorentitäten, unter anderem in Leukämie, 
exprimiert und ist dabei ebenfalls nachweislich am Zelltod beteiligt (Inamura et al. 
2003; Zhang et al. 2003; Zhang et al. 2006; Orfanelli et al. 2008; Zeng et al. 2010; 
Adachi et al. 2014). Die ROS-induzierte Aktivierung von TRPM2 verläuft dabei 
möglicherweise indirekt über ADPR (Perraud et al. 2005). 
 
DNA-Schäden, speziell DNA-Doppelstrangbrüche, können auf vielerlei Arten, 
beispielsweise durch Bestrahlung, entstehen. Die meiste Energie ionisierender 
Strahlung wird hierbei durch das intrazelluläre Wasser absorbiert und resultiert in der 
Bildung von Hydroxyl-Radikalen (OH●) (Huber et al. 2013). Im Zuge der DNA-
Schädigung werden durch Poly-ADP-Ribose-Polymerasen (PARPs) vermehrt ADPR-
Polymere gebildet, welche bei der DNA-Reparatur durch Glycohydrolasen wieder in 
ADPR-Monomere gespalten werden (Fonfria et al. 2004; Eisfeld and Luckhoff 2007). 
Die Folge ist eine Freisetzung von ADPR, was zu einer Aktivierung von TRPM2 und 
einer [Ca2+]i Veränderung  führt. Diese Veränderung in der Ca2+-Konzentration 
wiederum steht unter der Kontrolle von Bcl-2. Das anti-apoptotische Protein Bcl-2 ist 
ein wichtiger Regulator in der Ca2+-Homöostase, da es unter anderem ein 
unkontrolliertes Fluten der Zelle mit Ca2+ verhindert (Rudner et al. 2002; Oakes et al. 
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2003; Pinton and Rizzuto 2006; Monaco et al. 2013). Eine weitere wichtige Quelle für 
ADPR-Monomere stellen die Mitochondrien dar (Dolle et al. 2013). 
 
TRPM8 im Glioblastom 
 
Neben der Expression von TRPM8 in sensorischen Neuronen, wo der Kanal an der 
Perzeption von Kälte und Schmerz beteiligt ist, wird TRPM8 normalerweise nur in 
Prostatagewebe, der Lunge und in der Blase exprimiert. In vielen malignen 
Tumorentitäten konnte jedoch gezeigt werden, dass TRPM8 stark überexprimiert 
wird. Beispiele hierfür sind: Prostatakarzinom (Tsavaler et al. 2001; Zhang and Barritt 
2004; Bidaux et al. 2007), Bauchspeicheldrüsenkrebs (Yee et al. 2010; Yee et al. 
2012), Brustkrebs (Chodon et al. 2010; Dhennin-Duthille et al. 2011), Blasenkrebs (Li 
et al. 2009), Glioblastom (Wondergem et al. 2008), Krebs der Mundhöhle (Okamoto 
et al. 2012), neuroendokrinen Tumoren (Mergler et al. 2007) und Melanomen 
(Yamamura et al. 2008).  
 
Während die funktionelle Aufgabe von TRPM8 in sensorischen Neuronen bereits 
identifiziert wurde (Bautista et al. 2007), ist dies in Krebszellen bislang noch nicht 
vollständig geklärt (Zhang and Barritt 2004). Im Glioblastom konnte gezeigt werden, 
dass die Überexpression von TRPM8 an der Invasion und Metastasierung im Gehirn 
beteiligt ist (Wondergem et al. 2008; Alptekin et al. 2015). Dies kann möglicherweise 
mit der Regulation des BK (big conductance) K+-Kanals durch Ca2+ erklärt werden. 
Spezielle Spleißvarianten des BK K+-Kanals sind ebenfalls im Glioblastom 
überexprimiert und besonders Ca2+-sensitiv (Ransom and Sontheimer 2001; Liu et 
al. 2002; Ransom et al. 2002). Da der BK Kanal nachweislich an der Migration von 
Glioblastomzellen und somit an der schlechten Prognose für diesen Tumor beteiligt 
zu sein scheint, ist es von essentieller Bedeutung, den zugrundeliegenden 
Regulierungsmechanismus über TRPM8 näher zu untersuchen (Wondergem and 
Bartley 2009; Steinle et al. 2011). 
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Zielsetzung 
 
Diese Arbeit soll eine mögliche Funktion zweier Mitglieder - TRPM2 und TRPM8 - 
der Melastatin-TRP-Kanalfamilie bei der Radioresistenz von Tumoren identifizieren. 
Dazu wurden die beiden Tumorentitäten T-Zell-Lymphom und Glioblastom 
ausgewählt, die TRPM2 bzw. TRPM8 sehr stark exprimieren und eine besonders 
maligne Form von Tumoren darstellen. Mit Hilfe verschiedenster zellphysiologischer 
und molekularbiologischer Methoden wurden die Zellen untersucht und der Einfluss 
von Bestrahlung  sowie unterschiedlicher pharmakologischer Agonisten und 
Antagonisten in in vitro Experimenten bestimmt. Insbesondere wurde der Effekt von 
Inhibition und knock-down von TRPM2 auf die Membranströme, das Ca2+-Signaling, 
die mitochondriale Superoxid-Produktion sowie auf den Zellzyklus untersucht und die 
Ergebnisse von bestrahlten und unbestrahlten T-Zell-Leukämiezellen verglichen. In 
den untersuchten Glioblastomzelllinien wurde besonderes Augenmerk auf die 
Kanalaktivität von TRPM8, das daraus resultierende Ca2+-Signaling, die Zellmigration 
und das klonogenem Überleben gelegt. Zusammen sollen diese Daten für ein 
besseres Verständnis der durch Ca2+-Signale induzierten Resistenz gegenüber 
Bestrahlung sorgen und mögliche Strategien für zukünftige Krebstherapien eröffnen. 
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Ergebnisse TRPM2  
 
Die Inhibition von TRPM2 stört den strahlungsinduzierten Zellzyklus Arrest und 
erhöht die Apoptoserate von T-Zell-Leukämie in Abhängigkeit von Bcl-2  
 
Um die Kanalaktivität unter Einfluss von ionisierender Strahlung zu ermitteln, wurden 
Jurkat Zellen (T-Zell-Leukämie) mit einer Dosis von 10 Gy bestrahlt und 
anschließend die Whole-Cell-Ströme mit Hilfe der Patch-Clamp-Methode gemessen. 
Es konnte gezeigt werden, dass die strahlungsinduzierte Erhöhung der Whole-Cell-
Ströme 2-6 h nach Applikation am stärksten ausgeprägt war und anschließend 
abflachte (Klumpp et al., 2016a; Abb. 1A-B). Des Weiteren wurde durch das 
Austauschen von Na+ in der Badlösung durch Ca2+ beziehungsweise NMDG+ sowohl 
eine Kationenselektivität als auch die Ca2+-Permeabilität der strahlungsinduzierten 
Ströme nachgewiesen (Klumpp et al., 2016a; Abb. 1C-E).  
Anschließend wurde die aus der Literatur beschriebene Korrelation zwischen der 
Bcl-2 und TRPM2-Expression mittels Immunoblotting analysiert. Im Gegensatz zu 
den mRNA Daten der Broad-Novartis Cancer Cell Line Encyclopedia (CCLE) 
(Klumpp et al., 2016a; Abb. 2A), konnte die Korrelation im Jurkat Zellmodell nicht 
bestätigt werden. Die TRPM2-Proteinmenge war in den Bcl-2 überexprimierenden 
Zellen sogar etwas geringer als in den Kontrollzellen (Klumpp et al., 2016a; Abb. 2B). 
Die Bestrahlung der Zellen nahm dabei auf die Menge des Proteins keinen Einfluss 
(Klumpp et al., 2016a; Abb. 2B). 
Um nun die funktionelle Expression von TRPM2 im Jurkat-Zellmodell nachzuweisen, 
wurden ungepaarte Patch-Clamp-Versuche, jeweils in An- und Abwesenheit des 
spezifischen TRPM2-Agonisten ADP-Ribose in der Pipette, durchgeführt. 
Intrazelluläre ADP-Ribose stimulierte in den Experimenten eine Stromfraktion, 
welche durch den unspezifischen TRPM2-Inhibitor ACA (N-(p-
amylcinnamoyl)anthranilic) (Kraft et al. 2006) gehemmt werden konnte (Klumpp et 
al., 2016a; Abb. 2C-D). Die einzigartige Charakteristik der analysierten Ströme 
bestätigte die Annahme, dass es sich bei dem in den Versuchen gemessenen Kanal 
tatsächlich um TRPM2 handelt und dieser in Jurkat Zellen funktionell exprimiert wird 
(Klumpp et al., 2016a; Abb. 2E). 
Im darauf folgenden Experiment wurde der Zusammenhang zwischen TRPM2 und 
der mitochondrialen Superoxid-Produktion untersucht. Hierzu wurden Empty Vector 
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und Bcl-2 überexprimierende Jurkat Zellen bestrahlt (0 bzw. 10 Gy), für 6 h kultiviert 
und im Anschluss 10 min mit dem Superoxid-sensitiven Fluoreszenzfarbstoff 
MitoSOX behandelt. Zusätzlich wurden die Zellen während der Färbung in An- und 
Abwesenheit des TRPM2-Inhibitors ACA inkubiert. Wie in Abb. 3 A-B (Klumpp et al., 
2016a) zu sehen ist, ergab die Auswertung drei unterschiedliche Populationen: 
jeweils eine Population mit einer niedrigen, eine mit einer mittleren und eine mit einer 
hohen MitoSOX Fluoreszenz. Hierbei wiesen die beiden letzteren eine deutlich 
geringere Zellgröße verglichen mit jenen, die eine niedrigere Fluoreszenz zeigten, 
auf. Dies könnte auf eine durch die Superoxid-Produktion verursachte 
Zellschrumpfung zurückzuführen sein. Parallel durchgeführte Experimente, bei 
welchen das Potential der inneren Mitochondrienmembran (ΔΨm) mit einem 
spezifischen Farbstoff (Tetramethylrhodamin Etylester - TMRE) bestimmt wurde, 
konnten zeigen, dass bei den meisten geschrumpften Zellen ΔΨm bereits 
zusammengebrochen war. Daraus lässt sich folgern, dass bei einem Großteil der 
Zellen mit einer mittleren und einer hohen MitoSOX Fluoreszenz die Apoptose 
bereits eingeleitet wurde.  Zellen mit einer geringen Fluoreszenz stellten den größten 
Anteil der gemessenen Population dar. Hier zeigten die Bcl-2 überexprimierenden 
Jurkat Zellen eine signifikant niedrigere Superoxid-Produktion, verglichen mit den 
Jurkat vector Zellen (Klumpp et al., 2016a; Abb. 3 C-D, links). Die Bestrahlung führte 
bei den gering-fluoreszierenden Populationen nur in den Jurkat Bcl-2 Zellen zu einer 
Erhöhung der Superoxid-Formation, wobei diese weiterhin unter dem Level der 
Jurkat vector Zellen lag (Klumpp et al., 2016a; Abb. 3 C). Wie die Behandlung mit 
ionisierenden Strahlen hat auch der TRPM2-Inhibitor ACA einen, wenn auch nur 
geringen, hemmenden Effekt einzig auf die Jurkat Bcl-2 Zellen. Diese Reduktion der 
Superoxid-Produktion ist sowohl bei den bestrahlten als auch bei den unbestrahlten 
Zellen signifikant (Daten nicht gezeigt). Auf die Populationen mit einer mittleren und 
hohen MitoSOX Fluoreszenz hat Bestrahlung keinerlei Einfluss (Klumpp et al., 
2016a; Abb. 3 A). Während der Effekt von ACA in den gering-fluoreszierenden 
Populationen schwach ausfiel, verschwand unter ACA-Behandlung jener Teil der 
Zellen mit einer hohen Superoxid-Produktion komplett, sowohl bei den bestrahlten 
als auch bei den unbestrahlten Jurkat vector und Jurkat Bcl-2 Zellen (Klumpp et al., 
2016a; Abb. 3 E). 
Zusammenfassend lässt sich sagen, dass Bcl-2 überexprimierende Jurkat Zellen 
eine deutlich niedrigere mitochondriale Superoxid-Produktion aufwiesen als die 
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vector Zellen und auch nur in den Jurkat Bcl-2 Zellen eine Steigerung der Produktion 
nach Bestrahlung detektierbar war. Im Gegenzug hat ACA einen inhibitorischen 
Effekt auf die Superoxid-Formation, unabhängig vom Zelltyp oder der Behandlung. 
All dies lässt auf ein Zusammenspiel von einem TRPM2-vermittelten Ca2+-Einstrom 
und der Bildung reaktiver Sauerstoffspezies schließen. 
Um festzustellen, inwieweit Bestrahlung die Kanalaktivität von TRPM2 modifiziert, 
wurden beide Jurkat Zelltypen bestrahlt (0 und 5 Gy) und Whole-Cell-Messungen, in 
An- und Abwesenheit des TRPM2-Inhibitors, durchgeführt (Klumpp et al., 2016a; 
Abb. 4 A-C). Die ACA-sensitive Stromfraktion der unbestrahlten Gruppe zeigte sich 
in den Jurkat vector Zellen deutlich größer als in den Bcl-2 überexprimierenden 
Zellen (Klumpp et al., 2016a; Abb. 4 C). Dies lässt sich auch mit der 
unterschiedlichen TRPM2-Proteinkonzentration erklären und spiegelt die 
gewonnenen Erkenntnisse der Superoxid-Formation wider. Die strahlungsinduzierte 
Erhöhung der ACA-sensitiven Ströme trat dagegen in den Jurkat Bcl-2 Zellen 
deutlich ausgeprägter auf als in den Jurkat vector Zellen, was sich ebenfalls mit der 
Strahlensensibilität der Jurkat Bcl-2 Zellen, gemessen an der ROS-Produktion, deckt.  
Ob eine durch Bestrahlung induzierte Steigerung der TRPM2-Aktivität einen Einfluss 
auf den Ca2+-Einstrom hat, wurde mittels Fura-2 Ca2+-Messungen in An- und 
Abwesenheit von ACA mit einem definierten Ca2+-Depletion/-Repletion Protokoll 
bestimmt. Im Gegensatz zu den basalen ACA-sensitiven Whole-Cell-Strömen 
(Klumpp et al., 2016a; Abb. 4 B) war der basale ACA-sensitive Ca2+-Einstrom in Bcl-
2 überexprimierenden Zellen höher als in den Jurkat vector Zellen (Klumpp et al., 
2016a; Abb. 4 E). Ebenso wie bei den Whole-Cell-Strömen stimulierte eine 
Bestrahlung bei den Jurkat Bcl-2 Zellen einen größeren Ca2+-Einstrom als bei den 
Kontrollzellen (Klumpp et al., 2016a; Abb. 4 E). In Anwesenheit von ACA in der 
Badlösung, konnte kein Unterschied im Ca2+-Anstieg zwischen bestrahlten vector 
und Bcl-2 Jurkat Zellen festgestellt werden (Klumpp et al., 2016a; Abb. 4 E). 
Zusammenfassend lässt sich sagen, dass die Bestrahlung einen durch Bcl-2 
regulierten und möglicherweise TRPM2-vermittelten Anstieg der Ca2+-Konzentration 
in Jurkat Zellen induziert.  
Ein stetiger Anstieg der intrazellulären Ca2+-Konzentration kann jedoch neben den 
überlebensnotwendigen Signalen durchaus auch negative Konsequenzen für die 
Zelle haben. So kann es passieren, dass sie bei einem stetigen Einstrom mit Ca2+ 
überflutet wird, was letztendlich zum Tod der Zelle führt. Tatsächlich konnte in dieser 
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Arbeit gezeigt werden, dass 24 h nach Bestrahlung (10 Gy) der Anteil der Jurkat 
Zellen mit einer stark erhöhten [Ca2+]i auf ca. 25% anstieg (Klumpp et al., 2016a; 
Abb. 5 A-B).  
 
Die Bestrahlung mit 5 Gy stimulierte die Autophosphorylierung und damit die 
Aktivierung von Isoformen der Ca2+/Calmodulin-abhängigen Proteinkinase II (CaMK 
II) sowie die Phosphoylierungs-abhängige Inaktivierung des CaMKII Zielproteins 
cdc25b (Klumpp et al., 2016a; Abb. 5 C). Die strahlungsinduzierte Inaktivierung der 
Phosphatase cdc25b verhindert die Dephosphorylierung und somit die Aktivierung 
des mitose-promoting-factors cdc-2, was wiederum zu einer Blockade des Zellzyklus 
führt (Klumpp et al., 2016a; Abb. 5 C). Aus diesen Erkenntnissen lässt sich ein 
Zusammenhang zwischen Ca2+-Effektorproteinen wie CaMKII und dem Auftreten 
eines G2/M-Arrestes 24 h nach Bestrahlung folgern (Klumpp et al., 2016a; Abb. 5 D).  
Um eine Beteiligung von TRPM2 und CaMKII an der Stressantwort nach Bestrahlung 
zu belegen, wurden Jurkat Zellen (Bcl-2 und vector) bestrahlt (0 und 5 Gy) und 
anschließend in An- und Abwesenheit  der TRPM2-Inhibitoren ACA und Clotrimazol 
inkubiert (Hill et al. 2004; Chung et al. 2011). Im Anschluss wurde die Kinaseaktivität 
von CaMKII und cdc-2 mit Hilfe von Immunoblots bestimmt sowie Zellzyklus- und 
Zelltodrate mittels Durchflusszytometrie analysiert. Die Messwerte wurden jeweils 4 h 
beziehungsweise 24 h nach Bestrahlung erstellt. Die Auswertung ergab eine 
verringerte basale und strahlungsinduzierte Menge an phosphoryliertem CaMKII in 
den ACA behandelten (Klumpp et al., 2016a; Abb. 6A). Weiterhin verhinderte ACA 
die strahlungsinduzierte Inaktivierung von cdc-2 in beiden untersuchten Zelltypen 
(Klumpp et al., 2016a; Abb. 6A). Daraus lässt sich folgern, dass der ACA-sensitive 
Ca2+-Anstieg essentiell für den Zellzyklus Arrest in der G2/M-Phase ist (Klumpp et al., 
2016a; Abb. 6B-E). Die Zellzahl in G2/M verringerte sich unter der Behandlung mit 
ACA und Clotrimazol, während die Anzahl der toten Zellen anstieg (Klumpp et al., 
2016a; Abb. 6B-E). Dieser ACA- und Clotrimazol-vermittelte Zelltod war in 
bestrahlten Jurkat vector Zellen wesentlich stärker ausgeprägt als in Bcl-2 
überexprimierenden Zellen (Klumpp et al., 2016a; Abb. 6B-E). Die Beteiligung von 
TRPM2 in diesem Zusammenhang wurde anhand eines TRPM2 knock-downs näher 
untersucht. Das reduzierte TRPM2-Proteinlevel, nach erfolgter Transfektion mit der 
TRPM2 siRNA, wurde hierbei im Immunoblot erfolgreich nachgewiesen. (Klumpp et 
al., 2016a; Abb. 6F). Daraufhin wurden die transfizierten Jurkat Zellen bestrahlt (0 
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und 5 Gy) und der Zellzyklus 24 h später analysiert. Der beobachtete Effekt war, 
ähnlich dem von ACA und Clotrimazol, eine verringerte G2-Population und ein 
Anstieg der Zahl toter Zellen (Klumpp et al., 2016a; Abb. 6F). 
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Diskussion TRPM2 
 
Der Kationenkanal TRPM2 spielt bei der Resistenzentwicklung von Krebszellen 
gegenüber einer Bestrahlung eine bedeutende Rolle. Vor allem, wie in dieser Arbeit 
gezeigt, im Zusammenspiel mit dem anti-apoptotischen Protein Bcl-2 führt TRPM2 
durch Veränderungen des Ca2+-Signalosoms zu strahlungsresistenteren T-Zell-
Leukämiezellen, wodurch eine effektive Behandlung erheblich erschwert wird. 
 
Aktivierung von TRPM2. Eine Art der Aktivierung von TRPM2 erfolgt durch ADP-
Ribose. Hierbei handelt es sich um ein kleines Molekül, welches u.a. in den 
Mitochondrien produziert wird. Es kann als Zwischenprodukt der NAD-abhängigen 
Deacetylierung, aus Mono- und Poly-ADP-ribosylierten Proteinen oder aus NAD+ 
freigesetzt werden (Dolle et al. 2013). In früheren Studien konnte bereits gezeigt 
werden, dass oxidativer sowie nitrosativer Stress die Freisetzung von ADP-Ribose 
aus den Mitochondrien begünstigt, wodurch die Kanalaktivität von TRPM2 zunimmt, 
der Ca2+-Einstrom über die Membran ansteigt, was schlussendlich zu einer 
Depolarisierung der Plasmamembran führt (Perraud et al. 2005). Eine übermäßige 
Aktivität von TRPM2 steht allerdings im Verdacht, Signale zu erzeugen und zu 
verstärken, welche zum Zelltod führen können. Eine erhöhte [Ca2+]i führt dabei zu 
einer Entkoppelung der Atmungskette, was eine Hyperpolarisierung von ΔΨm und 
somit die Freisetzung von Superoxidanionen bedingt. Anschließend kommt es zu 
einem mitochondrialen Ca2+-Überschuss und zum Zusammenbruch des ΔΨm 
(Review siehe (Huber et al. 2013)). 
 
Interaktion von TRPM2 und Bcl-2. In dieser Arbeit konnte gezeigt werden, dass 
bestrahlte T-Zell-Leukämiezellen den Kanal TRPM2 verwenden, um wichtige Ca2+-
Signale für das Überleben zu generieren. Der Vergleich von Jurkat vector und Jurkat 
Bcl-2 Zellen ließ erkennen, dass die strahlungsinduzierten Membranströme und der 
Ca2+-Einstrom bei den Bcl-2 überexprimierenden Jurkat Zellen höher war als in den 
vector Kontrollzellen. Dies lässt den Schluss zu, dass es eine Verbindung zwischen 
Bcl-2 im ER sowie in der äußeren Mitochondrienmembran und TRPM2 in der 
Plasmamembran gibt. Die positive Korrelation zwischen den mRNA Level von Bcl-2 
und TRPM2 in verschiedenen Lymphohematopoetischen Krebszelllinien stützt diese 
Vermutung (Klumpp et al., 2016a; Abb. 2A). In einigen Zellmodellen konnte zudem 
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beobachtet werden, dass Zellen, die durch die Überexpression von Bcl-2 einem 
erhöhten Austritt von Ca2+ aus den intrazellulären Speichern ausgesetzt waren, 
diesem entgegenwirkten, indem sie den Ca2+-Einstrom über die Plasmamembran 
aktiv herunterregulierten (Review siehe (Dolle et al. 2013)). Dies kann auch eine 
mögliche Erklärung für die, im Vergleich zu den vector Zellen, unter basalen 
Bedingungen beobachtete geringere Protein-Abundanz von TRPM2 in Bcl-2 
überexprimierenden Jurkat Zellen sein (Klumpp et al., 2016a; Abb. 2B). Ein basaler, 
ACA-sensitiver Ca2+-Einstrom konnte in den hier gezeigten Experimenten nur in Bcl-
2 überexprimierenden Jurkat Zellen beobachtet werden. Dies liegt möglicherweise an 
einer Inaktivität von TRPM2, wie sie bei Kontrollzellen vorkommt, welche sich im 
Ruhezustand befinden (Klumpp et al., 2016a; Abb. 4E). Verglichen mit den Jurkat 
vector Zellen ist der in Bcl-2 überexprimierenden Zellen andauernde, erhöhte Ca2+-
Einstrom mit einer Verschiebung des [Ca2+]i-Setpoints hin zu einem höheren 
Normalwert zu erklären (Klumpp et al., 2016a; Abb. 4D-E). Fura-2 und fluo-3 Ca2+-
Messungen bestätigen die erhöhte [Ca2+]i sowohl in konstitutiv als auch in 
induzierbaren Bcl-2 überexprimierenden Jurkat Zellen (Klumpp et al., 2016a; Suppl. 
Abb. A). Es ist bekannt, dass eine erhöhte [Ca2+]i nachweislich die ADP-Ribose-
vermittelte Aktivität von TRPM2 steigert (McHugh et al. 2003). Aus diesem Grund 
können die, nur in Jurkat Bcl-2 Zellen beobachteten basalen, ACA-sensitiven Ströme 
auf dieses erhöhte basale Ca2+-Level zurückzuführen sein.  
 
Bcl-2 und ROS. Bemerkenswerterweise fällt die mitochondriale ROS Produktion trotz 
des erhöhten [Ca2+]i in Jurkat Bcl-2 Zellen, verglichen mit den Jurkat vector Zellen 
geringer aus (Klumpp et al., 2016a; Abb. 3C). Erklären lässt sich dies durch eine Bcl-
2-vermittelte Hemmung der mitochondrialen Superoxid-Produktion. So stimuliert Bax, 
ein pro-apoptotisches Mitglied der Bcl-2 Familie und Antagonist des anti-
apoptotischen Proteins Bcl-2 in neuronalen Zellen, die Produktion von ROS und 
bewirkt somit den gegenteiligen Effekt (Kirkland et al. 2010). 
 
Strahlungsinduzierte Kanalaktivierung. Ein verändertes Ca2+-Signalosom in 
unterschiedlichen Tumorentitäten ist das Ergebnis vieler Studien. Beispielsweise 
geht die maligne Progression in Prostatatumoren mit einer TRPM8-vermittelten 
Speicherentleerung und der Herunterregulierung des Speicher-abhängigen Ca2+-
Einstromes einher. Im Gegenzug werden andere TRP-Kanäle wie zum Beispiel 
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TRPV6 hochreguliert und in die Plasmamembran rekrutiert. Zusammen mit IK 
(intermediate conductance) K+-Kanälen generieren sie Wachstumsfaktor-
unabhängige Ca2+-Signale, die das Überleben fortgeschrittener Prostatatumoren 
sichern (Review siehe (Huber 2013)). In dieser Arbeit konnte eindeutig belegt 
werden, dass Bestrahlung einen aktivierenden Effekt auf TRPM2 hat. So stimulierte 
Bestrahlung ACA-sensitive Ströme in Patch-Clamp-Messungen und führte zu einer 
Erhöhung des ACA-sensitiven Ca2+-Einstroms in den untersuchten Jurkat Zellen. 
Eine strahlungsinduzierte Modifikation der Ionenkanal-Aktivität konnte bereits in 
Studien zu verschiedenen Tumoren belegt werden. Diese Modifikationen werden in 
Verbindung mit Stress-Antwort (Steinle et al. 2011), dem Glucosegehalt (Huber et al. 
2012; Dittmann et al. 2013), der Zellzykluskontrolle (Heise et al. 2010; Palme et al. 
2013) oder Radioresistenz (Stegen et al. 2015) gebracht. 
 
TRPM2 als Radioresistenzfaktor. Die p53-mutierten Jurkat Zellen (Cheng and Haas 
1990) akkumulierten aufgrund von strahlungsinduzierten DNA-Schäden in einem 
G2/M-Phase Arrest (Klumpp et al., 2016a; Abb. 5D), welcher mit großer 
Wahrscheinlichkeit durch den strahlungsinduzierten erhöhten Ca2+-Einstrom mit-
hervorgerufen wurde. Diese Annahme wird dadurch bestätigt, dass zwei 
unspezifische TRPM2-Inhibitoren sowie der knock-down von TRPM2 mittels siRNA 
die Zahl der arretierten Zellen in der G2-Phase verringerte und die der toter Zellen 
erhöhte (Klumpp et al., 2016a; Abb. 6). Möglicherweise wird durch die 
pharmakologische Inhibition sowie durch den TRPM2 knock-down der G2-
Kontrollpunkt des Zellzyklus übergangen, so dass die Zellen mit DNA-Schäden in die 
Mitose eingeschleust werden, was zu der sogenannten mitotic catastrophe und 
schlussendlich zum Zelltod führt. Bestätigt wird dies durch die Beobachtung, dass 
Bestrahlung die [Ca2+]i-abhängige Phosphorylierung von CaMKII und derer 
Zielproteine cdc25b und cdc-2 in einer ACA-sensitiven Weise förderte (Klumpp et al., 
2016a; Abb. 5C und 6A). Durch die Phosphorylierungs-abhängige Inaktivierung der 
Phosphatase cdc25b akkumuliert die ebenfalls durch Phosphorylierung inaktiv-
gehaltene Form von cdc-2, welche Teil des MPF (mitosis promoting factor) ist (Palme 
et al. 2013). Zusammenfassend lässt sich sagen, dass durch Steigerung der Aktivität 
von TRPM2 Ca2+-Signale generiert werden, die in der Lage sind, eine 
Autophosphorylierung und somit eine Aktivierung von CaMKII zu induzieren. 
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Interaktionen von TRPM2 und K+-Kanälen. Wie auch in den hier untersuchten T-Zell-
Leukämiezellen konnte in einer früheren Arbeit mit myeloischen Leukämiezellen 
belegt werden, dass durch ein Zusammenspiel von TRP- und K+-Kanälen in der 
Membran Ca2+-Signale erzeugt werden, welche in einem G2/M-Arrest gipfeln, ähnlich 
dem in dieser Arbeit untersuchten Mechanismus über CaMKII, cdc25b und cdc-2 
(Heise et al. 2010; Palme et al. 2013). Befinden sich aktive K+-Kanäle in direkter 
Nachbarschaft zu Ca2+-Kanälen führt dies durch den zellulären Ausstrom von K+-
Ionen zu einem stark einwärtsgerichteten elektrochemischen Gradienten für Ca2+, 
was für stabile Ca2+-Signale unverzichtbar ist. Ebenso wie bei K562 Leukämiezellen 
stimuliert Bestrahlung die Aktivität von IK K+-Kanälen in der Plasmamembran von 
Jurkat Zellen (Klumpp et al., 2016a; Suppl. Abb. B). Diese gewonnenen Erkenntnisse 
lassen zwei verschiedene Schlüsse zu: Zum einen ähneln sich die 
strahlungsinduzierten Signalwege in myeloischer und lymphatischer Leukämie und 
zum Anderen können die während der DNA-Reparatur generierten Ca2+-Signale 
durch verschiedene Kombinationen aus sich in der Plasmamembran befindlichen 
TRP- und K+-Kanälen erzeugt werden.  
 
Zusammenfassung. Im Ca2+-Signalosom humaner T-Zell-Leukämiezellen spielt 
TRPM2 eine bedeutende Rolle. Er wird während der DNA-Schadensantwort aktiviert 
und reguliert in bestrahlten Jurkat Zellen den G2/M-Arrest. Durch die Aktivierung der 
CaMKII und der daraus resultierenden Inhibition  von cdc25b und cdc2 verbleiben die 
Zellen in G2 und sind in der Lage DNA-Schäden zu reparieren. Das antiapoptotische 
Protein Bcl-2 im ER und der äußeren Mitochondrienmembran wiederum verstärkt die 
Aktivität von TRPM2 indem es höhere [Ca2+]i induziert und gleichzeitig die Produktion 
reaktiver Sauerstoffspezies verhindert. Durch diesen Umstand sind Bcl-2 
überexprimierende Jurkat Zellen dazu in der Lage, TRPM2-generierte Ca2+-Signale 
zu nutzen, ohne einen gefährlichen Ca2+-Overload und der damit verbundenen ROS-
Produktion zu riskieren. Zusammen führen die stabilisierende Funktion von Bcl-2 auf 
die Mitochondrien und das stressbedingte, TRPM2-vermittelte Ca2+-Signaling zur 
Radioresistenz von T-Zell-Leukämiezellen. 
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Ergebnisse TRPM8 
 
TRPM8-vermitteltes Ca2+-Signaling verstärkt die Migration und erhöht die 
Radioresistenz von Glioblastomzellen 
 
Der Ionenkanal TRPM8 wird unter Standardbedingungen ausschließlich in 
sensorischen Neuronen exprimiert, wo er bei dem Empfinden von Kälte eine wichtige 
Rolle spielt. In benignem Gewebe ist das Vorkommen dieses Kationenkanals auf die 
Prostata, die Lunge und die Blase beschränkt. Es konnte jedoch auch gezeigt 
werden, dass TRPM8 neben diesen Organen in vielen Tumorentitäten überexprimiert 
ist. So zum Beispiel im Glioblastom, wo er die Krankheitsprogression und das 
Überleben der Patienten negativ beeinflusst (Alptekin et al. 2015). Zu Beginn dieser 
Arbeit wurde mit Hilfe des Onlineportals „The Cancer Genome Atlas“ (TCGA) der 
Zusammenhang der TRPM8 mRNA Abundanz mit dem krankheitsfreien Überleben 
und dem Gesamtüberleben von Patienten mit low-grade Gliomen beziehungsweise 
mit Glioblastomen verglichen. Weiter wurde auch die mRNA Abundanz von TRPM8 
in low-grade Gliomen und Glioblastomen mit der mRNA Abundanz des Ca2+-
aktivierten Kaliumkanals IK und dem Chemokinrezeptor CXCR4 verglichen, welche 
nachweislich an der Malignizität von Gliomen und Glioblastomen beteiligt sind 
(Chatterjee et al. 2014; Stegen et al. 2015). Es konnte bestätigt werden, dass eine 
höhere Expression von TRPM8 in low-grade Gliomen mit einem geringeren 
Gesamtüberleben und einer verkürzten krankheitsfreien Zeit der Patienten 
einhergeht (Klumpp et al., 2016b; Abb. 1A und B). Im Gegensatz dazu zeigte sich in 
Glioblastomen, welche durchschnittlich eine höhere TRPM8 Expression aufwiesen 
als low-grade Gliome (Klumpp et al., 2016b; Abb. 1C), kein Unterschied im 
Überleben in Abhängigkeit von der mRNA Abundanz (Daten nicht gezeigt). Die 
Expression von TRPM8 scheint außerdem signifikant mit jener der Malignitätsmarker 
CXCR4 und IK zu korrelieren. Dieser Zusammenhang war besonders deutlich bei 
Patienten, welche mit Bestrahlung und Temozolomid therapiert wurden (Stupp et al. 
2009) (Klumpp et al., 2016b; Abb. 1D). 
In den ersten Experimenten dieser Arbeit wurde die mRNA Abundanz von TRPM8 in 
unterschiedlichen Glioblastomzelllinien mittels real-time RT-PCR untersucht. Neben 
TRPV1 und TRPV2 (Klumpp et al., 2016b; Abb. 1E) konnte in den Zelllinien auch 
TRPM8 nachgewiesen werden, wobei die Abundanz an mRNA in den verschiedenen 
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Linien unterschiedlich ausfiel (Klumpp et al., 2016b; Abb. 1F). Für die weiteren 
Experimente wurden ausschließlich die Zelllinien mit hoher (U251, U-87MG), 
beziehungsweise niedriger (T98G) TRPM8 mRNA Abundanz genutzt. Anschließend  
wurde die Funktionalität der TRPM8-Kanäle mit Hilfe von On-Cell-Patch-Clamp-
Messungen untersucht. Glioblastomzellen wurden hierfür mit dem 
pharmakologischen TRPM8-Agonist Icilin behandelt und die Aktivierung des Ca2+-
aktivierten Kaliumkanals BK untersucht, welcher als Surrogatmarker für den TRPM8-
vermittelten Ca2+-Einstrom in die Zelle diente (Klumpp et al., 2016b; Abb. 2 und 3). 
Die bereits dokumentierte Eigenschaft von TRPM8, eine Rolle bei der Migration von 
Glioblastomzellen zu spielen (Wondergem et al. 2008; Wondergem and Bartley 
2009), konnte in Wundheilungs- (Klumpp et al., 2016b; Abb. 5A-D) und 
Transfiltermigrations-Assays (Klumpp et al., 2016b; Abb. 5 E-H) bestätigt werden. 
Zusammengefasst zeigen diese Daten eine funktionelle Expression von TRPM8 in 
den untersuchten humanen Glioblastomzelllinien und belegen eine essentielle Rolle 
von TRPM8 bei der Zellmigration. 
Um einen möglichen Einfluss von TRPM8 bei der Radioresistenz des Glioblastoms 
zu untersuchen,  wurden die Zelllinien T98G und U251 fraktioniert bestrahlt. 
Appliziert wurden Photonen-Einzeldosen zu je 2 Gy, was der gängigen Therapie von 
Patienten mit einem Glioblastom entspricht. Anschließend wurden 
strahlungsinduzierte Veränderungen in Expression und Funktion von TRPM8 mit 
Hilfe von real-time RT-PCR und Fura-2 Ca2+-Messungen untersucht. Es konnte 
gezeigt werden, dass eine fraktionierte Bestrahlung (5 x 2 Gy) die mRNA Abundanz 
von TRPM8 erhöht (Klumpp et al., 2016b; Abb. 6A-D). Des Weiteren konnte bereits 2 
h nach Applikation einer Einzeldosis von 2 Gy ein Menthol-stimulierter Anstieg des 
Ca2+-Einstroms in T98G Zellen detektiert werden (Klumpp et al., 2016b; Abb. 6E und 
F). Dies zeigt, dass Bestrahlung sowohl die Expression als auch die Funktion von 
TRPM8 beeinflusst. 
Um auszuschließen, dass die strahlungsinduzierte Aktivierung von TRPM8 kein 
Epiphänomen, sondern elementar am Überleben bestrahlter Glioblastomzellen 
beteiligt ist,  wurde TRPM8 mittels siRNA in U251 und T98G Zellen herunterreguliert 
(Klumpp et al., 2016b; Abb. 4). In einem parallel durchgeführten Experiment ging die 
Herunterregulierung des mRNA-Bindeproteins Musashi (MSI1) mit einem Anstieg der 
TRPM8 mRNA Abundanz einher. In diesem speziellen Fall wurde der knock-down 
von MSI1 als Hilfsmittel verwendet, um eine Überexpression von TRPM8 zu 
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erzeugen (Klumpp et al., 2016b; Abb. 4). Anschließend wurden sowohl die 
Kontrollzellen (ntRNA), die TRPM8-herunterregulierten Zellen (U251, T98G) als auch 
die TRPM8-überexprimierenden Zellen (U251) auf ihr klonogenes Überleben 
untersucht. Zu diesem Zweck wurden die Zellen bestrahlt (0-6 Gy) und nach 24 h ein 
Koloniebildungstest durchgeführt. Es zeigte sich, dass sich ein knock-down von 
TRPM8 negativ auf das Überleben beider Zelllinien auswirkte (Klumpp et al., 2016b; 
Abb. 7A und B). Genauer verminderte der knock-down von TRPM8 den Anteil der 
überlebenden Zellen nach einer Bestrahlung mit 2 Gy bis zu 30% (U251) (Klumpp et 
al., 2016b; Abb. 7C) bzw. 10% (T98G) (Klumpp et al., 2016b; Abb. 7D). Gleichzeitig 
verschlechterte sich die plating efficiency um 30% (U251) (Klumpp et al., 2016b; 
Abb. 7E) beziehungsweise um 60% (T98G) (Klumpp et al., 2016b; Abb. 7F). Im 
Gegenzug dazu erhöhte die Überexpression von TRPM8 (MSI1 knock-down) die 
Radioresistenz in U251 Zellen verglichen mit den Kontrollzellen (ntRNA) (Klumpp et 
al., 2016b; Abb. 7A). Diese Daten zeigen, dass TRPM8 eine entscheidende Rolle in 
der Klonogenität und Radioresistenz von Glioblastomzellen spielt. 
Anknüpfend an diese Experimente wurde untersucht, inwieweit sich die TRPM8-
Aktivität auf die Apoptose-Resistenz der Glioblastomzellen auswirkt. Hierfür wurde 
die Caspasenaktivität 24 h nach Bestrahlung (0 und 4 Gy) mit Hilfe eines speziellen 
Farbstoffes untersucht. Ein siRNA-vermittelter TRPM8 knock-down erhöhte in beiden 
Zelllinien die Zellzahl mit einer Caspaseaktivität um den Faktor 3 (Klumpp et al., 
2016b; Abb. 8B und C), was auf eine essentielle Funktion von TRPM8 schließen 
lässt. Interessanterweise war der kombinierte Effekt von Bestrahlung und TRPM8 
knock-down auf die Aktivität der Caspasen lediglich additiv (T98G) (Klumpp et al., 
2016b; Abb. 8B), wenn überhaupt vorhanden (U251) (Klumpp et al., 2016b; Abb. 
8C). Dies lässt den Schluss zu, dass es einen anderen Mechanismus geben muss, 
welcher zu der beobachteten, TRPM8-vermittelten Radioresistenz führt (Klumpp et 
al., 2016b; Abb. 7). Im Folgenden wurde daher der Effekt eines TRPM8 knock-downs 
auf den Zellzyklus von T98G und U251 Glioblastomzellen 48 h nach Bestrahlung 
untersucht. Hierzu wurden die Zellen permeabilisiert, die DNA mit dem 
Fluoreszenzfarbstoff Propidiumiodid angefärbt und anschließend mittels 
Durchflusszytometrie analysiert (Nicoletti Protokoll, Klumpp et al., 2016b; Abb. 9A). 
In beiden Zelllinien erhöhte Bestrahlung die Zellpopulation in der G2- und S-Phase 
und verringerte die Population in G1 (Vergleich Balken 1 und 2 der ersten drei 
Diagramme, Klumpp et al., 2016b; Abb. 9B und C). Diese Daten deuten daher auf 
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einen durch Bestrahlung induzierten S- und G2/M-Arrest hin, der in beiden Zelllinien 
beobachtet werden konnte. 
Obwohl eine Signifikanz nicht immer erreicht werden konnte, zeigten sich nach 
einem TRPM8 knock-down in beiden Zelllinien vergleichbare Effekte auf den 
Zellzyklus. So führte die Herunterregulation von TRPM8 sowohl zu einem 
strahlungsinduzierten Arrest der Zellen in der G2-Phase als auch zu einer 
Verminderung der Zellpopulation, welche sich in der G1-Phase befindet. Gleichzeitig 
schwächte (U251) beziehungsweise verhinderte (T98G) der knock-down die durch 
Bestrahlung verursachte Akkumulation in der S-Phase (Klumpp et al., 2016b; Abb. 
9B und C, ersten drei Diagramme) und erhöhte die hyperG Population in bestrahlten 
Zellen ausschließlich (U251) beziehungsweise in verstärktem Maße (T98G) (Klumpp 
et al., 2016b; Abb. 9B und C, letztes Diagramm). Da die hyperG Population jene 
Zellen repräsentiert, die einen abnorm erhöhten DNA-Gehalt besitzen, lässt dies auf 
eine Störung in der Mitose oder Zytokinese schließen, welche durch einen TRPM8 
knock-down hervorgerufen wird. Dieses Fehlverhalten in der Zellteilung deckt sich 
mit der Beobachtung, dass nach einem TRPM8 knock-down die Zellen in der G2-
Phase akkumulierten und sich demzufolge die G1-Population verringerte. Um den 
direkten Einfluss von TRPM8 auf den Wiedereintritt in die Mitose und den Zellyklus 
zu untersuchen, wurden T98G und U251 Glioblastomzellen bestrahlt (0 und 4 Gy) 
und für 48 h inkubiert. Anschließend wurde 5-Ethynyl-2`-Deoxyuridin (EdU) 
hinzugegeben und für weitere 8 h inkubiert. Die Auswertung erfolgte anschließend 
mittels Durchflusszytometrie (Klumpp et al., 2016b; Abb. 10A).  
In beiden Zelllinien verursachte Bestrahlung einen Anstieg EdU-negativer Zellen in 
der S- und G2-Phase (Klumpp et al., 2016b; Abb. 10B und C, vergleiche Balken 1 
und 2) sowie einen Rückgang in der G1-Phase (Klumpp et al., 2016b; Abb. 10B und 
C, vergleiche Diagramme 1-3). Auf Zellen in der S- und G2-Phase, welche EdU in 
ihre DNA eingebaut hatten, nahm die Bestrahlung keinen Einfluss (Klumpp et al., 
2016b; Abb. 10B und C, Vergleich Diagramme 4-5). Diese Beobachtung lässt den 
Schluss zu, dass der Übergang von der G1- zur S-Phase, so wie das Fortführen der 
S-Phase (DNA-Replikation) bereits 48-56 h nach Bestrahlung mit 4 Gy auf dem Level 
von unbestrahlten Zellen war. Die Herunterregulation von TRPM8 führte bei beiden 
Zelllinien sowohl zu einem weiteren Anstieg EdU-negativer Zellen in der S- und G2-
Phase wie auch zu einem Rückgang der EdU-negativen Zellen in der G1-Phase. Dies 
war in bestrahlten und unbestrahlten Zellen gleichermaßen der Fall (Klumpp et al., 
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2016b; Abb. 10B und C, vergleiche Balken 1 mit 3 und 2 mit 4 der Diagramme 1-3). 
Zusammen deutet dies auf eine entscheidende Rolle von TRPM8 bei der Mitose hin. 
Mehr noch, der TRPM8 knock-down-vermittelte Anstieg EdU-negativer Zellen in der 
S-Phase legt nahe, dass TRPM8 neben der Mitose ebenfalls eine Funktion in der S-
Phase zu haben scheint. 
Die Verringerung der Anzahl an EdU-positiven Zellen in der S- und G2-Population 
nach einem TRPM8 knock-down stimmt überein mit dem gleichzeitigen Anstieg EdU-
negativer Zellen unter diesen Bedingungen. (Klumpp et al., 2016b; Abb. 10B und C, 
4.-5.Diagramm). Ein Vergleich der Populationen EdU-positiver mit EdU-negativer 
Zellen zeigt, dass Bestrahlung alleine keinen Effekt auf den Zellzyklus hat (Klumpp et 
al., 2016b; Abb. 10D und E, vergleiche 1. und 2. Balken), was ebenfalls auf eine 
normalisierte DNA-Replikation, 48-56 h nach Bestrahlung schließen lässt (siehe 
oben). Nach einem knock-down von TRPM8 jedoch verändert sich dieses Verhältnis 
EdU-positiver zu EdU-negativer Zellen (Klumpp et al., 2016b; Abb. 10D und E, 
vergleiche 1. und 3. Balken). In U251 Zellen reduzierte eine kombinierte Behandlung 
mit TRPM8 knock-down und Bestrahlung dieses Verhältnis noch weiter (Klumpp et 
al., 2016b; Abb. 10D, vergleich 3. und 4. Balken). In T98G Zellen war dies nicht der 
Fall (Klumpp et al., 2016b; Abb. 10E, vergleiche 3. und 4. Balken). 
Zusammengefasst zeigen diese Daten, dass  TRPM8 eine signifikante Funktion im 
Zellzyklus unbestrahlter Glioblastomzellen einnimmt. Weiter konnte in U251 Zellen 
gezeigt werden, dass ein TRPM8 knock-down die hyperG Population, speziell in 
bestrahlten Zellen, erhöhte (Klumpp et al., 2016b; Abb. 9B, 4. Diagramm).  
Zusammen mit den Ergebnissen der EdU-Messungen lässt sich ebenfalls eine Rolle 
von TRPM8 in der Zellzykluskontrolle von bestrahlten Glioblastomzellen belegen 
(Klumpp et al., 2016b; Abb. 10D). 
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Diskussion TRPM8 
 
Es ist bekannt, dass  TRPM8-Kanäle für die Generierung von Ca2+-Signalen in 
Glioblastomzellen verantwortlich und maßgeblich an der Zellmigration von 
Tumorzellen beteiligt sind. Neue Erkenntnisse aus dieser Arbeit zeigen nun, dass 
eine fraktionierte Bestrahlung, wie sie in der Klinik bei der Behandlung von 
Glioblastompatienten angewandt wird, zu einer Hochregulation von TRPM8 führt, 
was wiederum eine erhöhte Radioresistenz zur Folge hat.  
 
Bestrahlungsinduziertes Ca2+-Signaling. Ähnlich wie in Glioblastomzellen konnte 
bereits in chronisch myeloischen sowie in T-Zell Leukämiezellen gezeigt werden, 
dass Bestrahlung Einfluss auf die durch TRP-Kanäle generierten Ca2+-Signale nimmt 
(Heise et al. 2010; Klumpp et al. 2016a). Diese TRP-Kanäle besitzen nachweislich 
eine regulatorische Funktion im Zellzyklus und beeinflussen im Zusammenspiel mit 
spannungsaktivierten Kv3.4 (Palme et al. 2013) sowie Ca2+-aktivierten IK K+ Kanälen 
(Klumpp et al. 2016b) das zelluläre Überleben. Durch Re- beziehungsweise 
Hyperpolarisierung der Plasmamembran wirken diese spannungs- und Ca2+-
aktivierten K+-Kanäle einer, durch Eintritt von Ca2+ verursachten, Depolarisation der 
Zellmembran entgegen. Befinden sich diese K+-Kanäle in direkter Nachbarschaft zu 
Ca2+-Kanälen, halten sie einen starken einwärts gerichteten elektrochemischen Ca2+ 
Gradienten aufrecht und steuern die Aktivität von spannungsabhängigen und 
spannungsaktivierten Ca2+-Kanälen. Somit spielen K+-Kanäle eine bedeutende Rolle 
im Ca2+-Signalosom von Tumorzellen (Review siehe (Huber 2013)). 
 
TRPM8, IK- und BK-Kanal Interaktionen. Wie bereits mehrfach dokumentiert, führt 
die Bestrahlung von Glioblastomzellen zu einer Aktivierung von BK (Steinle et al. 
2011) und IK Ca2+-aktivierten K+-Kanälen (Stegen et al. 2015), was wiederum eine 
Signalkaskade, bestehend aus Ca2+ und anderen biochemischen Signalen, erzeugt. 
Es konnte gezeigt werden, dass die strahlungsinduzierte Aktivierung von BK für die 
Aktivierung von downstream Effektoren wie der Ca2+/Calmodulin-abhängigen 
Protein-Kinase II (CaMKII) essentiell ist und eine wichtige Rolle bei der Migration von 
Glioblastomzellen spielt (Steinle et al. 2011). Gleichzeitig sind die durch Bestrahlung 
aktivierten IK K+-Kanal-Signale nachweislich an der Zellzykluskontrolle, der 
Reparatur von DNA-Schäden und dem klonogenen Überleben beteiligt (Stegen et al. 
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2015). Der Kationenkanal TRPM8 scheint sowohl Einfluss auf die Zellmigration, als 
auch auf das Zellüberleben zu haben. Es ist daher anzunehmen, dass in 
Glioblastomzellen der TRPM8-Kanal in einem sehr engen räumlichen Verhältnis zu 
den beiden K+-Kanälen steht und mit diesen interagiert. Die Kationenströme des 
stark auswärts gleichrichtenden Kanals TRPM8 (Review siehe (Yudin and Rohacs 
2012)) nehmen mit steigender Hyperpolarisation der Plasmamembran immer weiter 
ab. Ein möglicher Ablauf wäre somit folgender: Die Aktivität von IK und BK führt zu 
einer Hyperpolarisation der Membran, welche wiederum den TRPM8-vermittelten 
Ca2+-Einstrom schwächt. Dies hat zur Folge, dass IK und BK aufgrund des fehlenden 
Ca2+-Signals inaktiviert werden, die Membran repolarisiert und durch diese 
Depolarisierung TRPM8 erneut aktiviert wird. Diese wechselseitigen Aktivierungen 
und Inaktivierungen generieren Ca2+-Oszillationen, die im Inneren der Zelle von 
speziellen Ca2+-Effektoren, wie zum Beispiel CaMKII Isoformen erkannt werden 
(Review siehe (Huber 2013)) und somit die Migration (Cuddapah and Sontheimer 
2010; Steinle et al. 2011; Cuddapah et al. 2013) sowie die Zellteilung (Cuddapah et 
al. 2012) von Glioblastomzellen regulieren. 
 
Aktivierung von TRPM8 in Glioblastomzellen. Im Gegensatz zu seiner 
physiologischen Funktion in sensorischen Neuronen ist TRPM8 im Gehirn unter 
Normalbedingungen keinen Temperaturen unter 20°C ausgesetzt, welche zu einer 
Aktivierung führen könnten. Zudem wurde die Osmolariät in den Experimenten dieser 
Arbeit (z.B. Migration, Koloniebildungstest) stets stabil gehalten, weshalb auch die 
bereits dokumentierte Funktion von TRPM8 als Sensor für Osmolarität (Quallo et al. 
2015) keine Erklärung für die Aktivität im Glioblastom darstellt. Belegt ist, dass die 
Kanalaktivität von TRPM8 durch G-Protein gekoppelte Rezeptoren (Bavencoffe et al. 
2010), Phosphatidylinositolen (Yudin and Rohacs 2012), Serin/Threonin- (Mandadi et 
al. 2011), Tyrosin-Kinasen/-Phosphatasen (Morgan et al. 2014) sowie UBA1-
abhängige Ubiquitinilierung (Asuthkar et al. 2015) moduliert wird. Des Weiteren 
steuern Protein-Protein-Interaktionen mit dem Zwei-Transmembrandomänen Protein 
Pirt (Tang et al. 2015) und TRP-Kanal-assoziierten Faktoren (TCAFs) (Gkika et al. 
2015) die räumliche Verteilung und die Aktivität von TRPM8 in der Zelle. Ein weiterer 
Antagonist von TRPM8 scheint Testosteron zu sein. Es konnte gezeigt werden, dass 
bereits Konzentrationen im picomolaren Bereich die Öffnung von TRPM8-Kanälen in 
planaren Lipiddoppelschichten stimulierten (Asuthkar et al. 2015). 
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Zusammenfassend lässt sich sagen, dass die Regulation von TRPM8 höchst 
komplex ist und die gesteigerte Aktivität im Glioblastom möglicherweise mit einer 
Sollwertverschiebung der Aktivierungstemperatur zur normalen Körpertemperatur zu 
erklären ist. Der genaue molekulare Mechanismus bleibt bislang jedoch noch 
unverstanden. 
 
Erhöhte Expression von TRPM8 in Glioblastomzellen. Wie bereits dokumentiert, 
handelt es sich bei TRPM8 unter anderem um ein Zielgen des Androgenrezeptors 
sowie des Tumorsupressorproteins p53 (Bidaux et al. 2005; Asuthkar et al. 2015).  
Die erhöhte Expression des Androgenrezeptors im Glioblastom (Yu et al. 2015) kann 
somit auch an der Überexpression von TRPM8 beteiligt sein. In U251 
Glioblastomzellen ging eine Herunterregulation des Genes musashi-1 (MSI1) mit 
einer Hochregulation von TRPM8 einher, was in den Experimenten dieser Arbeit 
dazu genutzt wurde, eine Überexpression von TRPM8 zu simulieren (Klumpp et al., 
2016b; Abb. 4). Dies kann wiederum auf eine negative Regulation des mRNA 
Bindeproteins MSI1 auf TRPM8 hindeuten. Nach eigenen Recherchen im Cancer 
Genome Atlas auf mögliche Korrelationen zwischen den mRNA Abundanzen von 
MSI1 und TRPM8 in Glioblastompatienten, konnte diese Hypothese nicht belegt 
werden (Daten nicht gezeigt). Das Phänomen scheint somit auf die Zelllinie U251 
beschränkt zu sein. Durch fraktionierte Bestrahlung konnte in dieser Arbeit ebenfalls 
eine Steigerung der TRPM8-Expression induziert werden, was in den 
Glioblastomzelllinien T98G und U251 signifikant und in U-87MG schwach, aber 
erkennbar ausgeprägt war (Klumpp et al., 2016b; Abb. 6A-D). Dieser Effekt resultiert 
möglicherweise aus der durch Bestrahlung erfolgenden Akkumulation/Selektion 
TRPM8-überexprimierender und somit resistenterer Zellen. Eine weitere Erklärung 
wäre eine Adaptation an die Bestrahlung, was auf eine Stabilisierung von p53 
schließen lässt. Diese Vermutung konnte allerdings nicht belegt werden, da U251 
Glioblastomzellen, welche p53-mutiert sind, eine ähnliche TRPM8-Expression wie 
die heterogenen p53-Wildtyp/-mutierten T98G Zellen und sogar eine gesteigerte 
Expression gegenüber den p53-Wiltyp U-87MG Zellen zeigten. Eine p53-vermittelte 
Regulierung von TRPM8 scheint somit nicht ausschlaggebend für die Resistenz zu 
sein. 
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Mögliche Funktion von TRPM8 in der malignen Progression. In den hier 
durchgeführten Koloniebildungsassays konnte gezeigt werden, dass ein knock-down 
von TRPM8 eine Radiosensibilisierung von T98G und U251 Glioblastomzellen zur 
Folge hat, weswegen TRPM8 als möglicher Resistenzfaktor betrachtet werden kann. 
Zusätzlich war TRPM8 auch essentiell für die Migration von Glioblastomzellen. Da 
die Fähigkeit von Glioblastomzellen, infiltrativ in das Gehirnparenchym 
einzuwandern, ein bedeutender Grund für die Schwere der Erkrankung darstellt, 
kommt TRPM8 ebenfalls als Malignitätsfaktor in Betracht. Dies lässt sich auch durch 
die schlechte Prognose von low-grade Gliompatienten belegen, welche im 
Gegensatz zu anderen low-grade Patienten eine höhere TRPM8-Expression 
aufwiesen (Klumpp et al., 2016b; Abb. 1A-B). Obwohl in diesem Falle weder eine 
Subgruppenanalyse stattfand, noch eine zweite Patientengruppe hinzugezogen 
wurde, lässt dieses Ergebnis darauf schließen, in Zukunft TRPM8 als prognostischen 
Marker in der Diagnose hinzuzuziehen. Diese Theorie wird gestützt durch die 
Beobachtung, dass low-grade Gliompatienten mit IDH1-Wildtyp 
(Isocitratdehydrogenase) eine signifikant höhere TRPM8-Expression zeigten als 
Patienten mit einer Mutation in IDH1 (ähnlich der von Glioblastompatienten). Die 
Prognose für das Langzeitüberleben von low-grade Gliompatienten mit mutiertem 
IDH1 ist dabei wesentlich besser im Vergleich zu IDH1-Wildtyp Patienten (Wick et al. 
2009).  
 
Verbindung von TRPM8 mit dem Chemokinrezeptor CXCR4 und dem IK K+-Kanal. 
Gewebeproben von Glioblastompatienten zeigten eine positive Korrelation von 
TRPM8 mRNA mit der des CXCR4 Chemokinrezeptors sowie des IK K+-Kanals 
(Klumpp et al., 2016b; Abb. 1D). Frühere Arbeiten belegen, dass IK sowohl zur 
Radioresistenz von Glioblastomen beiträgt (Stegen et al. 2015) als auch bei der 
Infiltration des Gehirns benötigt wird (Catacuzzeno et al. 2012; Cuddapah et al. 2013; 
D'Alessandro et al. 2013). CXCR4 wiederum wird als Biomarker für die 
Radioresistenz von Krebsstammzellen beschrieben und das Vorkommen dieses 
Rezeptors geht mit einer schlechten Prognose des Krankheitsverlaufes einher 
(Review siehe (Chatterjee et al. 2014; Trautmann et al. 2014)). Dies wiederum lässt 
die Vermutung zu, dass die Expression von TRPM8 im Zusammenhang mit einem 
hoch infiltrativen und radioresistenten Glioblastom Phänotyp steht. Im Gegensatz zu 
dieser Annahme zeigt eine kürzlich veröffentliche Studie, dass bei 33 
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Glioblastompatienten mit erhöhter TRPM8-Expression ein längeres Überleben 
dokumentiert wurde als bei Vergleichspatienten (Alptekin et al. 2015). Die in dieser 
Arbeit, mit Hilfe des Cancer Genom Atlas, erhobenen Daten, in welcher mRNAs von 
mehr als 500 Glioblastompatienten verglichen wurden, bestätigen diese Ergebnisse 
nicht (Daten nicht gezeigt). 
 
Zusammenfassung. Die hier vorliegende in vitro Studie belegt eine mögliche 
funktionelle Signifikanz des nichtselektiven Kationenkanals TRPM8 für die Migration 
und die Radioresistenz von Glioblastomzellen. TRPM8 als alleiniges Target 
beziehungsweise in Kombination mit fraktionierter Bestrahlung eröffnet nun ein 
weiteres Fenster in der zukünftigen Behandlung von Glioblastompatienten. Aktuell 
kommen immer neuere und spezifischere pharmakologische Inhibitoren gegen 
TRPM8 auf den Markt (Ohmi et al. 2014; Lehto et al. 2015). Zudem werden 
Antikörper entwickelt, welche an extrazelluläre Domänen von TRPM8 binden und 
den Kanal somit blockieren (Miller et al. 2014). Diese Erkenntnisse und 
Errungenschaften machen eine Therapie mit TRPM8 als Target somit theoretisch 
möglich. Ob und inwiefern eine Therapie mit TRPM8 in Kombination oder als 
alleiniges Ziel Nebenwirkungen beinhaltet und ob eine Behandlung tatsächlich das 
Überleben von Glioblastompatienten verlängern kann, muss in kommenden, 
vorklinischen Studien am orthotopen Mausmodell untersucht werden. 
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Messenger RNA data of lymphohematopoietic cancer lines suggest a correlation between expression of the cation channel TRPM2
and the antiapoptotic protein Bcl-2. The latter is overexpressed in various tumor entities and mediates therapy resistance. Here,
we analyzed the crosstalk between Bcl-2 and TRPM2 channels in T cell leukemia cells during oxidative stress as conferred
by ionizing radiation (IR). To this end, the effects of TRPM2 inhibition or knock-down on plasma membrane currents, Ca2+
signaling, mitochondrial superoxide anion formation, and cell cycle progression were compared between irradiated (0–10Gy) Bcl-
2-overexpressing and empty vector-transfected Jurkat cells. As a result, IR stimulated a TRPM2-mediated Ca2+-entry, which was
higher in Bcl-2-overexpressing than in control cells and which contributed to IR-induced G2/M cell cycle arrest. TRPM2 inhibition
induced a release from G2/M arrest resulting in cell death. Collectively, this data suggests a pivotal function of TRPM2 in the DNA
damage response of T cell leukemia cells. Apoptosis-resistant Bcl-2-overexpressing cells even can afford higher TRPM2 activity
without risking a hazardous Ca2+-overload-induced mitochondrial superoxide anion formation.
1. Introduction
Transient Receptor Potential (TRP) Cation Channels.The TRP
superfamily comprises a diverse range of Ca2+-permeable
cation channels [1]. TRP channels contribute to changes in
cytosolic free Ca2+ ( free[Ca2+]i) by directly acting as Ca2+
entry channels in the plasma membrane or by changing
membrane potentials, modulating the activity and/or driving
forces for the Ca2+ entry channels [2]. The melastatin sub-
family (TRPM) has been subdivided into three subgroups on
the basis of sequence homology (TRPM1/TRPM3, TRPM4/
TRPM5, and TRPM6/7) with TRPM8 and TRPM2 being
distinct proteins [3]. The Ca2+-permeable TRPM2 channels,
formerly known as TRPC2 and LTRPC2, were first identified
in 1998 [4]. Reactive oxygen species (ROS) have been demon-
strated to induce TRPM2 currents and increase free[Ca2+]i in
various cell types transfected with TRPM2 [5], as well as in
pancreatic 훽-cells [6], neutrophil granulocytes [7], and U937
monocytes [8].
TRPM2 and Cell Death. By increasing free[Ca2+]i, TRPM2
may increase the susceptibility to cell death suggesting that
TRPM2 channels function as “death channels.” As amatter of
fact, heterologous expression of TRPM2 in human embryonic
kidney cells [9] or A172 human glioblastoma cells [10] facil-
itates oxidative stress-induced cell death. Moreover, expres-
sion of TRPM2 has been demonstrated in several tumor
entities such as insulinoma [6], hepatocellular carcinoma [6],
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prostate cancer [11], lymphoma [12], leukemia [13], and lung
cancer cell lines [14] in which TRPM2 reportedly may foster
cell death [15].
Ca2+-Signaling by TRPM2, Bcl-2, and Mitochondria. ROS-
induced TRPM2 channel activation most probably occurs
indirectly via formation of adenosine diphosphate ribose
(ADPR) which activates the channel by binding to a special
domain located at the C-terminus of the channel [16]. ADP-
ribose polymers are formed duringDNAdamage response by
poly(ADP-ribose) polymerases (PARPs). Upon DNA repair
ADPR is released from the ADPR polymers by glycohydro-
lases [17, 18]. Another main source of ADPR is the mito-
chondria [19].
Mitochondrial Ca2+ absorbance exerts Ca2+ buffering
function (for review see [20]).The mitochondrial respiratory
chain and the mitochondrial permeability transition pore
(PTP) are regulated by Ca2+. Moderate mitochondrial Ca2+
increase may disinhibit the respiratory chain leading to ΔΨ푚
hyperpolarisation [21] which in turn is accompanied by
increasing superoxide anion formation [22]. Mitochondrial
Ca2+ overload, in contrast, opens the PTP leading toΔΨ푚 dis-
sipation, cytochrome C release, and apoptotic cell death [20].
The antiapoptotic protein Bcl-2 is a key player in cellular
Ca2+ homeostasis. In some cell models, overexpression of
Bcl-2 reportedly may increase the Ca2+ leakage through IP3
receptor subtypes in the ER membrane and decrease the
ER Ca2+ filling. More recent studies, in contrast, suggest an
inhibition of IP3-receptor-mediated Ca2+ release by Bcl-2.
Like Bcl-2-caused Ca2+ store depletion, Bcl-2-mediated IP3-
receptor inhibition is thought to prevent proapoptotic bulk
Ca2+ release from the ER (for review see [23–26]).
Direct and Indirect Oxidative Stress Conferred by Ionizing
Radiation. Most energy of ionizing radiation (IR) is absorbed
by cell water leading to formation of hydroxyl radicals (for
review see [27]). Oxidative stress- andDNA repair-associated
release of ADP-ribose is supposed to increase the plasma
membrane Ca2+ permeability by activating TRPM2 channels.
Subsequent changes in free[Ca2+]i and mitochondrial func-
tion are under the control of Bcl-2. Together, this hints to a
crosstalk between Ca2+ and ROS signaling involving TRPM2
Ca2+-permeable channels in the plasmamembrane, theCa2+-
regulated ΔΨ푚 across the inner mitochondrial membrane,
and the antiapoptotic protein Bcl-2 in the ER and outer
mitochondrial membrane of irradiated cells.
Aim of the Study. The present study aimed to define this
crosstalk in human T cell leukemia cells subjected to ionizing
radiation. To this end, Jurkat cells stably transfected with
Bcl-2 or the empty control vector were irradiated with 0, 5,
or 10Gy by 6MV photons. Ion channel activity, Ca2+ sig-
naling, mitochondrial superoxide anion formation, cell cycle
control, and cell death were assessed by patch-clamp whole-
cell recording, fura-2 Ca2+ imaging, immunoblotting, and
flow cytometry in irradiated and nonirradiated cells, respec-
tively. In addition, mRNA data of hematopoietic and lym-
phoid tissue cancer cell lines of the Novartis and Broad
Institute Cancer Cell Line Encyclopedia were queried for
TRPM2 and Bcl-2mRNA abundance.
2. Material and Methods
2.1. Cell Culture. Jurkat E6.1 T cell leukemia cells were
from ATCC (Bethesda, Maryland, USA). Jurkat cells stably
expressing Bcl-2 (Jurkat-Bcl-2) or a control vector (Jurkat-
vector) were prepared as described before [28, 29]. Inducible
Bcl-2 transfectants were generated as described [30]. To
suppress Bcl-2 expression in Tet-off Jurkat cells, Bcl-2 trans-
fectants were treated with 1 휇g/mL doxycycline (Clontech,
Heidelberg, Germany) for 48 h. As control cells, the maternal
Jurkat Tet-off cells were used. Cells were grown in RPMI
1640medium supplemented with 10% fetal calf serum (Gibco
Life Technologies, Eggenstein, Germany) and maintained in
a humidified incubator at 37∘C and 5% CO2.
2.2. Transfection with siRNA. Transfection with siRNA was
performed as described [31]. In brief, cells were cultured at
a low density to ensure log phase growth. For transfection,
2 × 106 cells were resuspended in 200휇L RPMI 1640 without
phenol red. Shortly before transfection, TRPM2 or nontar-
geting siRNA was added at a concentration of 1휇M. TRPM2
ON-TARGET SMARTpool and the siCONTROL NON-
TARGETING pool siRNA were purchased from Dharmacon
(Chicago, IL, USA). Cells were electroporated in a 4mm
cuvette in an EPI2500 electroporator (Fischer, Heidelberg,
Germany) at 370V for 10ms. Immediately after transfection,
cells were resuspended in 6mL prewarmed medium and
continued to be cultured as described above. Transfection
efficiency as well as viability was determined by transfecting
the cells with 400 nM green fluorescence siRNA (siGLO
from Dharmacon, Chicago, IL, USA) followed by propidium
iodide exclusion dye and flow cytometric analysis.
2.3. Patch-ClampRecording. Maternal, Bcl-2-overexpressing,
and control vector-transfected Jurkat cells were irradiated
(IR) with 0, 5, or 10Gy 6MV photons by the use of linear
accelerator (LINAC SL25 Philips) at a dose rate of 4Gy/min
at room temperature. Whole-cell currents were evoked by
9–11 voltage pulses (700ms each) to voltages between −100
(−80)mV and +100 (+80)mV delivered in 20mV increments.
Mean steady state current values were analyzed 2–49 h after
IR. The liquid junction potentials between the pipette and
the bath solutions were estimated according to [32], and data
were corrected for the estimated liquid junction potentials.
Applied voltages refer to the cytoplasmic face of the mem-
branewith respect to the extracellular space. Inward currents,
defined as flow of positive charge from the extracellular to
the cytoplasmic membrane face, are negative currents and
depicted as downward deflections of the original current
traces.
Cells were superfused at 37∘C temperature with NaCl
ringer solution (in mM: 125NaCl, 32 n-2-hydroxyethylpiper-
azine-n-2-ethanesulfonic acid (HEPES), 5KCl, 5 d-glucose,
1 MgCl2, and 1 CaCl2, titrated with NaOH to pH 7.4). Upon
GΩ-seal formation and entry into the whole-cell recording
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mode, cells were recorded with NaCl bath solution (in mM:
140 NaCl, 10 HEPES titrated with NaOH to pH 7.4), KCl
bath solution (in mM: 140KCl, 10 HEPES titrated with KOH
to pH 7.4), CaCl2 bath solution (in mM: 100 CaCl2, 10
HEPES, titrated with Ca(OH)2 to pH 7.4), or n-methyl-d-
glucamine-Cl (NMDG-Cl) bath solution (in mM: 180mM
n-methyl-d-glucamine titrated with HCl to pH 7.4). The K-
d-gluconate/KCl pipette solution contained (in mM) 60K-
d-gluconate, 80KCl, 5 HEPES, 1 MgCl2, 1K2-EGTA, and
1K2-ATP, titrated with KOH to pH 7.4. To activate TRPM2
channels, ADP-ribose (1 휇M, Sigma, Taufkirchen, Germany)
was added to the pipette solution. To inhibit TRPM2 and IK
channels N-(p-amylcinnamoyl)anthranilic acid (ACA, 0 or
20휇M) and TRAM-34 (0 or 10 휇M, both from Sigma, both
prepared from a 10mM stock solution in DMSO) were added
to the bath solution, respectively.
2.4. Querying the Cancer Genome Atlas (TGCA) Data Sets.
Via the cBIOportal Web resource [33, 34], 178 hematopoietic
and lymphoid tissue cancer cell lines of the Novartis and
Broad Institute Cancer Cell Line Encyclopedia [35] were
queried for TRPM2 and Bcl-2mRNA abundance.
2.5. Western Blotting. Irradiated Jurkat cells (0, 5, or 10Gy,
2–4 h after IR) were lysed in a buffer (containing in mM 50
HEPES, pH 7.5, 150NaCl, 1 EDTA, 10 sodium pyrophosphate,
10 NaF, 2 Na3VO4, 1 phenylmethylsulfonyl fluoride (PMSF)
additionally containing 1% triton X-100, 5휇g/mL aprotinin,
5 휇g/mL leupeptin, and 3휇g/mL pepstatin) and separated
by SDS-PAGE under reducing condition. In some experi-
ments, cells were preincubated (0.25 h), irradiated (5Gy), and
postincubated (4 h) in the presence of the TRPM2 channel
inhibitor ACA (20휇M). Segregated proteins were electro-
transferred onto PVDF membranes (Roth, Karlsruhe, Ger-
many). Blots were blocked in TBS buffer containing 0.05%
Tween 20 and 5% nonfat dry milk for 1 h at room tem-
perature. The membrane was incubated overnight at 4∘C
with the following primary antibodies: rabbit anti-phospho-
CaMKII (Thr286) antibody (Cell Signaling #3361, New
England Biolabs, Frankfurt, Germany, 1 : 1000), rabbit anti-
CaMKII (pan) antibody (Cell Signaling #3362, 1 : 1000), rabbit
anti-phospho-cdc25b (Ser187) antibody (Epitomics #T1162,
Biomol Hamburg, Germany, 1 : 1000), rabbit anti-cdc25b
antibody (Cell Signaling #9525, 1 : 1000), rabbit-anti TRPM2
(Bethyl Laboratories Inc., #A300-414A-2, Montgomery, TX,
USA, 1 : 300), or mouse anti-Bcl-2 antibody (Santa Cruz Bio-
technology, sc-509, Heidelberg, Germany, 1 : 1000). Equal
gel loading was verified by an antibody against 훽-actin
(mouse anti-훽-actin antibody, clone AC-74, Sigma #A2228
1 : 20,000). Antibody binding was detected with a horseradish
peroxidase-linked goat anti-rabbit or horse anti-mouse IgG
antibody (Cell Signaling #7074 and #7076, resp.; 1 : 1000–
1 : 2000 dilution in TBS-Tween/5% milk) incubated for 1 h at
room temperature and enhanced chemoluminescence (ECL
Western blotting analysis system,GEHealthcare/Amersham-
Biosciences, Freiburg, Germany) was detected by film autog-
raphy.
2.6. Fura-2 Ca2+ Imaging. Fluorescence measurements were
performed using an inverted phase-contrast microscope
(Axiovert 100; Zeiss, Oberkochen, Germany). Fluorescence
was evoked by a filter wheel (Visitron Systems, Puchheim,
Germany) mediated alternative excitation at 340/26 or 387/
11 nm (AHF, Analysentechnik, Tu¨bingen, Germany). Excita-
tion and emission light was deflected by a dichroic mirror
(409/LP nm beamsplitter, AHF) into the objective (Fluar
x40/1.30 oil; Zeiss) and transmitted to the camera (Visitron
Systems), respectively. Emitted fluorescence intensity was
recorded at 587/35 nm (AHF). Excitation was controlled and
data acquired by Metafluor computer software (Universal
Imaging, Downingtown, PA, USA). The 340/380 nm fluo-
rescence ratio was used as a measure of cytosolic free Ca2+
concentration ( free[Ca2+]i). The cells were irradiated (0 or
5Gy) and loaded with fura-2/AM (2 휇M for 30min at 37∘C;
Molecular Probes, Goettingen, Germany) in supplemented
RPMI medium. free[Ca2+]i was determined 1.5–5 h after IR
at 37∘C during superfusion with NaCl ringer (see above),
upon Ca2+ depletion with Ca2+-free NaCl ringer solution (in
mM: 125 NaCl, 32 HEPES, 5KCl, 5 d-glucose, 1 MgCl2, and
0.5 EGTA, titrated with NaOH to pH 7.4), and during Ca2+
readdition in NaCl ringer solution additionally containing
ACA (0 or 20휇M).
2.7. Flow Cytometry. To test for mitochondrial production of
superoxide anion, Jurkat cells were irradiated (0 or 10Gy),
further cultured for 6 h, harvested, washed, and incubated
for 10min at 37∘C in NaCl ringer solution (see above) con-
taining 5휇M of the superoxide anion-sensitive dye MitoSOX
(Invitrogen) and 0 or 20 휇M ACA, and superoxide anion-
sensitive fluorescence was recorded by flow cytometry in flu-
orescence channel Fl-2 (logarithmic scale, 488 nm excitation
and 564–606 nm emission wavelengths). To confirm equal
fluorescence dye loading, samples were oxidized (10mM
tert-butylhydroperoxide) for 12min and recorded (data not
shown).
To monitor mitochondrial function, Jurkat cells were
irradiated (0 or 10Gy) and further cultured for 6 h.Thereafter,
cells were harvested, washed, and incubated for 30min at
37∘C in NaCl ringer solution (see above) containing 25 nM of
the inner mitochondrial membrane potential (ΔΨ푚) specific
dye tetramethylrhodamine ethyl ester perchlorate (TMRE,
Invitrogen) and ΔΨ푚 was analyzed by flow cytometry in
fluorescence channel FL-2 (logarithmic scale).
For cell cycle analysis, Jurkat cells were preincubated
(0.25 h), irradiated (0, 5 or 10Gy), and incubated for fur-
ther 24 h in supplemented RPMI 1640 medium additionally
containing either ACA or clotrimazole (Sigma, 0 or 20휇M,
each). Cells were permeabilized and stained (0.5 h at room
temperature) with unsteril (i.e., not RNase-free) propidium
iodide (PI) solution (containing 0.1% Na-citrate, 0.1% triton
X-100, 10 휇g/mL PI in phosphate-buffered saline, PBS), and
the DNA amount was analyzed by flow cytometry (FACS
Calibur, Becton Dickinson, Heidelberg, Germany, 488 nm
excitation wavelength) in fluorescence channel FL-3 (linear
scale, >670 nm emission wavelength). In parallel, cells with
degraded DNA were defined by the subG1 population of the
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PI histogram recorded in fluorescence channel FL-2 (loga-
rithmic scale).
For determination of free[Ca2+]i cells were loaded inNaCl
ringer solution (see above) for 0.5 h with fluo-3-AM (2 휇M
in NaCl ringer, Calbiochem; Bad Soden, Germany) and
recorded in fluorescence channels FL-1 (logarithmic scale,
515–545 nm emission wavelengths). As loading control for
fluo-3, cells were incubated with the Ca2+ ionophore iono-
mycin (1 휇M for 10min) prior to analysis by flow cytometry.
Datawere analyzedwith the FCSExpress 3 software (DeNovo
Software, Los Angeles, CA, USA).
2.8. Statistics. Data are expressed as means ± SE and statis-
tical analysis was made by normal or Welch-corrected two-
tailed 푡-test or ANOVA where appropriate using InStat soft-
ware (GraphPad Software Inc., San Diego, CA, USA).
3. Results and Discussion
3.1. Modulation of on Channel Activity by Ionizing Radiation.
To assess the effect of ionizing radiation (IR) of ion channel
activity, Jurkat cells were irradiated with 10Gy and whole-
cell currents were recorded at different time periods after IR.
As shown in Figures 1(a) and 1(b), IR induced an increase in
whole-cell currents 2–6 h after IR. Substitution of Na+ in the
bathing solution by Ca2+ or the impermeable Na+ substitute
NMDG+ indicated both cation-selectivity and Ca2+ perme-
ability of the IR-induced currents (Figures 1(c)–1(e)).
Next, the functional expression of TRPM2 channels and
its dependence on Bcl-2 was determined in Jurkat cells. Such
dependence was suggested by a positive correlation of the
TRPM2 and Bcl-2 mRNA abundances in 178 hematopoietic
and lymphoid tissue cancer cell lines of the Novartis and
Broad Institute Cancer Cell Line Encyclopedia (Figure 2(a)).
In the Jurkat cell model, in contrast, TRPM2 protein abun-
dance seemed to be lower in Bcl-2-overexpressing (Jurkat-
Bcl-2) cells as in the control vector-transfected (Jurkat-vec-
tor) cells as suggested by immunoblotting (Figure 2(b)). IR
did not modify total TRPM2 protein content of the cells
(Figure 2(b)).
To activate TRPM2 in Jurkat cells, whole-cell currents
were recorded with the TRPM2 agonist ADP-ribose in the
pipette and compared in unpaired experiments with those
recorded under control conditions. Intracellular ADP-ribose
stimulated a whole-cell current fraction which was sensi-
tive to the unspecific TRPM2 inhibitor ACA [36] (Figures
2(c) and 2(d)). Importantly, ADP-ribose-stimulated currents
exhibited unitary current transitions with a unitary conduc-
tance of some 50 pS as reported for heterologously expressed
TRPM2 channels [37] (Figure 2(e)). Together, these data
indicated functional expression of TRPM2 in Jurkat cells.
3.2. Mitochondrial Superoxide Anion Formation: Effect of Ion-
izing Radiation, Bcl-2Overexpression, and TRPM2 Inhibition.
To assess IR-stimulated formation of superoxide anion by
mitochondria and to estimate a potential role of TRPM2
channels herein, Jurkat-Bcl-2 and Jurkat-vector cells were
irradiated (0 or 10Gy), postcultured for 6 h, and incubated
for 10min with the superoxide anion-sensitive fluorescence
dye MitoSOX. The dye incubation was performed in the
absence or presence of the TRPM2 inhibitor ACA. As shown
in Figure 3(a), upper panel, and Figure 3(b), three distinct
cell populations with low, intermediate, or high MitoSOX
fluorescence were apparent.The latter two showed lower cell
sizes as compared to the low-fluorescent population, sug-
gestive of superoxide anion formation-associated cell shrink-
age. Staining of the cells in parallel experimentswith the inner
mitochondrial membrane potential (ΔΨ푚) specific dye
TMRE indicated dissipation of ΔΨ푚 in most of the shrunken
cells (Figure 3(a), lower panel) suggesting that the vastmajor-
ity of cells with intermediate and highMitoSOX fluorescence
underwent apoptotic cell death.
The low-fluorescent, nonshrunken cell population was
larger and exhibited significant lower superoxide anion for-
mation in Jurkat-Bcl-2 cells as compared to this population in
Jurkat-vector cells (open bars in Figures 3(c) and 3(d), left).
In the low-fluorescent populations, irradiation significantly
increased the superoxide formation only in Jurkat-Bcl-2 cells
to levels which still remained below those of control or
irradiated Jurkat-vector cells (compare open and closed bars
in Figure 3(c)). Importantly, ACA slightly but significantly
(푝 ≤ 0.05, ANOVA) decreased superoxide anion formation
in unirradiated (from 20.9 ± 0.21 to 18.2 ± 0.22 relative units,푛 = 4) and irradiated (from 23.8 ± 0.26 to 21.6 ± 0.79 rel.
units, 푛 = 4) low-fluorescent Jurkat-Bcl-2 cells while having
no inhibiting effect on superoxide anion formation in low-
fluorescent Jurkat-vector cells (data not shown). IR effects
on the intermediate- or high-fluorescent populations of both
cell clones, in contrast, were not apparent (Figure 3(a)).
ACA markedly decreased the superoxide formation of the
intermediate- or high-fluorescent populations in all control
or irradiated cells (compare Figures 3(a) and 3(b)) resulting in
the disappearance of the high-fluorescent cells (Figure 3(e)).
Combined, these data demonstrate lower mitochondrial
superoxide anion formation in Jurkat-Bcl-2 cells as compared
to Jurkat-vector cells. Only in the former cells, IR induced an
increase in superoxide anion formation. In addition, super-
oxide anion formation was lowered by the TRPM2 inhibitor
ACA in cells of both clones independent of IR stress. This
might suggest a contribution of TRPM2-mediated Ca2+
uptake to mitochondrial ROS formation.
3.3. Ionizing Radiation-Stimulated Ca2+ Uptake: Regulation
by Bcl-2 and Involvement of TRPM2 Channels. To determine
IR-induced changes in TRPM2 activity, irradiated (0 or
5Gy) Jurkat-Bcl-2 and Jurkat-vector cells were whole-cell
recorded in the absence and presence of ACA (Figures 4(a)–
4(c)). The ACA-sensitive current fraction of nonirradiated
cells was higher in Jurkat-vector than in Jurkat-Bcl-2 cells
(compare 1st with 3rd and 5th with 7th bar in Figure 4(c),
resp.) whichmight reflect the observed differences in TRPM2
protein abundance and which is in accordance with the
observed differences in mitochondrial ROS formation. IR
(5Gy) stimulated an increase in the ACA-sensitive currents
predominately in Jurkat-Bcl-2 cells (Figure 4(c)) which again
might be mirrored by the observed IR sensitivity of mito-
chondrial ROS formation exclusively in Jurkat-Bcl-2 cells.
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Figure 1: Ionizing radiation (IR) increases the cation and the Ca2+ conductance of the plasma membrane in human Jurkat T cell leukemia
cells. (a, b) Current density-voltage relationships (I/V curves, a) and conductance densities (b) of Jurkat cells at different time periods (as
indicated) after IR with 0Gy (control, open circles and bar) or 10Gy (closed symbols and bars). Currents were recorded in whole-cell voltage-
clamp mode with K-gluconate/KCl pipette and NaCl bath solution and elicited by 9 voltage square pulses to voltages between −80mV and
+80mV (20mV increments). Conductance densities were calculated for the inward currents as shown by the blue and red line in (a) for
control cells and irradiated cells (2–6 h after IR), respectively. (c, d) I/V curves of control (c) and irradiated Jurkat cells (2–6 h after 10Gy, d)
recorded as in (a) with NaCl bath solutions (circles) or after replacement of Na+ with Ca2+ (squares) or the impermeable cation n-methyl-d-
glucamine (NMDG, triangles). (e) Ca2+ conductance density of control cells (open bar) and irradiated Jurkat cells (2–6 h after 10Gy, closed
bar). The blue and red line in (c) and (d), respectively, show the voltage range used for calculation of the Ca2+ conductance densities. Data
are means ± SE, 푛 = 5 for the 46–49 h values in (a) and 푛 = 8–15 for all other data. ∗ and ∗∗ indicate 푝 ≤ 0.05 and 0.01 as tested by ANOVA
(b) and Welch-corrected 푡-test (e), respectively.
In accordance with an IR-induced increase in TRPM2
activity, IR stimulated an ACA-sensitive Ca2+ uptake as
measured by fura-2 Ca2+ imaging using an extracellular
Ca2+ depletion/repletion protocol (Figure 4(d)). In contrast
to the ACA-sensitive basal whole cell currents (Figure 4(b)),
basal (ACA-sensitive) Ca2+ uptake was higher in Jurkat-
Bcl-2 than in Jurkat-vector cells (compare 1st with 5th
bar in Figure 4(e)). Similarly to the whole-cell currents, IR
(5Gy) stimulated a larger Ca2+ uptake in Jurkat-Bcl-2 as
compared to Jurkat-vector cells (compare 2nd with 6th bar
in Figure 4(e)). In the presence of ACA, Ca2+ uptake did not
differ between control and irradiated Jurkat-vector and Jur-
kat-Bcl-2 cells (3rd, 4th, 7th, and 8th bar in Figure 4(e)).
Together, these observations indicated an IR-stimulated Bcl-
2-regulated Ca2+ uptake in Jurkat cells which probably
involves TRPM2 channels.
3.4. Role of TRPM2Channels in Ionizing Radiation-Stimulated
Activation of Ca2+ Effector Proteins Involved in Cell Cycle Ar-
rest. This IR-stimulated Ca2+ uptake might be hazardous for
the cells leading to Ca2+ overflow and subsequent cell death.
In fact, 24 h after IR with 10Gy, some 25% of the Jurkat cells
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Figure 2: T cell leukemia cells functionally express TRPM2 Ca2+-permeable cation channels and TRPM2 expression correlates with that of
the antiapoptotic protein Bcl-2. (a) Dot blot showing the relative mRNA abundances of TRPM2 and Bcl-2 in 178 hematopoietic and lymphoid
tissue cancer cell lines. Data are from the Novartis and Broad Institute Cancer Cell Line Encyclopedia. (b) Immunoblots fromwhole lysates of
irradiated (0, 5, or 10Gy, 4 h after IR) stably transfected control (Jurkat-vector) and Bcl-2-overexpressing (Jurkat-Bcl-2) cells probed against
Bcl-2, TRPM-2, and 훽-actin. (c) Current tracings recorded as in Figure 1(a) in Jurkat-Bcl-2 cells with vehicle alone (1st tracings) or in an
unpaired experiment with the TRPM-2 activator ADP-ribose (1휇M) in the pipette (2nd–4th tracings).The recordings with ADP-ribose were
performed before (2nd tracings, control), during (3rd tracings, ACA), and after (4th tracings, wash-out) bath application of the TRPM-2
inhibitor n-(p-amylcinnamoyl)-anthranilic acid (ACA, 20휇M, zero currents are shown by red lines). (d) I/V curves of the mean whole cell
currents (± SE, 푛 = 3) of Jurkat-Bcl-2 cells recorded the absence (left) or presence of the TRPM2-activator ADP-ribose (right) in the pipette
before (open circles) and after bath superfusion with the TRPM2 inhibitor ACA (closed triangles). (e) Single channel characteristics of the
ADP-ribose-stimulated channel. Unitary current transitions were apparent in whole-cell currents tracings as depicted here for −100mV and
+100mV clamp-voltage in the upper panel.The lower panel shows the relationship between unitary current transitions and voltage indicating
a unitary conductance of about 50 pS.
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Figure 3: IR increases mitochondrial superoxide anion formation in Bcl-2-overexpressing cells. (a, b) Dot plots showing forward scatter
and the superoxide anion-selective MitoSOX fluorescence (a, upper panel, and b) as well as the inner mitochondrial membrane potentialΔΨ푚-specific TMRE fluorescence (a, lower panel) of Jurkat-vector- (1st and 2nd panels) and Jurkat-Bcl-2 cells (3rd and 4th panels) 6 h after
irradiation with 0Gy (1st and 3rd panels) or 10Gy (2nd and 4th panels). Incubation (10min at 37∘C) with the superoxide anion-sensitive
fluorescence dye was carried out in the absence (a) or presence (b) of the TRPM2 inhibitor ACA (20휇M).Three distinct cell populations with
low (black), intermediate (lilac), or high (blue) superoxide anion formation were apparent.The majority of intermediate and high superoxide
anion-forming cells exhibited a low forward scatter which was associated with dissipation of ΔΨ푚 (a, lower panel). (c) Mean (± SE, 푛 = 4)
MitoSOX fluorescence intensity in the low-fluorescent populations of 0Gy- (open bars) or 10Gy-irradiated (closed bars, 6 h after irradiation)
Jurkat-vector- (left) and Jurkat-Bcl-2 cells (right). (d, e) Mean (± SE, 푛 = 4) fraction of MitoSOX low-fluorescent (d) and high-fluorescent
Jurkat-vector- (1st, 2nd, 5th, and 6th bars) and Jurkat-Bcl-2 cells (3rd, 4th, 7th, and 8th bars) 6 h after irradiation with 0Gy (open bars) or
10Gy (closed bars).The incubation with the fluorescence dye was carried out in the absence (1st–4th bars) or presence (5th–8th bars) of ACA
(20 휇M). ∗∗ and ∗ ∗ ∗ indicate 푝 ≤ 0.01 and 푝 ≤ 0.001, respectively, ANOVA.
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Figure 4: IR stimulates Ca2+ entry through TRPM2 channels especially in Bcl-2-overexpressing Jurkat cells. (a) Whole-cell current tracings
recorded in Jurkat-Bcl-2 cells irradiated with 0Gy (1st and 2nd tracings) or 5Gy (3rd and 4th tracings, 2 h after IR). Records were obtained
in unpaired experiments as described in Figure 1(a) before (1st and 3rd tracings) and during bath application of the TRPM2 inhibitor ACA
(20 휇M, 2nd and 4th tracings). (b) Relationship of the mean (± SE, 푛 = 7–10) current density and the voltage recorded as in (a) in Jurkat-
Bcl-2 cells irradiated with 0Gy (open circles) or 5Gy (closed triangles). (c) Mean (± SE, 푛 = 6–12) conductance density of control (0Gy,
open bars) and irradiated (5Gy, 2–5 h after IR) Jurkat-vector (left) and Jurkat-Bcl-2 cells (right) recorded as in (a) in the absence or presence
of ACA. Conductance densities were calculated for the outward currents as shown by the blue and red line in (b) for control and irradiated
cells, respectively. (d, e) Mean (± SE, 푛 = 197–336) fura-2 340/380 nm ratio (d) and delta fura-2 ratio (e) as measures of cytosolic free Ca2+
concentration and Ca2+ entry in Ca2+-depleted cells, respectively. Ca2+-specific fura-2 fluorescence was recorded by imaging in control (0Gy,
open circles and bars) and irradiated (5Gy, closed triangles and bars, 1.5–5 h after IR) Jurkat-vector and Jurkat-Bcl-2 cells using extracellular
Ca2+ removal/readdition protocol. Ca2+ readdition was performed in the absence (vehicle) or presence of ACA (20휇M). ∗ ∗ ∗ indicates푝 ≤ 0.001, ANOVA.
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Figure 5: IR induces Ca2+ signaling and a G2/M cell cycle arrest in Jurkat cells. (a) Dot plot recorded by flow cytometry showing the Ca2+-
specific fluo-3 fluorescence intensity in dependence on side scatter of Jurkat cells 24 h after IR with 0Gy (grey) or 10Gy (red). (b) Mean (±
SE, 푛 = 4) percentage of control and irradiated Jurkat cells with high cytosolic free Ca2+ concentrations (determined by fluo-3 fluorescence
in flow cytometry as described in (a), ∗∗ indicates 푝 ≤ 0.01, Welch-corrected 푡-test). (c) Immunoblots from whole lysates of irradiated (0
or 5Gy, 4 h after IR) Jurkat cells probed against phosphorylated and total Ca2+/CaM-dependent kinase II (CaMKII) isoforms, against the
phosphorylated and total phosphatase cdc25b, the phosphorylated cell division cycle protein 2 (cdc2), and 훽-actin for loading control. (d)
Flow cytometry histogram depicting the fluorescence intensity of the DNA-specific dye propidium iodide (PI) in Jurkat cells 24 h after IR
with 0 (black) or 5Gy (red).
exhibited a highly increased free[Ca2+]i as deduced from fluo-
3 flow cytometry (Figures 5(a) and 5(b)). Ca2+ uptake might
also contribute to Ca2+ signaling that is required for DNA
damage response of the irradiated T cell leukemia cells. IR
(5Gy) stimulated autophosphorylation and activation of
Ca2+/calmodulin-dependent protein kinase II (CaMKII) iso-
forms and phosphorylation-dependent inactivation of the
CaMKII downstream target cdc25b as suggested by immun-
oblotting (Figure 5(c)). Inactivation of the phosphatase
cdc25b was parallel by radiation-induced phosphorylation-
dependent inactivation of the cdc25b substrate cdc2
(Figure 5(c)). This might hint to an involvement of Ca2+
effector proteins such as CaMKII in G2/M arrest as observed
in PI flow cytometry 24 h after IR (5Gy, Figure 5(d)).
To confirm an involvement of TRPM2 and CaMKII in
the stress response of Jurkat cells, Jurkat-Bcl-2 and Jurkat-
vector cells were irradiated (0 or 5Gy) and postincubated
in the presence or absence of the TRPM2 inhibitors ACA
or clotrimazole [38, 39] and kinase activities of the CaMKII
isoforms and cdc2 and cell cycle distribution and cell death
were analyzed by immunoblotting and PI flow cytometry, 4 h
and 24 after IR, respectively. ACA decreased the basal and
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radiation-induced abundance of phosphorylated CaMKII
in Jurkat-Bcl-2 and Jurkat-vector cells (Figure 6(a), 1st and
2nd blot). Most importantly, ACA blocked the radiation-
induced phosphorylation-dependent inactivation of cdc2 in
both genotypes (Figure 6(a), 3rd blot) suggesting a functional
significance of ACA-sensitive Ca2+ entry for G2/M cell cycle
arrest. Accordingly, ACA and clotrimazole decreased the
number of irradiated cells arrested in G2/M (Figures 6(b)–
6(e)) and increased the number of dead cells. ACA- and
clotrimazole-induced cell death was more pronounced in
irradiated Jurkat-vector than in Jurkat-Bcl-2 cells (subG1
population, Figures 6(b)–6(e)).
Finally, the function of TRPM2 in radiation-induced G2/
M arrest of Jurkat cells was directly tested by TRPM2 knock-
down. Transfection of Jurkat-vector cells with TRPM2 siRNA
resulted in downregulation of TRPM2 protein level as com-
pared to nontargeting (nt) RNA-transfected cells (Figure 6(f),
insert). Transfected Jurkat cells were irradiated (0 or 5Gy)
and G2/M arrest and cell death analyzed 24 h thereafter.
TRPM2 knock-down exerted small but significant effects
on radiation-induced G2/M arrest and cell death mimicking
those of ACA and clotrimazole (Figure 6(f)).
3.5. Regulation of TRPM2-Mediated Ca2+ Influx byMitochon-
dria and Bcl-2. ADP-ribose is liberated in the mitochondria
from, for example, NAD-dependent deacetylation intermedi-
ates, from mono- or polyADP-ribosylated proteins, or from
NAD+, and released into the cytosol [19]. Oxidative and
nitrosative stress have been demonstrated to stimulate the
mitochondrial release of ADP-ribose into the cytosol which
in turn activates TRPM2 channels in the plasma membrane
resulting in Ca2+ entry and depolarization of the membrane
potential [16]. Since an elevated free[Ca2+]i may disinhibit the
respiration change leading to ΔΨ푚 hyperpolarisation and
superoxide anion formation and, eventually, to mitochon-
drial Ca2+ overload and ΔΨ푚 dissipation, TRPM2 activation
has been proposed to amplify signals that trigger cell death
(for review see [27]).
The present study demonstrates that irradiated human T
cell leukemia cellsmay utilize the TRPM2 “death channel” for
prosurvival Ca2+ signaling. Noteworthy, IR-induced TRPM2
currents and Ca2+ entry were larger in cells overexpressing
Bcl-2 pointing to a crosstalk between Bcl-2 in the ER and
outer mitochondrial membrane and TRPM2 in the plasma
membrane. The correlation between TRPM2 and Bcl-2
mRNA abundances in a panel of lymphohematopoietic can-
cer cell lines (see Figure 2(a)) further suggests a functional
interdependence between both proteins.
In some cell models, Bcl-2-overexpressing cells have been
proposed to counteract the Bcl-2-mediated Ca2+ leakage
from the stores by downregulating Ca2+ uptake through the
plasma membrane (for review see [19]). In line with such
compensatory mechanism might be the observation of the
present study that Bcl-2-overexpressing Jurkat cells exhibited
under basal conditions lower TRPM2 protein abundance,
smaller ACA-sensitive currents in patch-clamp whole-cell
recordings than the control vector-transfected cells (see
Figure 2(b)).
In intact cells (i.e., in fura-2 Ca2+ imaging experiments,
see Figure 4(e)), however, a basal ACA-sensitive Ca2+ uptake
fraction was only apparent in Bcl-2-overexpressing cells sug-
gestive of a TRPM2 inactivity in control cells under resting
conditions. Compared to control cells, the more sustained
Ca2+ uptake in Bcl-2-overexpressing cells (see Figures 4(d)
and 4(e)) suggests that Bcl-2 overexpression might be asso-
ciated with a set-point shift of the resting free[Ca2+]i towards
higher levels. Fura-2Ca2+ imaging and fluo-3 flow cytometry
recordings of the present study indeed demonstrated a
higher basal free[Ca2+]i in constitutively and inducibly Bcl-2-
overexpressing Jurkat cells as compared to the respective
control cells (see Supplementary Figure A, in Supplementary
Material available online at http://dx.doi.org/10.1155/2016/
8026702). Elevated free[Ca2+]i levels reportedly facilitate
TRPM2 activation by ADP-ribose [40]. The observed basal
ACA-sensitive Ca2+ uptake that occurred exclusively in Bcl-
2-overexpressing cells might, therefore, be simply explained
by a higher basal free[Ca2+]i in Bcl-2-overexpressing as com-
pared to control cells.
Noteworthy, despite higher basal free[Ca2+]i, Bcl-2-over-
expressing cells exhibited lower basal mitochondrial ROS
formation than control cells (see Figure 3(c)) suggestive of
a Bcl-2-mediated protection of mitochondrial superoxide
anion formation. As amatter of fact, a direct promoting func-
tion of mitochondrial superoxide anion formation has been
attributed to the Bcl-2 opponent Bax in neuronal cells [41].
3.6. Rearrangements of the Ca2+ Signalosome in Tumor Cells:
Functional Significance for Cell Cycle Control and Stress
Response. In many tumor entities rearrangements of the
Ca2+ signalosome have been reported. In prostate cancer, for
instance, malignant progression is reportedly accompanied
by TRPM8-mediated Ca2+ store depletion and downregula-
tion of store-dependent Ca2+ entry across the plasma mem-
brane. In exchange, TRP channels such as TRPV6 are upreg-
ulated in the plasma membrane of advanced prostate cancer
cells which have been proposed to generate in concert with
IKK+ channels survival and growth factor-independent Ca2+
signaling (for review see [42]).
In the present study, IR stimulated the ACA-sensitive
currents of Jurkat cells in patch-clamp recordings and the
ACA-sensitive Ca2+ uptake in fura-2 imaging experiments
suggesting an IR-induced increase in TRPM2 activity. IR-
induced modifications of ion channel activity have been
reported in different tumor entities where they contribute to
stress evasion [43], glucose fueling [44, 45], cell cycle control
[46, 47], or radioresistance [48].
The p53-mutated Jurkat cells [49] accumulate in G2M
cell cycle arrest upon IR-mediated DNA damage (see
Figure 5(d)).The proposed IR-stimulated Ca2+ entry through
TRPM2 channels most probably contributed to the G2M
cell cycle arrest. This was evident from the observation of
the present study that two nonspecific TRPM2 inhibitors or
TRPM2 knock-down decreased the number of cells accu-
mulating in G2 and increased the number of dead cells (see
Figure 6). One might speculate that TRPM2 inhibition or
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Figure 6: Ca2+-signaling via ACA-sensitive Ca2+ entry contributes to IR-induced G2/M cell cycle arrest and decreases IR-induced cell death
of Jurkat cells. (a) Immunoblots from whole lysates of irradiated (0 or 5Gy, 4 h after IR) Jurkat-vector and Jurkat-Bcl-2 cells probed against
phospho-CaMKII and total CaMKII isoforms, against phospho-cdc2, and against 훽-actin. Cells were irradiated and postincubated in the
presence of ACA (0 or 20휇M). (b, d) Histograms showing the DNA-specific PI fluorescence intensity of irradiated (5Gy, 24 h after IR) Jurkat-
vector cells pre- (0.25 h) and postincubated (24 h) with 0 휇M (black) or 20 휇MACA (red) in (b) or 0휇M (black) or 20 휇M clotrimazole (CLT,
red) in (d). (c, e)Mean (± SE, 푛 = 9–12) percentage of irradiated (0Gy, open bars, or 5Gy, closed bars) andACA- in (d) orCLZ- in (e) (both 0or
20 휇M) cotreated Jurkat-vector and Jurkat-Bcl-2 cells arrested inG2 phase of cell cycle (upper line) or belonging to the dead cells accumulating
in the subG1 population (lower line). (f) Knock-down of TRPM2 by RNA interference mimics the effect of ACA. Electroporation with
TRPM2-specific siRNA decreases the TRPM2 protein abundance in Jurkat-vector cells to about a half of that of nontargeting RNA- (nt RNA-)
transfected control cells as analyzed by TRPM2 and 훽-actin immunoblots, 48 h after electroporation (insert, mock: electroporation without
RNA). Lower line: mean (± SE, 푛 = 3–6) percentage of irradiated (0Gy, open bars, or 5Gy, closed bars, 24 h after IR) in G2/M arrest (left) or
in subG1 population as analyzed by PI staining and flow cytometry as shown in (b, d). Cells were either mock-electroporated or transfected
with nt RNA or TRPM2-specific siRNA. Mock and nt RNA data did not differ and were pooled. ∗ and ∗∗∗ indicate 푝 ≤ 0.05 and 푝 ≤ 0.001,
ANOVA, respectively.
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knock-down overrides G2M cell cycle arrest and forces cells
with unrepaired DNA damage into mitosis.
This scenario is strengthened by the observation that IR
promoted the free[Ca2+]i-dependent phosphorylation of
CaMKIIs and their downstream targets cdc25b and cdc2 in an
ACA-sensitive manner (see Figures 5(c) and 6(a)). CaMKIIs
phosphorylate and thereby inactivate the phosphatase cdc25b
which results in accumulation of the phosphorylated, inactive
formof themitosis promoting factor subunit cdc2 [47]. Com-
bined, these observations suggest that IR-dependent TRPM2
activation contributes to Ca2+ signals that are able to induce
autophosphorylation and thereby activation of CaMKIIs.
Likewise, irradiated human myeloid leukemia cells have
been shown to generate Ca2+ signals by the concerted action
of TRPV5/6 and Kv3.4K+ channels in the plasmamembrane.
These Ca2+ signals program G2M cell cycle arrest similarly
to proposed mechanism of the present study via CaMKIIs,
cdc25b, and cdc2 [46, 47]. K+ channel activity in close
vicinity to Ca2+ entry pathways maintains a high inwardly
directed driving force for Ca2+ and, thus, is indispensable for
robust Ca2+ signals. In analogy to the leukemia cells [47], IR
induced the coactivation of IK K+ channels in the plasma
membrane of Jurkat cells (see supplementary Figure B).This
points to both a common signaling in irradiated myeloid
and lymphoblastic leukemia cells and the possibility that
functionally equivalent Ca2+ signals can be generated during
DNA damage response by different sets of TRP and K+
channels in the plasma membrane.
3.7. Conclusions. Plasma membrane TRPM2 channels have
been attributed tumor suppressor function in several tumor
entities.The Ca2+ signalosome of human T cell leukemia cells
comprises TRPM2 channels that are activated during DNA
damage response. In particular, irradiated Jurkat cells utilize
TRPM2 to control theG2/M cell cycle arrest probably via acti-
vation of the Ca2+ effector protein CaMKII and subsequent
inhibition of cdc25b and cdc2.The antiapoptotic protein Bcl-
2 in the ER or outer mitochondrial membrane even fosters
TRPM2 activity presumably by inducing higher free[Ca2+]i
levels and decreases at the same time mitochondrial ROS
formation. By doing so, Bcl-2-overexpressing cells may har-
ness TRPM2-generated Ca2+ signals without running into
the risk of hazardous mitochondrial ROS formation. Thus,
Bcl-2 function onmitochondrial integrity and stress-induced
TRPM2-mediated Ca2+ signaling cooperate in resistance to
radiation therapy in T cell leukemia cells.
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UCP-3 uncoupling protein confers 
hypoxia resistance to renal 
epithelial cells and is upregulated 
in renal cell carcinoma
Norbert Braun1, Dominik Klumpp1, Jörg Hennenlotter2, Jens Bedke2, Christophe Duranton3, 
Martin Bleif1,† & Stephan M. Huber1
Tumor cells can adapt to a hostile environment with reduced oxygen supply. The present study 
aimed to identify mechanisms that confer hypoxia resistance. Partially hypoxia/reoxygenation (H/R)-
resistant proximal tubular (PT) cells were selected by exposing PT cultures to repetitive cycles of H/R. 
Thereafter, H/R-induced changes in mRNA and protein expression, inner mitochondrial membrane 
potential (∆Ψm), formation of superoxide, and cell death were compared between H/R-adapted and 
control PT cultures. As a result, H/R-adapted PT cells exhibited lower H/R-induced hyperpolarization 
of ∆Ψm and produced less superoxide than the control cultures. Consequently, H/R triggered ∆Ψm 
break-down and DNA degradation in a lower percentage of H/R-adapted than control PT cells. 
Moreover, H/R induced upregulation of mitochondrial uncoupling protein-3 (UCP-3) in H/R-adapted 
PT but not in control cultures. In addition, ionizing radiation killed a lower percentage of H/R-
adapted as compared to control cells suggestive of an H/R-radiation cross-resistance developed by 
the selection procedure. Knockdown of UCP-3 decreased H/R- and radioresitance of the H/R-adapted 
cells. Finally, UCP-3 protein abundance of PT-derived clear cell renal cell carcinoma and normal 
renal tissue was compared in human specimens indicating upregulation of UCP-3 during tumor 
development. Combined, our data suggest functional significance of UCP-3 for H/R resistance.
Intermittent or chronic hypoxia due to insufficient vascularization and tissue malperfusion is a common 
feature of human solid tumors. In anti-cancer therapy, tumor hypoxia is a severe risk factor since the 
causative malperfusion limits not only oxygen supply but also the perfusion of the tumor with chem-
otherapeutics. In addition, low oxygen pressure during radiation therapy decreases the number of ion-
izing radiation-induced DNA double strand breaks and thereby the therapy efficacy by a factor of up 
to 3. Moreover, adaptation of tumor cells to a malperfused hypoxic microenvironment often induces/
selects tumor cells with higher malignancy, metastatic potential and intrinsic resistance to radiation 
or chemotherapy. For instance, upregulation of highly efficient Na+-coupled glucose uptake by several 
tumor entities does not only ensure glucose supply by the malperfused glucose-depleted environment 
but also confer radioresistance1–3.
Hypoxia and reoxygenation may result in oxidative insults as reported for ischemia/reperfusion injury 
of the heart. During reoxygenation of hypoxic tissue, oxidative stress may be triggered by Ca2+ overload 
of the mitochondria, concomitant hyperpolarization of the voltage (∆ Ψ m) across the inner mitochon-
drial membrane and superoxide formation as a consequence thereof (for review see Ref. 4). Tumor cells 
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surrounded by a microenvironment with varying oxygen pressure are, therefore, under continuous risk 
of mitochondria-derived oxidative insults.
The present study aimed to define mechanisms of hypoxia/reoxygenation (H/R) adaptation in vitro 
by comparing H/R-adapted with highly hypoxia-sensitive parental cells. For H/R adaptation, immortal-
ized primary cultures of mouse proximal convoluted tubule (PT) which are highly dependent on oxi-
dative respiration and, therefore, highly hypoxia-sensitive were subjected to repeated cycles of hypoxia 
and reoxygenation5. That way H/R-adapted PT cultures were then compared with the continuously 
normoxic-grown parental control cells in terms of H/R-induced impairment of mitochondrial func-
tion, formation of reactive oxygen species (ROS), cell death and gene expression. Our data suggest that 
up-regulation of the mitochondrial uncoupling protein-3 (UCP-3) contributes to H/R adaptation in vitro. 
Finally, to estimate whether this in vitro finding might be translated to the in vivo situation, the present 
study analyzed UCP-3 expression in PT-derived clear cell renal cell carcinoma demonstrating marked 
up-regulation of UCP-3 by the tumor cells.
Results
Selection of partial H/R-resistant proximal convoluted tubule (PT) cells. Four parallel cultures 
of PT cells were passaged (once per week) for 12 weeks. During this period of time, cells where subjected 
to weekly cycles of hypoxia (0.1% oxygen for 48 h) and reoxygenation (5 days). Each cycle started 2–3 d 
after passaging the cells. As a control, further four PT cultures were grown under continuous normoxia, 
and passaged twice weekly for 12 weeks (Fig. 1A). Thereafter, all cultures were passaged twice to increase 
the cell number, aliquoted and frozen. To test for an acquired H/R resistance, sub-confluent H/R-adapted 
and control cultures were grown for 48 h under normoxia or hypoxia (0.1% oxygen) followed by 0.5, 24 
or 48 h of reoxygenation. Thereafter, the DNA of the cells was stained with propidium iodide (Nicoletti 
protocol). As shown in the histograms of Fig. 1B, H/R induced a G2/M cell cycle arrest in both, control 
and H/R-adapted PT cells, suggestive of H/R-caused genotoxic stress. In addition, H/R resulted in cell 
death as defined by the sub G1 population of the propidium iodide histogram. Cell death induction was 
dependent on reoxygenation time (Fig. 1B). Most importantly, cell death was significantly reduced in 
the H/R-adapted cells as compared to the control cultures (Fig. 1C) indicating acquisition of a partial 
H/R resistance during the selection time. Fig. 1D shows the selection cycle-dependent acquisition of the 
partial H/R resistance.
H/R-induced hyperpolarization of the inner mitochondrial membrane potential 
(∆Ψm). Reportedly, reoxygenation may be associated with hyperpolarization of ∆ Ψ m. We, there-
fore, tested for the effect of hypoxia (48 h)/reoxygenation (24 h) on ∆ Ψ m in control and H/R-adapted 
PT-cultures by flow cytometry applying the voltage-sensitive fluorescence dye TMRE. H/R induced 
break-down of ∆ Ψ m (Fig. 2) in a significant cell fraction confirming H/R-induced cell death (Fig. 2A–C). 
In the surviving cells, on the other hand, H/R hyperpolarized ∆ Ψ m (Fig. 2B,D). Markedly, H/R-adapted 
PT cultures exhibited both, significantly less H/R-induced ∆ Ψ m break-down (Fig. 2C) and significantly 
less ∆ Ψ m hyperpolarization in the surviving cell population (Fig. 2D).
H/R-induced formation of reactive oxygen species (RS). Mitochondrial superoxide formation 
increases with hyperpolarization of ∆ Ψ m. Next, we analyzed cumulative superoxide formation of the 
control and selected cultures during normoxia and upon hypoxia (48 h)/reoxygenation (24 h) by flow 
cytometry using the redox-sensitive fluorescence dye MitoSOX. As shown in Fig. 3, H/R-induced super-
oxide formation was significantly lower in H/R-adapted than in control PT cultures.
Function of Uncoupling Protein-͛ (UCP-͛). To define candidate genes that might confer H/R 
resistance, mRNA abundances (quantitative RT-PCR microarrays) were compared between control 
and H/R-adapted PT cultures after normoxic culture conditions and upon hypoxia (48 h)/reoxygena-
tion (24 h). Several gene transcripts involved in apoptosis and antioxidative defense seemingly differed 
in abundance between the control and H/R-adapted PT cultures (see Supplementary Material, Fig. I) 
suggesting that long-term H/R adaptation was accompanied by upregulation of oxidative defense, 
DNA-repair and the apoptosis inhibitor survivin on the one hand, and by an enhancement of the apop-
totic cell death machinery on the other. In addition, H/R-adapted PT cultures upregulated uncoupling 
protein-3 (UCP-3) mRNA, in particular, upon acute H/R (Fig 4A). Western blotting experiments con-
firmed that H/R induced a significant upregulation of UCP-3 protein expression (~4-fold increase) in 
the H/R-adapted but not in the control cultures (Fig. 4B,C).
Since UCP-3 has been demonstrated to reduce mitochondrial ROS formation, to lower ischemia/rep-
erfusion insults, and to become up-regulated by anaerobic muscle exercise (see discussion), upregulation 
of UCP-3 might directly contribute to the observed partial H/R resistance. Therefore, we knocked-down 
UCP-3 in control and H/R-adapted cultures by RNA interference (Fig 5A) and determined mitochon-
drial superoxide formation and the the sub G1 fraction of propidium iodide-stained cells after nor-
moxia or hypoxia (48 h)/reoxygenation (24 h). As shown in Fig. 5, a knock-down-mediated decrease by 
~40% of UCP-3 protein abundance (Fig. 5A) significantly increased mitochondrial superoxide formation 
(Fig.  5B,C) in control and H/R-adapted PT cultures. Moreover UCP-3 knock-down lowered survival 
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Figure 1. Repetitive exposure to hypoxia/reoxygenation (H/R) selected partial H/R-resistent proximal 
convoluted tubule (PT) cells. (A) Selection protocol. (B) Histograms showing the propidium iodide 
fluorescence intensity of permeabilized control and H/R-adapted PT cells. Cells were recorded by flow 
cytometry either under control conditions (72 h of normoxia, black line) or after 48 h of hypoxia (0.1% 
oxygen) followed by 24 h of reoxygenation (red line). The marker indicates the dead cells (sub G1 
population). (C) Mean percentage (± SE, n = 24 from 4 cultures each measured in hexaduplicate) of dead 
cells (sub G1 population) in control (open bars) and H/R-adapted cultures (closed bars) grown under 
normoxia (left) or under hypoxia (48 h of 0.1% oxygen) followed by 0.5 h (top), 24 h (middle) and 48 h 
(bottom) of reoxygenation. * and *** indicate p ≤ 0.05 and p ≤ 0.001, respectively (ANOVA). (D) Time 
course of resistance acquisition. Shown is the selection-cycle-dependent H/R-induced cell death of the H/R-
adapted cultures normalized to that of the particular control cultures (means ± SE, n = 4).
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Figure 2. H/R induces an up-regulation of the mitochondrial uncoupling protein-3 (UCP-3) in H/R-
adapted but not in control PT cultures. (A) Mean (± SE, n = 3) GAPDH-normalized UCP-3 mRNA 
abundance of control (open bars) and H/R-adapted PT cultures (closed bars) under normoxia (left) or after 
hypoxia (48 h)/reoxygenation (24 h) as determined by quantitative RT-PCR. (B) Immunoblot of PAGE-
separated proteins from control (1st and 2nd lane) H/R-adapted PT cultures (3rd and 4th lane) probed against 
UCP-3 and β -actin. Cell lysates were prepared from normoxic (upper blot) and cultures which underwent 
H/R stress (lower blot). (C). Densitometrically semi-quantified increase in UCP-3 protein of control (open 
bar) and H/R-adapted PT-cultures induced by hypoxia(48 h)/reoxygenation (24 h; means ± SE, n = 3 cultures 
each; * indicates p ≤ 0.05, two-tailed Welch-corrected t-test).
Figure 3. H/R-adapted cultures exhibit after H/R stress less hyperpolarization of the inner 
mitochondrial membrane potential (∆Ψm) than control cultures. (A,B) Dot plots (A) and histograms 
(B) showing forward scatter and tetramethylrhodamine-ethyl-ester-perchlorate (TMRE) fluorescence as 
a measure of cell size and ∆ Ψ m, respectively. Depicted are a control (left) and a H/R-adapted PT culture 
(right) recorded by flow cytometry under normoxic conditions (black lines in (B)) and after H/R stress (48 h 
hypoxia/24 h reoxygenation; (A) and red histograms in (B)). Cell populations with dissipated ∆ Ψ m (low 
∆ Ψ m) are indicated by gate and marker in A and B, respectively. (C,D) Mean percentage of control (open 
bars) and H/R-adapted cells (closed bars) with broken-down ∆ Ψ m (C) and (D) mean TMRE fluorescence 
intensity of the cell population with high ∆ Ψ m (± SE, n = 9 from 3 cultures each determined in triplicate) 
recorded as in (B) under normoxic conditions (left), after H/R stress (48 h hypoxia/24 h reoxygenation, 
middle), or after pharmacological break-down of ∆ Ψ m by the proton ionophore carbonyl cyanide-3-
chlorophenylhydrazone (CCCP, 1 µ M). * and ** indicate p ≤ 0.05 and p ≤ 0.01, respectively (ANOVA).
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after H/R of the H/R-adapted but not of the control PT cultures (Fig. 5D,E). This suggests that UCP-3 
upregulation contributes to the H/R adaptation.
UCP expression in renal cell carcinoma. To test whether UCP-3 might fulfill similar function 
in vivo, UCP-3 protein abundance was determined by immunoblotting in frozen specimens from human 
renal cell carcinoma (RCC) and normal renal tissue. Twentyseven tumor specimens (18 clear cell RCCs, 
ccRCS, 6 papillary RCCs, pRCCs, and 3 mixed clear cell/papillary RCCs, median histological grading 
G = 2) as well as 15 non-cancerous renal specimens were selected form 21 patients that underwent (par-
tial) nephrectomy. The patients (11 men, 10 women, mean age = 67 ± 2 years) developed large tumors 
ranging from 3 cm to 21 cm in diameter (mean diameter = 8 ± 1 cm). These tumors had large necrotic 
areas pointing to insufficient vascularization (Fig. 6A). The majority of tumor specimens showed var-
ious levels of UCP-3 protein abundance (Fig. 6B) that was on average significantly higher than in the 
non-cancerous renal samples (Fig.  6C) indicating upregulation of UCP-3 during tumor development. 
Although some tumor specimens close to necrotic tumor areas (i.e., from presumed hypoxic regions, 
TN in Fig. 6B) showed extremely high UCP-3 protein abundance while peripheral tumor (TP in Fig. 6B) 
exhibited very low expression, the average UCP-3 abundance of TN specimens was not significantly dif-
ferent from that of the tumor samples of non-defined origin (data not shown). No difference in UCP-3 
protein abundance was found between ccRCCs (Fig. 6C, red triangles) and pRCCs (Fig. 6C, blue trian-
gles). In addition, univariate testing of the data suggested that UCP-3 abundance was not associated with 
patients’ age, gender, tumor size, occurrence of lymph node or distant metastasis, or histological tumor 
grading (data not shown).
To test whether RCCs similarly to UCP-3 upregulate other mitochondrial uncoupling proteins, UCP-1 
and UCP-2 protein abundance was determined by immunoblotting in the RCC resection material (Suppl 
Fig. IIA). The results suggested downregulation of UCP-1 by all and upregulation of UCP-2 by some of 
the tested RCCs. In addition, the ccRCC database of The Cancer Genome Atlas (TCGA) was queried for 
UCP-1, -2, and 3 mRNA expression of the tumor and survival of the ccRCC patients (Suppl. Fig. IIB, 
C). The TCGA data suggest co-occurrence of high abundant UCP-2 and UCP3 mRNA in the ccRCC 
specimens (data not shown) as well as shorter survival of ccRCC patients with high UCP-2 or UCP-3 
mRNA abundance in the tumors as compared to the patients with “middle-rate” UCP expressions (Suppl. 
Fig. IIB, C). High abundance of UCP-1 mRNA, by contrast, was not associated with altered survival of 
the ccRCC patients. Since subgroup analysis concerning tumor staging, treatment regimes, etc. could not 
be performed, the conclusions drawn from the TCGA data is constrained. Nevertheless, the observed 
associations might point to a prognostic value of the UCP-3 or UCP-2 expression by the ccRCC. In 
addition, the data might hint to a functional redundancy of UCP-2 and UCP-3.
H/R-adapted cultures exhibit higher resistance against ionizing radiation. Finally, we tested 
the possibility whether adaptation to H/R is accompanied by increased resistance against anti-cancer 
therapies such as radiation therapy. To this end, control and H/R-adapted cultures were irradiated under 
normoxia with a single dose of 0, 5, or 10 Gy, and subG1 population was recorded by flow cytometry 
(DNA staining of propidium iodide-permeabilized cells applying the Nicoletti protocol) as a measure 
of cell death 24 h and 48 h thereafter. As shown in Fig.  7, irradiated (10 Gy) H/R-adapted cells died 
Figure 4. H/R produces less reactive oxygen species (ROS) in H/R-adapted than in control cultures. 
(A) Histograms showing the MitoSOX fluorescence as a measure of mitochondrial superoxide production. 
PT cells were recorded by flow cytometry from a control (top) and a H/R-adapted culture under normoxic 
conditions (black lines), after H/R stress (48 h hypoxia/24 h reoxygenation, red lines) or after oxidation with 
tertbutylhydroperoxide (tBHP, 1 mM). (B) Mean MitoSOX fluorescence intensities recorded as in (A) under 
normoxic conditions (left), after H/R stress (48 h hypoxia/24 h reoxygenation, middle, data are means ± SE, 
n = 10–12 from 4 cultures each determined in duplicate or triplicate), or after oxidation with tBHP 
(means ± SE, n = 4 from 4 cultures recorded under normoxia) *** indicates p ≤ 0.001 (ANOVA).
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significantly less than irradiated control cells as evident 48 h after irradiation. This might suggest that 
adaptation to H/R leads to partial cross-resistance against ionizing radiation possibly due to upregulation 
of DNA repair and oxidative defense (see Suppl. Fig. I). The latter might mitigate the radiation-caused 
cellular lesions.
To directly test for an involvement of UCP-3 in the acquired radioresitance of the H/R-adapted 
PT cultures, the effect of UCP-3 knockdown on radiogenic cell death was determined in control and 
H/R-adapted PT cultures. 48 h after irradiation (0 or 10 Gy) and 96 h after transfection with nt or 
UCP-3 siRNA, subG1 population of propidium iodide-stained cells was determined by flow cytometry 
(Fig. 7C,D). While having no effect on control cultures, UCP-3 knockdown increased slightly but signif-
icantly the fraction of dead cells caused by radiation (Fig. 7D,E).
Discussion
UCP-3 uncoupling protein belongs to the mitochondrial anion transporter superfamily and is highly 
expressed in the mitochondrial inner membrane of brown adipose tissue, skeletal muscle and heart6,7. 
In the present study, selected, partially HR-resistant PT cultures differed from continuously normoxic 
grown control cultures by expression of genes involved in DNA repair, apoptosis and oxidative defense 
and by the ability to up-regulate mitochondrial UCP-3 uncoupling protein during H/R stress. Evidence 
for a functional significance of this UCP-3 upregulation for the partial H/R resistance in the selected 
Figure 5. UCP-3 knock-down increases H/R-induced superoxide production and cell death. (A) 
Immunoblot showing the UCP-3 (upper gel) and—for loading control—the β -actin (lower gel) protein 
abundance in PT culture transfected with non-targeting (nt) RNA (left lane) or with UCP-3 siRNA (right 
lane). The ratio indicates the densitometrically semi-quantified β -actin-normalized relative UCP-3 protein 
abundance. (B) Histograms showing the MitoSOX fluorescence of nt- (black lines) and UCP-3 siRNA-
transfected (red lines) PT cells after normoxia (top) or H/R stress (48 h hypoxia/24 h reoxygenation, bottom), 
recorded as in Fig. 4. (C) Mean normalized MitoSOX fluorescence intensities of nt- (open bars) and UCP-3 
siRNA-transfected (closed bars) control and H/R-adapted PT cultures PT cells recorded in as in (B) under 
normoxic conditions or after H/R stress. Data are means ± SE, n = 6 from 2 cultures each determined in 
triplicate. (D) Histograms showing the propidium iodide fluorescence of permeabilized nt- (black line) 
and UCP-3 siRNA-transfected (red line) control (left) and H/R-adapted PT cultures (right) after hypoxia 
(48 h)/reoxygenation (24 h, recorded as in Fig. 1). (E) Mean percentage (± SE, n = 7–9 from 3 cultures each 
recorded in duplicate or triplicate) of dead cells (sub G1 population) in nt- (open bars) or UCP-3 siRNA-
transfected control and H/R-adapted PT cultures after H/R stress (48 h hypoxia/24 h reoxygenation. * and *** 
indicate p ≤ 0.05 and p ≤ 0.001, respectively (ANOVA).
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cultures came from the observation that knockdown of UCP-3 by RNA interference significantly attenu-
ated the H/R resistance in the selected cultures while having no effect in the control cultures.
An increasingly growing number of reports demonstrates that UCP-3 may lower mitochondrial ROS 
production by decreasing ∆ Ψ m as a “mild uncoupler”. This mild uncoupling function of UCP-3 is in par-
ticular evident from the observation that UCP-3 knockout results in increased mitochondrial ROS for-
mation and oxidative damage of isolated skeletal muscle mitochondria or permeabilized muscle cells8–11. 
Importantly, chemical uncoupling in UCP-3 knockout mitochondria partially mimics the function of 
UCP-311. Moreover, UCP-3 knockout lowers fatty acid- or reactive aldehyde-stimulated increase in pro-
ton leak of the inner mitochondrial membrane12,13. Accordingly, overexpression of UCP-3 in myotubes 
decreases both ∆ Ψ m14–16 and mitochondrial ROS formation15.
In addition to these in vitro data, animal studies utilizing UCP-3 knockout or UCP-3 overexpress-
ing mice demonstrated that UCP-3 decreases mitochondrial ROS-formation in fasted mice10 and pro-
tects from diet-induced obesity17 and insulin resistance18, two diseases associated with oxidative stress15. 
Moreover, downregulation of UCP-3 in rats that is associated with doxorubicin chemotherapy-induced 
heart failure improves efficiency of cardial ATP synthesis at an expense of increased mitochondrial ROS 
formation19. Finally, UCP-3 knockdown increased ischemia/reperfusion-induced mitochondrial ROS 
formation in the heart20. Again, chemical mitochondrial uncoupling partially compensated for UCP-3 
function in the UCP-3 knock-out heart20. Combined these data provide overwhelming evidence that 
UCP-3 lowers stress-induced mitochondrial ROS formation by preventing excessive hyperpolarization 
of ∆ Ψ m.
The UCP-3-generated transports that may short-circuit the inner mitochondrial membrane, however, 
are still ill-defined. It has been suggested that UCP-3 may export pyruvate21 and fatty acids including 
lipid radicals13,22 from the mitochondrial matrix along their electrochemical gradients. Besides lowering 
∆ Ψ m and directly decreasing the concentration of lipid radicals in the matrix, pyruvate and fatty acids 
transports are thought to ensure an equilibrium between glycolysis and oxidative phosphorylation and 
to prevent Co-enzyme A shortage in the matrix and consecutive lipid-induced mitochondrial damage, 
respectively23,24. As matter of fact, UCP-3 upregulation increases the efficiency of fatty acid oxidation 
in exercising muscle9. Along those lines, in animal models and in human beings, fastening25,26, high fat 
diet27, or direct infusion of fatty acids26 have been demonstrated to upregulate UCP-3 expression which 
is consistent with a specific function of UCP-3 in switching the metabolism from glucose to fatty acid 
respiration. A recent meta-analysis demonstrates an association between the -55C/T polymorphism in 
the UCP-3 gene and obesity further suggesting such a UCP-3 function28.
Figure 6. UCP-3 protein expression in human renal cell carcinoma and adjacent non-cancerous normal 
renal tissue. (A) Human nephrectomy specimen top view (upper panel) and opened cut halves (lower 
panel) with renal cell carcinoma (RCC). Areas of necrosis and residual normal tissue, as well as locations of 
the sample taking are indicated (N: normal renal tissue, T: tumor without defined origin. TN: tumor close 
to necrotic area, TP: tumor at the periphery). (B) Immunoblot of renal cell carcinoma and normal renal 
tissue (as shown in (A)) probed against UCP-3 (2nd panel), GAPDH (3rd panel) and β -actin (4th panel). 
The 1st panel depicts the corresponding protein stain (PageBlue). The low or even missing housekeeper 
bands of the 4th and 8th sample (from left) might be explained by strong overexpression of other proteins by 
theses two tumors. Since electrophoresis loading volume was adjusted to total protein concentration strong 
overexpression of some proteins dilutes the housekeeper proteins in these samples. Boxes indicate samples 
which originated from the same kidney. (C) Scoring of the UCP-3 protein abundance in non-cancerous 
renal tissue (open circles) and clear cell RCCs (closed red triangles), papillary RCCs (closed blue triangles) 
or mixed RCCs (closed violet triangles). ** indicates p ≤ 0.01, Welch-corrected, two-tailed t-test.
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Figure 7. Cross resistance of H/R-adapted cultures against ionizing radiation. (A) Histograms showing 
the propidium iodide fluorescence of permeabilized control (black) and H/R-adapted (red) PT cells. Cells 
were recorded by flow cytometry 48 h after irradiation (under normoxic conditions) with 0 Gy (top) or 
10 Gy (botom). The marker indicates the dead cells (sub G1 population). Percentage of dead cells (sub G1 
population) in control (open bars) and H/R-adapted cultures (closed bars) 24 h (top) and 48 h (bottom) 
after irradiation (under normoxic conditions) with 0, 5, or 10 Gy. (C) Propidium iodide histograms of nt 
RNA- (black) and UCP-3 siRNA (red) transfected H/R-adapted PT cells 48 h after irradiation with 0 Gy 
(left) or 10 Gy (right). (D) Sub G1 population control (left) and H/R-adapted PT cultures (right) 96 h after 
transfection with nt or UCP-3 siRNA (as indicated) and 48 h after irradiation with 0 Gy (open bars) and 
10 Gy (closed bars). Data are means ± SE, n = 9 in (B) or n = 6 in (D,E) from 3 (B) or 2 (D,E) cultures each 
determined in triplicates. * and *** indicate p ≤ 0.05 and p ≤ 0.001 (ANOVA), respectively.
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Further triggers of UCP-3 expression include (anaerobic) exercise of skeletal muscle9,29 and ischemia/
reperfusion of the heart20,30. Likewise, oxidative stress following inhibition of glutathione reductase have 
been demonstrated to upregulate UCP-3 expression in rat myocardium31 where UCP-3 has been demon-
strated to be indispensable for ischemic preconditioning20. Moreover, reversible glutathionylation during 
oxidative stress is reportedly required to activate/inhibit UCP-332. Together, these reported data indicate a 
function of oxidative-stress induced up-regulation of UCP-3 in mitigating ischemic/hypoxia-reperfusion/
reoxygenation injury of heart and skeletal muscle.
In the present study, UCP-3 upregulation was paralleled by an attenuated H/R-mediated ∆ Ψ m hyper-
polarization and mitochondrial superoxide formation of the PT cultures hinting to a UCP-3 function 
similar to that proposed in ischemic heart or anaerobic muscle contraction. UCP-3 protein was also 
upregulated in the majority of specimens from human renal cell carcinoma (RCC) as compared to the 
protein abundance of co-resected normal kidney tissue. Since clear cell RCC originates from neoplastic 
transformation of proximal tubular cells it might be allowed to speculate that UCP-3 in RCC might also 
confer resistance to H/R. One might further speculate that UCP-3-mediated hypoxia tolerance and sur-
vival of the tumor cells in hypoxic areas indirectly confers resistance to chemo- and radiation therapy: 
the wash-in of chemotherapeutics is hampered by the malperfusion and the efficacy of ionizing radiation 
is lowered by the low oxygen pressure of hypoxic tumor areas. Along those lines, the TGCA query of the 
present study hint to the possibility that high UCP-3 expression by the RCC might be associated with 
poor prognosis.
Similar to the upregulation of UCP-3 by RCC in the present study, other UCPs such as UCP-1, UCP-
2, UCP-4 or UCP-5 are reportedly upregulated in a number of aggressive human tumors (leukemia, 
breast-, colorectal-, ovarian-, bladder-, esophagus-, testicular-, kidney-, pancreatic-, lung-, and prostate 
cancer) where they are proposed to contribute to the malignant progression of tumors (for review see 
Ref. 4). Moreover, UCP-2 expression has been associated with paclitaxel resistance of p53 wildtype lung 
cancer, CPT-11 resistance of colon cancer, and gemcitabine resistance of pancreatic adenocarcinoma, 
non-small cell lung adenocarcinoma, or bladder carcinoma. Accordingly, experimental targeting of UCPs 
has been demonstrated to sensitize tumor cells to chemotherapy in vitro. (for review see Ref. 4).
In the present study, some RCC specimens exhibited elevated UCP-2 protein amounts as compared 
to normal renal tissue. UCP-1 protein, in sharp contrast, was downregulated in the RCCs. UCP-2 might 
exert a function in RCC similar to that proposed for UCP-3. This might be deduced from the TCGA 
database query of the present study which suggested that—likewise UCP-3—high RCC UCP-2 expres-
sion might be associated with bad prognosis.
In the present study, adaptation to H/R was accompanied by partial radioresistance. Knockdown of 
UCP-3 did, however, only slightly increase radiation-induced cell death of the H/R-adapted PT cultures. 
Upon UCP-3 knockdown the radiation-induced cell death of the control cultures was still much higher 
than in the selected cultures (see Fig. 7E) suggesting that radioresistance in the H/R-adapted PT cultures 
was substantially mediated by upregulation of DNA-repair and other oxidative defense mechanisms (see 
Suppl. Fig. I).
Ionizing radiation has been reported to upregulate UCP-2 expression in colon carcinoma cells33 and 
in a radiosensitive subclone of B cell lymphoma34, as well UCP-3 expression in rat retina35. Moreover, 
multi-resistant subclones of leukemia cells reportedly show higher UCP-2 protein expression, lower ∆Ψ m, 
lower radiation induced formation of reactive oxygen species and decreased DNA damage as compared 
to their parental sensitive cells36. Combined, these reported data hint to a possible function of UCPs in 
the development of radioresitance also in other tumor entities.
In conclusion, hypoxia/reoxygenation-tolerant PT cultures as well as renal cell carcinoma upregulate 
UCP-3 uncoupling protein in the inner mitochondrial membrane. UCP-3 upregulation attenuates at least 
in the in vitro PT model mitochondria-born oxidative stress during hypoxia/reoxygenation, and thus, 
confers partial hypoxia/reoxygenation resistance. Since tumor hypoxia promotes both, malignancy and 
therapy resistance, UCP-3 protein expression might be a prognostic and predictive marker in human 
neoplasms.
Methods
Selection of partially H/R-resistant proximal convoluted tubules (PT) cells. PT were microdis-
sected from newborn mice as described elsewhere37. PT cells were immortalized by SV40 large T antigen 
transformation38 as accomplished by transfection with SV3 neo, selected in geneticin-containing medium 
and cultured on collagenated surfaces in equal quantities of DMEM and Ham’s F-12 (GIBCO) medium 
containing 29 mM NaHCO3 (GIBCO), 5% serum, 2.5 mM glutamine, 2.5 mg/l insulin, 2.5 mg/l transfer-
rin, 15 nM sodium selenite (ITSS Supplement, Roche Diagnostics), 25 nM dexamethasone (Sigma), 5 ng/l 
epidermal growth factor (Calbiochem) and G418-BC (60U/ml, Biochrom). Four parallel cultures of PT 
cells were passaged (once per week) for 12 weeks. In this period of time, cells where weekly subjected 
to hypoxia (0.1% oxygen for 48 h starting 2–3 d after passaging the cells as applied by the BD GasPak 
EZ Pouch System,Becton and Dickinson). For control, further four PT cultures were grown under con-
tinuous normoxia, passaged twice weekly for 12 weeks. Thereafter, all cultures were passaged twice to 
increase cell number, aliquoted and frozen.
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H/R- and radiation-induced cell death. To test for an acquired hypoxia resistance, sub-confluent 
H/R-adapted and control cultures (from different selection cycles) were grown for 48 h under nor-
moxia or hypoxia (0.1% oxygen) followed by 0.5, 24 or 48 h of reoxygenation. In further experiments, 
H/R-adapted and control cultures were irradiated with single doses of 0, 5, or 10 Gy photons by the 
use of a linear accelerator (LINAC SL25 Philips) at a dose rate of 4 Gy/min at room temperature under 
normoxia. Following irradiation, cells were post-incubated in supplemented medium for 24 h or 48 h. 
H/R-treated or irradiated cells were trypsinated and then permeabilized and stained (30 min at room 
temperature) with propidium iodide (PI) solution (containing 0.1% Na-citrate, 0.1% triton X-100, 10 µ g/
ml PI in phosphate-buffered saline, PBS), and the DNA amount was analyzed by flow cytometry (FACS 
Calibur, Becton Dickinson, Heidelberg, Germany, 488 nm excitation wavelength) in fluorescence channel 
FL-2 (logarithmic scale, 564–606 nm emission wavelength). Dead cells with degraded DNA were defined 
by the sub G1 population of the PI histogram. Data were analyzed with the FCS Express 3 software (De 
Novo Software, Los Angeles, CA, USA).
Inner mitochondrial membrane potential (∆Ψm). To determine ∆ Ψ m, hypoxia (48 h)/reoxygen-
ation (24 h)-subjected as well as normoxic grown H/R-adapted and control PT cultures were trypsi-
nated, washed and incubated for 30 min at room temperature in a NaCl solution (in mM: 125 NaCl, 5 
d-glucose, 5 KCl, 1 MgCl2, 1 CaCl2, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES) 
titrated with NaOH to pH 7.4) containing the ∆ Ψ m specific dye tetramethylrhodamine ethyl ester per-
chlorate (TMRE, 25 nM, Invitrogen). ∆ Ψ m was analyzed by flow cytometry in FL-2 in the absence or 
presence of the proton ionophore carbonyl cyanide-3-chlorophenylhydrazone (CCCP, 1 µ M).
Formation of reactive oxygen species (RS). To test for mitochondrial production of superox-
ide anion, control or H/R-adapted PT cells were pretreated (normoxia or hypoxia (48 h)/reoxygena-
tion (24 h)), detached, incubated for 10 min at 37 °C in NaCl solution (see above) containing 5 µ M of 
the superoxide anion-sensitive dye MitoSOX, Invitrogen), and ROS-specific fluorescence was recorded 
by flow cytometry in Fl-2. To test for fluorescence dye loading, control samples were oxidized (1 mM 
tert-butylhydroperoxide) for 30 min and recorded.
uantitative RT-PCR. Messenger RNAs of H/R-adapted and control PT cultures (normoxic and after 
hypoxia (48 h)/reoxygenation (24 h)) were isolated (Qiagen RNA extraction kit, Hilden, Germany) and 
reversely transcribed in cDNA (RT2 First Strand Kit, SABiosciences, Qiagen). mRNA fragments were 
amplified by the use of an “oxidative stress” and an “apoptosis” PCR array (RT Profiler PCR Array, 
SABiosciences, Qiagen, Hilden, Germany) and a Roche Light Cycler 480. Ct (threshold cycle) values of 
the PCR amplifications were normalized to that of the housekeeper genes. Mouse UCP-3 and GAPDH 
specific cDNAs were amplified by QuantiTect Primer Assays (#QT00115339 and QT01658692, respec-
tively, Qiagen).
Transfection with siRNA. Adherent PT cells were grown in normal medium and transfected at 60% 
confluence with a transfection reagent (TransIT-TKO, Mirus Bio, Madison, WI, USA) according to the 
manufacturer’s instructions. UCP-3 siRNA and non-targeting siRNA (ON-TARGETplus SMARTpool, 
ON-TARGET Non-targeting siRNA, ThermoScientific Dharmacon, Chicago, IL, USA) were used at a 
final concentration of 50 nM. Transfection efficiency and viability was determined by transfecting the cells 
with 400 nM green fluorescence siGLO siRNA (ThermoScientific Dharmacon) followed by propidium 
iodide exclusion dye and flow cytometric analysis (data not shown). Immediately after transfection, cells 
were cultured either under normal conditions or hypoxic (48 h)/reoxygenation (24 h). Downregulation 
of UCP-3 was controlled by immunoblotting.
Immunoblotting. Following normoxia or hypoxia (48 h)/reoxygenation (24 h) H/R-adapted and 
control PT cultures as well as frehly frozen specimens from dissected human renal cell carcinoma 
with adjacent normal renal tissue. Patients gave informed consent and the experiments were approved 
by the ethical committee of the Faculty of Medicine, University of Tübingen (Ethik-Kommission der 
Medizinischen Fakultät und am Universitätsklinikum Tübingen, Gartenstrasse 47, 72074 Tübingen, 
Germany) and carried out in accordance with the approved guidelines. Specimens were lysed in a 
buffer (containing in mM: 50 HEPES pH 7.5, 150 NaCl, 1 EDTA, 10 sodium pyrophosphate, 10 NaF, 
2 Na3VO4, 1 phenylmethylsulfonylfluorid (PMSF) additionally containing 1% triton X-100, 5 µ g/ml apro-
tinin, 5 µ g/ml leupeptin, and 3 µ g/ml pepstatin) and separated by SDS-PAGE under reducing condition. 
Segregated proteins were electro-transferred onto PVDF membranes (Roth, Karlsruhe, Germany). Blots 
were blocked in TBS buffer containing 0.05% Tween 20 and 5% non-fat dry milk for 1 h at room temper-
ature. The membrane was incubated overnight at 4 °C with rabbit anti-UCP3 antibody (#ab3477, Abcam, 
Cambridge, UK). Equal gel loading was verified by an antibody against β-actin (mouse anti-β-actin 
antibody, clone AC-74, Sigma #A2228 1:20,000) or GAPDH (mouse anti-GAPDH, #ab8245 clone 6C5, 
Abcam, 1:20,000). Antibody binding was detected with a horseradish peroxidase-linked goat anti-rabbit 
or horse anti-mouse IgG antibody (Cell Signaling #7074 and #7076, New England Biolabs GmbH, 
Frankfurt am Main, Germany, 1:1000 and 1:2000 dilution in TBS-Tween/5% milk, respectively) incu-
bated for 1 h at room temperature and enhanced chemoluminescence (ECL Western blotting analysis 
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system, GE Healthcare/Amersham-Biosciences, Freiburg, Germany). Where indicated protein levels were 
quantified by densitometry using ImageJ software (ImageJ 1.40 g NIH, USA). UCP-3 expression of the 
tumor samples were categorized using an arbitrary score from 0 (not expressed, see Fig. 6B, 1st lane) to 
4 (highest expression, see Fig. 6B, 8th lane).
Statistics. Given data are means ± standard error (SE). Differences between experimental groups 
were assessed by (Welch-corrected) two-tailed student t-test or ANOVA where appropriate. P values of 
≤ 0.05 were defined significant.
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Neoadjuvant, adjuvant or deﬁnitive fractionated radiation therapy are implemented in ﬁrst line anti-cancer
treatment regimens of many tumor entities. Ionizing radiation kills the tumor cells mainly by causing double
strand breaks of their DNA through formation of intermediate radicals. Survival of the tumor cells depends on
both, their capacity of oxidative defense and their efﬁcacy of DNA repair. By damaging the targeted cells, ionizing
radiation triggers a plethora of stress responses. Among those is the modulation of ion channels such as Ca2+-
activated K+ channels or Ca2+-permeable nonselective cation channels belonging to the super-family of tran-
sient receptor potential channels. Radiogenic activation of these channels may contribute to radiogenic cell
death aswell as to DNA repair, glucose fueling, radiogenic hypermigration or lowering of the oxidative stress bur-
den. The present review article introduces these channels and summarizes our current knowledge on themech-
anisms underlying radiogenic ion channel modulation. This article is part of a Special Issue entitled: Membrane
channels and transporters in cancers.
© 2014 Elsevier B.V. All rights reserved.
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1. Introduction
Ionizing radiation kills or inactivates cells mostly by damaging the
nuclear DNA and cell survival critically depends on successful repair of
the DNA damage [1]. Ionizing radiation may lead to necrotic as well as
apoptotic cell death depending on cell type, dose and fractionation pro-
tocols [2]. The major death pathway in this scenario in normal tissue
cells is apoptosis. However, cancer cells which often have developed
strategies to evade apoptosis [3] may either undergo (regulated) necro-
sis or reenter the cell cycle with accumulated DNA damages. During the
subsequent cell divisions those cells will not be able to segregate the
chromosomes and end up asmultinucleated giant cells in mitotic catas-
trophe. Mitotic catastrophe again leads either to apoptotic or necrotic
cell death. Another possible mechanism of radiation-induced death in
cells with disturbed apoptosis machinery is excess autophagy. While
autophagy is a survival strategy [4] excess autophagy overdigests the
cytoplasm and cell organelles forcing the cell into apoptosis or necrosis
[5].
Meanwhile, the evidence is overwhelming that ion channels fulﬁll
pivotal functions in cell death mechanisms such as apoptosis (for
review see the article by Annarosa Arcangeli in this special issue on
“Membrane channels and transporters in cancers”) as well as in stress
response and survival strategies. Notably, tumor cells have been dem-
onstrated to express a set of ion channels which is different to that of
the parental normal cells. These channels may fulﬁll speciﬁc oncogenic
functions in neoplastic transformation, malignant progression or tissue
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invasion and metastasis (for review see [1]). In addition, they may con-
tribute to the cellular stress response for instance during fractionated
radiation therapy and may confer radioresistance.
The present review intends to sum up data on ion channel function
in the stress response to ionizing radiation. In particular, ion channels
that may induce cell death in tumor cells and facilitate radiogenic cell
killing are introduced. In addition, data on ion channels which, in con-
trast to the before mentioned, confer radioresistance are reviewed.
Finally, ion channels of tumor cells that might contribute to acquired
radioresistance, e.g. by promoting radiogenic hypermigration or transi-
tion into relatively radioresistant cancer stem (cell)-like cells (CSCs) are
described. Prior to that, a brief introduction into radiotherapy and its
radiobiological principles is given in the next paragraphs.
2. Radiotherapy
Radiation therapy together with surgery and systemic chemothera-
py is the main pillar of anti-cancer treatment. About half of all cancer
patients receive radiation therapy, half of all cures from cancer include
radiotherapy [6]. Despite modern radiation techniques and advanced
multimodal treatments, local failures and distant metastases often
limit the prognosis of the patients, especially due to limited salvage
treatments [7].
Ionizing radiation impairs the clonogenic survival of tumor cells
mainly by causing double strand breaks in theDNAbackbone. The num-
ber of double strand breaks increases linearly with the absorbed radia-
tion dose. The intrinsic capacity to detoxify radicals formed during
transfer of radiation energy to cellular molecules such as H2O (giving
rise to hydroxyl radicals, ˙OH) and the ability to efﬁciently repair DNA
double strand breaks by non-homologous end joining or homologous
recombination determines the radiosensitivity of a given tumor cell.
Irradiated tumor cells which leave residual DNA double strand breaks
un-repaired lose their clonogenicity meaning that these cells can not
restore tumor mass (for review see [8]).
In addition to these intrinsic resistance factors, the microenviron-
ment may lower the radiosensitivity of tumor cells. Hypoxic areas are
frequent in solid tumors reaching a certain mass. Tumor hypoxia, how-
ever, decreases the efﬁcacy of radiation therapy [9]. Ionizing radiation
directly or indirectly generates radicals in the deoxyribose moiety of
the DNA backbone. In a hypoxic atmosphere, cellular thiols can react
with those DNA radicals resulting in chemical DNA repair. At higher
oxygen partial pressure, in sharp contrast, radicals of the deoxyribose
moiety are chemically transformed to strand break precursors [10]. By
this mechanism, hypoxia increases radioresistance by a factor of two
to three (oxygen enhancement ratio) [11].
Fractionated treatment regimens which improve recovery of the
normal tissue after irradiation but not of the tumor have been
established in radiotherapy [12]. In addition to limit normal tissue tox-
icity, killing of tumor mass by initial radiation fractions has been dem-
onstrated to reoxygenate and thereby radiosensitize solid tumors
during further fractionated radiotherapy. Beyond that, fractionated
radiation regimens aim to redistribute tumor cells in a more vulnerable
phase of the cell cycle in the time intervals between two fractions [13].
Accelerated repopulation of the tumor after irradiation is a frequently
reported phenomenon. Possible mechanisms of accelerated repopula-
tion include induction of CSCs: It has been proposed that radiation ther-
apy induces CSCs to switch from an asymmetrical into a symmetrical
mode of cell division; i.e., a CSC which is thought to normally divide
into a daughter CSC and a lineage-committed progenitor cells is induced
by the radiotherapy to divide symmetrically into two proliferative CSC
daughter cells. This is thought to accelerate repopulation of the tumor
after end of radiotherapy. Importantly, CSCs are thought be relatively
radioresistant possibly due to i) high oxidative defense and, therefore,
low radiation-induced insults, ii) activated DNA checkpoints resulting
in fast DNA repair, and iii) an attenuated radiation-induced cell cycle
redistribution [14].
Finally, fractionated radiation therapy, which applies fractions of
sublethal radiation doses (usually 2 Gy per fraction), has been demon-
strated in a variety of tumor entities in vitro and in animal models to
stimulate hypermigration and hypermetastasis of tumor cells as well
as inﬁltration of the tumor by CD11b-positive myeloid cells and subse-
quent vasculogenesis. It is tempting to speculate that radiogenic
hypermigration boosts cellular interaction of tumor cells with non-
tumor cells, e.g. endothelial cells. It has been proposed that CSCs lodge
within perivascular niches where a complex regulatory network
supports CSC survival [15]. As a matter of fact, CSCs but not non-CSCs
gain radioresistance when transplanted orthotopically in mice [16]
supporting the idea of a tumor microenvironment-dependent acquired
radioresistance. Ion channels contribute to both, intrinsic and acquired
radioresistance of tumor cells as discussed in the next paragraphs
3. Radiosensitizing ion channels
Member 2 of the melastatin family of transient receptor potential
channel (TRPM2) is a Ca2+-permeable nonselective cation channel.
Heterologous expression of TRPM2 in human embryonic kidney cells
[17] or A172 human glioblastoma cells [18] facilitates oxidative stress-
induced cell death. Reactive oxygen species (ROS) have been demon-
strated to trigger TRPM2 activation [19,20]. The principal activator,
however, of TRPM2 is ADP-ribose (ADPR) that binds to a special domain
located at the C-terminus of the channel [21,22]. Sources of ADPR are
the mitochondria [23] or ADPR polymers. The latter are formed,
e.g., during DNA repair by poly (ADP-ribose) polymerases (PARPs).
ADPR is released from the ADPR polymers by glycohydrolases [21,24].
Expression of TRPM2 has been demonstrated in several tumor enti-
ties such as insulinoma [25], hepatocellular carcinoma [25], prostate
cancer [26], lymphoma [27], leukemia [28] and lung cancer cell lines
[29]. TRPM2 activity increases the susceptibility to cell death [30] prob-
ably by overloading cells with Ca2+ (Fig. 1A).
Remarkably, cancer cells may evade TRPM2-mediated cell death. In
lung cancer cells, de-methylation of a GpC island within the TRPM2
gene gives rise to new promoters that regulate transcription of a non-
functional truncated TRPM2 channel [29] and to a TRPM2 speciﬁc anti-
sense RNA. This antisense RNA inhibits TRPM2 translation. Moreover,
the truncated channel is non-functional and acts dominant negative,
thus switching off the tumor-suppressing function of the full-length
TRPM2 protein [29] (Fig. 1B).
The initially described member of the vanilloid family of TRP chan-
nels, the nociceptive and heat receptor TRPV1, is reportedly expressed
in several tumor entities such as uveal melanoma [31], pancreatic [32]
and prostatic neuroendocrine tumors [33], glioblastoma [34] and
urothelial cancer of human bladder [35]. At least in the latter two
tumor entities, TRPV1 exerts anti-oncogenic effects [35,36]. TRPV1
expression inversely correlates with glioma grading [34]. Remarkably,
neural precursor cells have been demonstrated to induce ER stress-
mediated cell death of glioblastoma cells by activating glioblastoma
TRPV1 channels through secretion of endogenous vanilloids [37].
Along those lines is the observation that a TRPV1 antagonist promotes
tumorigenesis in mouse skin [38].
Notably, targeting of TRPM2 and TRPV1 by RNA interference has
been demonstrated to decrease gamma irradiation-induced formation
of nuclear γH2AX foci and further DNA damage response in A549 lung
adenocarcinoma cells [39]. Since γH2AX foci are used as a surrogate
for DNA double strand breaks, one might speculate that TRPM2 or
TRPV1 may amplify ionizing radiation-induced insults (Fig. 1). Another
interpretation which has been favored by the author of the study [39]
would be that activity of TRPM2 and TRPV1 is required for the formation
of DNA repair complexes. In combination, the data hint to the possibility
of radiosensitizing cancer cells by pharmacologically activating TRPM2
or TRPV1 channels. Whether this might become a promising new strat-
egy of tumor radiosensitization has to await animal studies.
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4. Ion channels conferring intrinsic radioresistance
DNA repair involves cell cycle arrest, chromatin relaxation and for-
mation of repair complexes at the site of DNA damage. Moreover,
radiation-induced formation of radicals requires activated radical
detoxiﬁcation pathways and increased oxidative defense to constrain
the radiation-induced insults. All these processes of stress response
lead to elevated ATP consumption which requires intensiﬁed energy
supply. Recent in vitro observations suggest that these processes
depend at least partially on radiation-induced ion channel activation.
Studies of our laboratory indicate that survival of irradiated human
leukemia cells critically depends on Ca2+ signaling involving radiogenic
activation of TRPV5/6-like nonselective cation and Kv3.4 voltage-gated
K+ channels [40,41]. The nonselective cation channels in concert with
Kv3.4 generate radiogenic Ca2+ signals that contribute to G2/M cell
cycle arrest by CaMKII-mediated inhibition of the phosphatase cdc25B.
Activity of the latter is required in these cells for release from
radiation-induced G2/M arrest via dephosphorylation and thereby
activation of cdc2, a component of the mitosis promoting factor. Exper-
imental interference with the radiogenic Ca2+ signals, e.g. by pharma-
cological inhibition or knock-down of Kv3.4 overrides cell cycle arrest
resulting in increased apoptosis and decreased clonogenic survival of
irradiated leukemia cells [40,41]. This radiosensitization by Kv3.4
targeting demonstrates the pivotal role of radiogenic Kv3.4 channel
activation for cell cycle arrest and DNA repair.
Similar to leukemia cells, A549 lung adenocarcinoma cells reported-
ly respond to ionizing radiation with activation of Kv K+ channels [42]
and transient hyperpolarization of the plasma membrane. Later on,
the membrane potential of the irradiated A549 cells strongly depolar-
izes. This depolarization is dependent on external glucose and inhibited
by phlorizin, a sodium glucose cotransporter (SGLT) blocker. In parallel,
irradiation induces phlorizin-sensitive 3H-glucose uptake within few
minutes after irradiation [43]. Combined, these data suggest that radio-
genic activation of SGLT transporters and Kv K+ channels cooperate in
glucose fuelling of the irradiated A549 cells, the former by generating
the glucose entry routes, the latter by increasing and maintaining the
driving force for Na+-coupled glucose entry. Glucose uptake by SGLTs
is mainly driven by the inwardly directed electrochemical driving
force for Na+ which in turn is highly dependent on the K+ channel-
regulated membrane potential. SGLTs allow efﬁcient glucose uptake
even from a glucose-depleted microenvironment which is typical for
malperfused solid tumors [44]. It is therefore not surprising that several
tumor entities such as colorectal, pancreatic, lung, head and neck, pros-
tate, kidney, cervical, breast, bladder and prostate cancer as well as
chondrosarcomas and leukemia upregulate SGLTs [45–53].
SGLT has been shown to be in complex with the EGFR [50,53] and
radiogenic SGLT activation depends on EGFR tyrosine kinase activi-
ty [43]. Importantly, radiogenic increase in glucose fuelling seems to
be required for cell survival since the SGLT inhibitor phlorizin
radiosensitizes A549 lung adenocarcinoma and FaDu head and neck
squamous carcinoma cells [43].
Intracellular ATP concentration has been reported to drop in irra-
diated A549 cells indicative of an irradiation-caused energy crisis.
Notably, recovery from radiation-induced ATP decline is EGFR/SGLT-
dependent and associated with improved DNA-repair leading to
increased clonogenic cell survival. This is evident from the fact that
EGFR or SGLT blockade delays recovery of intracellular ATP concentra-
tion and histone modiﬁcations necessary for chromatin remodeling
during DNA repair. Vice versa, inhibition of the histone H3modiﬁcation
prevents chromatin remodeling as well as energy crisis [8]. Together,
these data suggest that irradiation-associated interactions between
SGLT1 and EGFR result in increased glucose uptake, which counteracts
the energy crisis in tumor cells caused by chromatin remodeling
required for DNA repair (Fig. 2) [8,43].
Besides plasma membrane ion channels, mitochondrial transport
pathways have been shown to contribute to cellular stress response.
Stress-induced upregulation of uncoupling proteins (UCPs) conveys
hyperpolarization of the membrane potential across the inner mito-
chondrial membrane (∆Ψm,) and thereby formation of reactive oxygen
species [54]. UCPs are reportedly upregulated in a number of aggressive
human tumors (leukemia, breast, colorectal, ovarian, bladder, esopha-
gus, testicular, kidney, pancreatic, lung, and prostate cancer) in which
they are proposed to contribute to malignant progression (for review
see [54]).
In addition to malignant progression, UCPs may alter the therapy
sensitivity of tumor cells. UCP-2 expression has been associated with
paclitaxel resistance of p53 wildtype lung cancer, CPT-11 resistance of
colon cancer and gemcitabine resistance of pancreatic adenocarcinoma,
lung adenocarcinoma, or bladder carcinoma. Accordingly, experimental
targeting of UCPs has been demonstrated to sensitize tumor cells to
chemotherapy in vitro (for review see [54]).
Notably, ionizing radiation induces up-regulation of UCP-2 expres-
sion in colon carcinoma cells [55] and in a radiosensitive subclone of B
cell lymphoma [56], as well as UCP-3 expression in rat retina [57].
Radioprotection might result from lowering the radiation-induced bur-
den of reactive oxygen species. As a matter of fact, multi-resistant
subclones of leukemia cells reportedly show higher UCP-2 protein
expression, lower ∆Ψm, lower radiation induced formation of reactive
oxygen species, and decreased DNA damage as compared to their
parental sensitive cells [58].
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In summary, these data indicate that ion transports through chan-
nels may regulate processes that mediate intrinsic radioresistance.
Only few laboratories worldwide including ours are working on the
radiophysiology of tumor cells. The investigation of ion transports in
irradiated cells therefore is at its very beginning and the few data
available are mostly phenomenological in nature. The molecular mech-
anisms that underlie e.g. radiogenic channel activation are still ill-
deﬁned. Nevertheless, the data prove functional signiﬁcance of ion
transports and electrosignaling for the survival of irradiated tumor
cells and might have translational implications for radiotherapy in the
future.
5. Ion channels in acquired radioresistance
Microenvironmental stress such as hypoxia, interstitial nutrient
depletion or low pH has been proposed to switch tumor cells from a
“Grow” into a “Go” phenotype. By migration and tissue invasion “Go”
tumor cells may evade the locally conﬁned stress burden and resettle
in distant and less hostile regions. Once resettled, tumor cells may
readapt the “Grow” phenotype by reentering cell cycling and may
establish tumor satellites in more or less close vicinity of the primary
focus (for review see [54]).
In accordance with this hypothesis, sublethal ionizing irradiation as
applied in single fractions of fractionated radiotherapy has been
demonstrated in vitro and/or in rodent tumor models to induce migra-
tion, invasion and metastasis or spreading of cervix carcinoma [59],
head and neck squamous cell carcinoma [60], lung adenocarinoma
[61,62], colorectal carcinoma [62], breast cancer [62–64], meningioma
[65], medulloblastoma [66] and glioblastoma. In particular, in glioblas-
toma the experimental evidence for such radiogenic hypermigration is
meanwhile overwhelming [67–80]. Glioblastoma cells show a highly
migrative phenotype that may “travel” large distances through the
brain [81]. At least in theory, radiogenic hypermigration might, there-
fore, contribute to locoregional treatment failure by promoting emigra-
tion of tumor cells from the target volume during fractionated radiation
therapy.
Migration and radiogenic hypermigration are well documented in
glioma cells. They invade the surrounding brain parenchyma primarily
by moving along axon bundles and the vasculature. During brain inva-
sion along those tracks cells have to squeeze between very narrow
interstitial spaces which requires effective local cell volume decrease
and reincrease. Glioblastoma cells are capable of losing all unbound
cell water [82]. The electrochemical driving force for this tremendous
cell volume decrease is provided by an unusually high cytosolic Cl−
concentration (100 mM) [83,84] which is utilized as an osmolyte. Dur-
ing local regulatory volume decrease, extrusion of Cl− and K+ along
their electrochemical gradients involves ClC-3 Cl−- channels [85,86],
Ca2+-activated high conductance BK- [74,87,88] and intermediate
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conductance IK K+ channels [86,89]. Inhibition of either of these chan-
nels attenuates glioblastoma cell migration or invasion [83,90–94]
conﬁrming their pivotal function in these processes.
Ionizing radiation has been demonstrated in our laboratory to acti-
vate BK K+ channels in glioblastoma cells in vitro [74]. Radiogenic BK
channel activity, in turn, is required for Ca2+/calmodulin kinase II
(CaMKII)- [74] and consecutive CaMKII-dependent ClC-3 channel acti-
vation (own unpublished observation and [85]). Inhibition of BK or
CaMKII abolishes radiogenic hypermigration [74] indicating BK channel
activation as key event of radiogenic hypermigration of glioblastoma
cells. Radiogenic hypermigration is paralleled by radiogenic expression
of the chemokine SDF-1 (stromal cell-derived factor-1, CXCL12) in
different tumor entities including glioblastoma [80,95–97]. Glioblasto-
ma cells reportedly express CXCR4 chemokine receptors and SDF-1
stimulates glioblastoma cell migration via CXCR4-mediated Ca2+ sig-
naling [93]. CXCR4 receptors reportedly signal through phospholipase
C and BK channels have been shown to be functionally coupled with
IP3 receptors in the ER [98] suggesting (and conﬁrmed by own unpub-
lished observations) that radiogenic SDF1/CXCR4 signaling is upstream
of BK channel activation. SDF-1, in turn, is a target gene of the transcrip-
tion factor HIF-1α which reportedly becomes stabilized, e.g. by S-
nitrosylation, upon irradiation [95,99–101] (Fig. 3). Together, this
gives a good example of radiogenic signalingwhich integrates biochem-
ical signaling, electrosignaling (i.e., BK-dependent regulation of mem-
brane potential) and Ca2+ signaling modules (more details are given
in the legend to Fig. 3).
Ionizing radiation has been demonstrated to select stem (cell)-like
glioblastoma cells (GSCs) or even induce transition of “differentiated”
cancer cells to GSCs/CSCs in glioblastoma [102–104] and other tumor
entities [14]. Notably, “stemness” is associated with SDF-1 secretion
[105] and markedly increased CXCR4 chemokine expression [106]. Im-
portantly, CXCR4 upregulation is required to maintain “stemness” of
non-small cell lung cancer [107] and glioblastoma cells [105]. In accor-
dance to CXCR4 upregulation, GSCs show a highly migratory/invasive
phenotype [108,109]. Most importantly, this phenotype is highly
dependent on the Ca2+-activated IK K+ channel [89,109]. Furthermore,
IK channels have been demonstrated to be overexpressed in about one
third of the glioma patients with IK protein expression correlating with
poor patient survival [89].
Unexpectedly, a previous report demonstrated that xenografted
CD133+ stem-like subpopulations of glioblastoma exhibit a higher
radioresistance than xenografted CD133− cells while radiosensitivity
of both subpopulations does not differ in vitro [16]. This clearly indicates
a function of the brain microenvironment for radioresistance. In partic-
ular, endothelial cells have been postulated to promote glioblastoma
therapy resistance [110]. Part of the reported reciprocal interaction
between glioblastoma cells and endothelial cells as well as of the com-
plex signaling network in perivascular “niches” is schematically sum-
marized in Fig. 4.
Albeit merely speculative, the idea that radiogenic hypermigration
might promote “homing” of (CXCR4-highly-expressing stem-like) glio-
blastoma cells to perivascular niches is highly attractive. The subse-
quent reciprocal modiﬁcations of glioblastoma and endothelial cells
might eventually induce radioresistance of glioblastoma cells. Together,
these data suggest that radiogenic hypermigration might contribute to
the apparently high radioresistance of glioblastoma cells either by pro-
moting evasion from the radiation target volume or by stimulating the
chemotaxis of glioblastoma cells to “radioprotective” perivascular
niches.
6. Concluding remarks
The radiation physiology of cancer cells is yet a neglected research
ﬁeld. While the number of reports on ion channel function in neoplastic
transformation, malignant progression or metastasis of cancer cells in-
creases constantly only little is known about the role of ion channels
in radiotherapy. The few data available strongly suggest that ionizing
radiation-induced ion channel modiﬁcations are a common phenome-
non. Importantly, these modiﬁcations impact on the stress response
and survival of irradiated tumor cells. By modulating intracellular
Ca2+ signals radiosensitive ion channels may directly crosstalk with
the biochemical signaling of the DNA damage response. By driving
local cell volume changes radiogenic ion channel modiﬁcations may
promote cell migration and stress evasion of irradiated tumor cells. By
stabilizing the membrane potential ionizing radiation-induced K+
channel activity might facilitate Na+-coupled glucose uptake providing
the energy for DNA-repair. Finally, mitochondrial channels upregulated
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speculative role of ionizing radiation herein. A. Irradiation induces secretion of SDF-1
[80,95–97] and transition of CD133− “differentiated” glioblastoma cells to CD133+ GSCs
with up-regulated CXCR4 [106], β1/α3 integrins [108], TGFB2 receptor [115], TGF-β
responsiveness [115], and IK Ca2+-activated K+ channel-dependent highly migratory
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sion by glioblastoma [114] and SDF-1 signaling of endothelial cells [110]. Importantly,
irradiation induces upregulation of MMP-2 in glioblastoma cells (B) which is required
for tissue invasion [67,71,72,79,114] and VEGF secretion (B) [71,75] which reportedly
may promote angiogenesis [116]. In addition, transition of glioblastoma cells into endo-
thelial cells [117] and pericytes [15] reconstruct the glioblastoma vasculature which sup-
ports both, vessel function and tumor growth.
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by ionizing radiation might lower the oxidative insults associated
with ionizing radiation. Given the aberrant and partly speciﬁc ion
channel expression of tumor cells, a more profound understanding
of the mechanisms underlying radiogenic ion channel modiﬁcations
might be harnessed in the future to develop new strategies for the
radiosensitization of tumors.
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The standard treatment of many tumor entities comprises fractionated radiation therapy
which applies ionizing radiation to the tumor-bearing target volume. Ionizing radiation
causes double-strand breaks in the DNA backbone that result in cell death if the number
of DNA double-strand breaks exceeds the DNA repair capacity of the tumor cell. Ionizing
radiation reportedly does not only act on the DNA in the nucleus but also on the plasma
membrane. In particular, ionizing radiation-induced modifications of ion channels and
transporters have been reported. Importantly, these altered transports seem to contribute
to the survival of the irradiated tumor cells. The present review article summarizes
our current knowledge on the underlying mechanisms and introduces strategies to
radiosensitize tumor cells by targeting plasma membrane ion transports.
Keywords: radiation therapy, cell cycle, DNA repair, ion channels
INTRODUCTION
Increasing pieces of evidence strongly indicate that ion trans-
ports across biological membranes fulfill functions beyond those
described by classical physiology such as epithelial transports and
neuronal or muscle excitability. More and more, it turns out that
ion transports are involved in virtually all cell-biological pro-
cesses. By modifying the chemistry, electricity and mechanics
of cells, ion transports directly interact with cellular biochem-
istry and constitute signaling modules that are capable of altering
protein function, gene expression (Tolon et al., 1996) and epige-
netics (Lobikin et al., 2012). Moreover, ion transport-generating
proteins such as ion channels have been identified to directly
signal in macromolecular complexes with, e.g., surface recep-
tors and downstream kinases (Arcangeli, 2011), or to directly
bind to DNA as transcription factors (Gomez-Ospina et al.,
2006).
Over the past two decades, ion transports camemore andmore
in the focus of oncological research. Increasingly, data accumu-
late indicating tumor-suppressing as well as oncogenic functions
of ion transport processes. In particular, ion transports have been
identified as key regulators of neoplastic transformation, malig-
nant progression, tissue invasion and metastasis (for review see
Huber, 2013). Most recent data suggest that ion transports may
also contribute to therapy resistance especially to radioresistance
of tumor cells. The second chapter of this review article aims at
giving an overview of those data. Since worldwide, only a hand-
ful of laboratories including ours are working in this research
field only few data on ion transports in radioresistance are avail-
able and in most cases, the underlying molecular mechanisms
of the observed phenomena remain ill-defined. Because tumor
hypoxia is a major obstacle in radiotherapy, the second chap-
ter also includes ion transports in the mitochondria that confer
hypoxia resistance to normal tissue and probably also to tumor
cells. At the end, this article provides some ideas how the acquired
knowledge might be harnessed in the future for new strategies
of anti-cancer therapy that combine ion transport-targeting and
radiotherapy. To begin with, a brief introduction into radio-
therapy and its radiobiological principles is given in the next
paragraphs.
RADIOTHERAPY
According to the GermanCancer Aid, 490,000 people in Germany
are diagnosed with cancer every year (German-Cancer-Aid,
2013a) (data originating from February 2012), 218,000 die from
their disease. About half of all cancer patients receive radia-
tion treatment, half of all cures from cancer include radio-
therapy (German-Cancer-Aid, 2013b). Radiotherapy is one of
the main pillars of cancer treatment together with surgery and
systemic therapy, mainly chemotherapy. Examples for curative
radiotherapy without surgery are prostate (Eckert et al., 2013;
Kotecha et al., 2013) and head and neck cancer (Glenny et al.,
2010). Preoperative radiotherapy is applied in rectal cancer
(Sauer et al., 2012), postoperative treatment in breast cancer
(Darby et al.). Yet, also rare tumor entities like sarcoma and
small cell carcinoma are treated with radiotherapy (Eckert et al.,
2010a,b; Muller et al., 2012). Despite modern radiation tech-
niques and advanced multimodal treatments local failures and
distant metastases often limit the prognosis, especially due to
limited salvage treatments (Muller et al., 2011; Zhao et al.,
2012).
INTRINSIC AND HYPOXIC RADIORESISTANCE
Radiation therapy impairs the clonogenic survival of tumor cells
mainly by causing double strand breaks in the DNA backbone.
The number of double strand breaks increases linearly with the
absorbed radiation dose (unit Gray, Gy). The intrinsic capacity
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to repair these DNA damages by non-homologous end joining
or homologous recombination determines how radio resistant a
given tumor cell is. Irradiated tumor cells which leave residual
DNA double strand breaks unrepaired lose their clonogenicity
meaning that these cells cannot restore tumor mass. Ion trans-
ports may directly be involved in the cellular stress response to
DNA damage by controlling cell cycle, metabolic adaptations or
DNA repair and, thus, contribute to intrinsic radioresistance and
the survival of the tumor cell.
Besides intrinsic factors, the microenvironment influences
the radiosensitivity of a tumor. Hypoxic areas frequently occur
in solid tumors. Hypoxic tumor cells, however, are somehow
“protected” from radiotherapy [reviewed in Harada (2011)].
This is because ionizing radiation generates directly or indi-
rectly radicals in the deoxyribose moiety of the DNA backbone.
In a hypoxic atmosphere, thiols can react with those DNA
radicals by hydrogen atom donation which results in chemi-
cal DNA repair. In the presence of oxygen, in contrast, oxy-
gen fixes radicals of the deoxyribose moiety to strand break
precursors (Cullis et al., 1987). This so called oxygen effect
radiosensitizes tumor cells by a factor of two to three (oxy-
gen enhancement ratio) as compared to the hypoxic situation
(Langenbacher et al., 2013). Accordingly, patients with hypoxic
tumors who undergo radiotherapy have a worse prognosis than
those with normoxic tumors [e.g., cervical cancer (Fyles et al.,
2002, 2006)]. Notably, ion transport processes have been iden-
tified as important players in the adaptation of tumor cells to
a hypoxic microenvironment. Hence, ion transports via adapta-
tion to hypoxia also indirectly contribute to the radioresistance
of tumors.
In radiotherapy, fractionated treatment regimens have been
established which may reoxygenate and thereby radiosensitize
the irradiated tumor during therapy time. In addition, frac-
tionated radiotherapy spaces out the single fractions in a way
that allows DNA repair of normal tissue, that re-distribute
cell cycle of the tumor cells in more sensitive phases and
that minimize repopulation of the tumor during therapy. The
next paragraphs will give an introduction to the underlying
radiobiology.
FRACTIONATED RADIATION THERAPY. REPAIR, REOXYGENATION,
REDISTRIBUTION, AND REPOPULATION
Early in historic development of radiotherapy fractionation was
introduced as a means to limit side effects when giving therapeu-
tic radiation doses (Bernier et al., 2004). Standard fractionation is
defined as single doses of 1.8–2 Gy, once daily, 5 days per week.
The principal rationale for fractionation is based on the fact
that recovery after radiation is better in normal tissue than in
tumors, especially concerning late reacting tissues responsible
for late side effects of radiotherapy (Jones et al., 2006) such
as fibrosis, damage of spinal cord and brain, as well as most
inner organs. Radiation with high single doses is only possi-
ble without increased side effects if the radiation field can be
confined to the tumor (e.g., stereotactic radiotherapy of brain
metastases [Rodrigues et al., 2013) and SBRT, stereotactic body
radiation therapy (Grills et al., 2012)]. Yet, many situations in
radiation oncology such as adjuvant treatment or irradiation of
nodal regions require irradiation of significant volumes of normal
tissue.
Alpha-beta ratios
Acute effects of ionizing irradiation on clonogenic cell sur-
vival in vitro as well as on late toxicity of the normal tissue
in patients which underwent radiotherapy are described by the
linear-quadraticmodel (Barendsen, 1982; Dale, 1985). The math-
ematical fit of the clonogenic survival (late toxicity) is calculated
as follows: N = N0 × E−(αD−βD∧2) with N being the number of
surviving cells (patients without late toxicity), N0 being the ini-
tial number of cells (number of patients receiving radiotherapy),
α [1/Gy] and β [1/Gy∧2] being cell (tissue)-specific constants and
D the delivered radiation dose. Low alpha-beta ratios (α/β) [Gy]
as determined for many normal tissues indicate that dose frac-
tionation in daily fractions of usually 2 Gy increases survival and
decreases late toxicity as compared to a single equivalent dose.
Tumors with high alpha-beta ratios, in contrast do not bene-
fit from fractionation. For some tumors such as squamous cell
carcinoma of the head and neck there is even a rationale for
hyperfractionated radiotherapy with twice daily irradiation of
1.2–1.4 Gy per fraction [reviewed in Nguyen and Ang (2002)].
The theoretical advantage has been confirmed in clinical tri-
als [e.g., EORTC trial 22791 in advanced head and neck cancer
Horiot et al. (1992)]. Different fractionation schedules for distinct
clinical situations are applied for example in whole-brain radio-
therapy. In prophylactic radiation 2–2.5 Gy fractions are applied
to limit neurocognitive deficits (Auperin et al., 1999; Le Pechoux
et al., 2011; Eckert et al., 2012). For therapeutic radiation 3 Gy
fractions or even 4 Gy fractions are preferred in a palliative set-
ting and limited life expectancy to shorten the treatment time to
5 or 10 days (Lutz, 2007; Rades et al., 2007a,b).
Reoxygenation
As mentioned above, fractionated radiation may also lead to
reoxygenation of the tumor during therapy (Withers, 1975;
Pajonk et al., 2010). Blood vessels of tumors lack normal archi-
tecture and are prone to collapse whenever tissue pressure of
the expanding tumor mass increases. This aggravates tumor mal-
perfusion and accelerates intermittent or chronic tumor hypoxia.
Being sublethal as related to the whole tumor, single radiation
fractions in the range of 2 Gy kill a significant percentage of the
tumor cells which give rise to tumor shrinkage. Shrinkage, in
turn, is thought to increase blood and oxygen supply of the tumor
by improving vessel perfusion and by increasing the ratio of vas-
cularization and the residual tumor mass (Maftei et al., 2011;
Narita et al., 2012). Increased oxygenation then reverses hypoxic
radioresistance of the tumor and improves the therapeutic out-
come of radiotherapy.
Redistribution and repopulation
The sensitivity to radiotherapy during cell cycle differs, being
highest inM and lowest in late S phase of cell cycle (Pawlik and
Keyomarsi, 2004). Often depending on p53 function, irradiated
tumor cells accumulate in G1 or G2 phase of cell cycle to repair
their DNA damages. In a radiation dose-dependent manner, irra-
diated cells are released from cell cycle arrest and re-enter cell
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cycling and tumor repopulation. Importantly, repopulation after
irradiation is often accelerated probably due to selection of more
aggressive tumor cells (Marks and Dewhirst, 1991). Fractionated
radiation regimes aim to re-distribute tumor cells in a more vul-
nerable phase of the cell cycle in the time intervals between two
fractions and to impair repopulation (Pawlik and Keyomarsi,
2004).
CANCER STEM CELLS (CSCs)
Cancer stem cells (CSCs) may resist radiation therapy [for review
see Pajonk et al. (2010)]. Mechanisms that might contribute to
the relative resistance of CSCs as compared to the non-CSC
cells of a given tumor include (i) higher oxidative defense and,
therefore, lower radiation-induced insults, (ii) activated DNA
checkpoints resulting in faster DNA repair, and (iii) an atten-
uated radiation-induced cell cycle redistribution. Fractionation
regimes are designed that way that the macroscopically visible
bulk of tumor cells (i.e., the non CSCs) and not the rare CSCs
become redistributed into a more vulnerable phase of cell cycle
between two consecutive fractions of radiotherapy. Finally, radia-
tion therapy is thought to switch CSCs from an asymmetrical into
a symmetrical mode of cell division; i.e., a CSC which normally
divides into a daughter CSC and a lineage-committed progenitor
cell is induced by the radiotherapy to divide symmetrically into
two proliferative stem daughter cells. This is thought to acceler-
ate repopulation of the tumor after end of radiotherapy (Pajonk
et al., 2010).
In summary, fractionated radiotherapy may radio sensitize
tumor cells by reoxygenation of the tumor and redistribution of
the tumor cells in more vulnerable phases of cell cycle while pro-
tecting at the same time normal tissue if the alpha-beta ratio of
the tumor exceeds that of the normal tissue. On the other hand,
the applied fractionation protocols might spare CSCs due to their
radiobiology that differs from that of the bulk of non-CSCs.
Furthermore, single radiation fractions apply sublethal doses of
ionizing radiation. Data from in vitro and animal studies suggest
that sublethal doses of ionizing radiationmay stimulate migration
and tissue invasion of the tumor cells. Translated into the in vivo
situation, this might imply that cells at the edge of solid tumors
might be stimulated by the first radiation fractions to migrate
out of the target volume of radiation resulting in survival of the
evaded cells and tumor relapse. Moreover, if radiation fractions
further induce tumor cell invasion into blood or lymph vessels,
fractionated radiotherapy regimes might also boost metastases.
As described in the next paragraphs, ion transports fulfill piv-
otal functions in cell migration especially in radiation-induced
migration.
ION TRANSPORTS AND RADIORESISTANCE
Ion transports can be assessed by tracer-flux measurements, flu-
orescence microscopy/photometry using ion species-specific flu-
orescence dyes such as the Ca2+-specific fluorochrome fura-2, as
well as by electrophysiological means. The latter can be applied
if ion transports are electrogenic. Measurements of ion trans-
ports during treatment with ionizing radiation are hardly feasible.
Reported electrophysiological in vitro data on irradiated tumor
cells indicate that radiation-induced transport modifications may
occur instantaneously and may last up to 24 h post irradiation
(Kuo et al., 1993). They further suggest that these modifica-
tions may be induced by doses used for single fractions in the
clinic (Steinle et al., 2011). The following paragraphs summarize
radiation-induced transport modifications as observed in in vitro
studies on tumor cell lines and their putative contribution to
the radioresistance of tumor cells. Whether these processes may
indeed underlie therapy failure in tumor patients can only be
answered if more data from tumor mouse models and clinical
trials become available.
Tumor cells have been proposed to adapt either a “Grow” or
a “Go” phenotype in dependence on changes in their microenvi-
ronment. When developing a certain mass, growing solid tumors
are prone to become malperfused because of the insufficient
tumor vasculature. As a consequence of malperfusion, microen-
vironmental stress by hypoxia, interstitial nutrient depletion, and
low pH increases (Stock and Schwab, 2009; Hatzikirou et al.,
2012) which is thought to trigger at a certain point the induc-
tion of the “Go” phenotype. By migration and tissue invasion
“Go” tumor cells may evade the locally reined stress burden and
resettle in distant and less hostile regions. Once re-settled, tumor
cells may readapt the “Grow” phenotype by reentering cell cycling
and may establish tumor satellites in more or less close vicinity
of the primary focus. Moreover, this stress evasion may lead to
metastases if the “Go” cells invade into blood or lymph vessels.
Migration and tissue invasion are directed by extracellular
hapto- and chemotactic signals which trigger preset “Go” pro-
grams (Schwab et al., 2007, 2012). The latter comprise intracel-
lular signaling, cellular motor functions including cell volume
changes and cytoskeletal dynamics, as well as extracellular matrix
digestion and reorganization. Ion transports have been suggested
to contribute to all of these processes (Schwab et al., 2007, 2012).
As a matter of fact, highly invasive and metastatic phenotypes of
tumor cells often show aberrant activity of certain ion transports.
The following paragraphs describe the role of these ion trans-
ports in particular of those across the plasma membrane using
the example of glioblastoma cells.
MOTOR FUNCTION
Glioblastoma cells exhibit a highly migrative phenotype and
“travel” long distances throughout the brain (Johnson et al.,
2009). Primary foci of glioblastoma show, therefore, even at early
stages of diagnosis a characteristic diffuse and net-like brain
infiltration (Niyazi et al., 2011). Tumor margins are often not
definable and complete surgical tumor resection as well as cap-
ture of all residual tumor cells by the radiation target volume
is hardly possible (Weber et al., 2009). This results in therapy
failure accompanied by very bad prognosis for the survival of
the patient in almost all cases of glioblastoma (Niyazi et al.,
2011). Glioblastoma cells typically migrate into the surround-
ing brain parenchyma primarily by using nerve bundles and the
vasculature as tracks. The close vicinity to the vasculature has
the advantage for the migrating glioblastoma cell of a continu-
ous and sufficient supply of oxygen, nutrients, growth factors,
chemokines, and cytokines (Montana and Sontheimer, 2011).
Glioblastoma cells have to squeeze through very narrow inter-
stitial spaces during their brain invasion along those tracks. This
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requires highly effective local cell volume decrease and re-increase
procedures. Notably, glioblastoma cells are capable to lose all
unbound cell water leading to maximal cell shrinkage (Watkins
and Sontheimer, 2011). Unusually high cytosolic Cl− concen-
trations (100mM) provide the electrochemical driving force for
this tremendous cell volume decrease. The cytosolic Cl− concen-
tration is built up highly above its electrochemical equilibrium
concentration by the Na/K/2Cl cotransporter NKCC1 (Haas and
Sontheimer, 2010; Haas et al., 2011) allowing glioblastoma cells
to utilize Cl− as an osmolyte.
Local regulatory volume increase and decrease have been pro-
posed to drive migration mechanics. The latter is generated by the
loss of Cl− and K+ ions along their electrochemical gradients fol-
lowed by osmotically obliged water fluxes. Involved transporters
probably are ClC-3 Cl− channels (Olsen et al., 2003; Cuddapah
and Sontheimer, 2010; Lui et al., 2010), Ca2+-activated high con-
ductance BK (Ransom and Sontheimer, 2001; Ransom et al.,
2002; Sontheimer, 2008) as well as intermediate conductance IK
K+ channels (Catacuzzeno et al., 2010; Sciaccaluga et al., 2010;
Ruggieri et al., 2012) and AQP-1 water channels (Mccoy and
Sontheimer, 2007; Mccoy et al., 2010). To a lower extent, K+
and Cl− efflux is probably also mediated by KCC1-generated
cotransport (Ernest et al., 2005). These transports are crucial for
glioblastoma migration since either transport blockade inhibits
glioblastoma cell migration and invasion (Ernest et al., 2005;
Mcferrin and Sontheimer, 2006; Catacuzzeno et al., 2010; Haas
and Sontheimer, 2010; Lui et al., 2010; Sciaccaluga et al., 2010).
Notably, Ca2+-activated BK (Ransom and Sontheimer, 2001;
Liu et al., 2002; Ransom et al., 2002; Weaver et al., 2006) and
IK K+ channels (Ruggieri et al., 2012) are ontogenetically down-
regulated or absent in mature glial cells but up-regulated with
neoplastic transformation and malignant tumor progression as
shown in expression studies in human glioma tissue. Moreover,
glioblastoma cells up-regulate a unique splice variant of the BK
channel (Liu et al., 2002) which exhibits a higher Ca2+ sensitivity
than the other isoforms (Ransom et al., 2002) and is indispensable
for glioblastoma proliferation in vitro. Similarly, ClC-3 Cl− chan-
nels aremal-expressed in glioblastoma tissue where they traffic, in
contrast to normal tissue, to the plasma membrane (Olsen et al.,
2003). The predominant (surface) expression of ClC-3 and the
BK splice variant by glioblastoma cells renders both channel types
putative glioblastoma-specific therapeutic targets.
EVASION FROM RADIATION STRESS
External beam radiation may induce the “Go” phenotype in
tumor cells similarly to the situation described for stress arising
from an adverse tumor microenvironment (Figure 1). Ionizing
radiation at doses used in single fractions during fractionated
radiotherapy has been demonstrated in vitro and by a mouse
study (Wild-Bode et al., 2001) to induce migration, invasion and
spreading of head and neck squamous carcinoma (Pickhard et al.,
2011), lung adenocarinoma (Jung et al., 2007; Zhou et al., 2011),
meningioma (Kargiotis et al., 2008), medulloblastoma (Asuthkar
et al., 2011), and glioblastoma cells (Wild-Bode et al., 2001; Wick
et al., 2002; Badiga et al., 2011; Canazza et al., 2011; Rieken et al.,
2011; Steinle et al., 2011; Kil et al., 2012; Vanan et al., 2012).
The phenomenon of radiation-stimulated migration might be
“grow”
“go”
ionizing radiation
repopulation
FIGURE 1 | Cellular stress such as ionizing radiation induces the
switch from “Grow” to “Go” phenotype.
particularly relevant for highly migrating and brain-infiltrating
glioblastoma cells.
After macroscopic complete resection glioblastoma is usually
treated by adjuvant radiotherapy of the tumor bed applying 54–60
Gy in daily fractions of 1.8–2 Gy combined with temozolomide
(Stupp et al., 2005). The median progression-free survival after
therapy ranges between 5 and 7 months (Stupp et al., 2005).
The recurrence of glioblastoma is typically observed within the
former target volume of the adjuvant fractionated radiotherapy.
This might be due either to a high intrinsic radioresistance of the
glioblastoma cells or to re-invasion of tumor cells into the area
of the irradiated primary. One might speculate that this necrotic
area, meanwhile cleared by phagocytes, offers optimal growth
conditions for such re-invading tumor cells. In this latter scenario,
re-invading cells might be recruited from glioblastoma (stem)
cells pre-spreaded prior to radiotherapy onset in areas outside
the target volume, or from cells that successfully evaded during
radiation therapy.
Radiation-induced up-regulation of integrin- (Wild-Bode
et al., 2001; Nalla et al., 2010; Canazza et al., 2011; Rieken et al.,
2011), VEGF- (Sofia Vala et al., 2010; Badiga et al., 2011; Kil et al.,
2012), EGF- (Kargiotis et al., 2008; Pickhard et al., 2011) or/and
TGFbeta signaling (Canazza et al., 2011; Zhou et al., 2011) has
been proposed to promote tumor cell migration. Downstream
ion transport processes have been reported for glioblastoma cells
(Steinle et al., 2011). In this study, BK K+ channel activation and
subsequent BK-dependent activation of the CaMKII kinase were
identified as key triggers of radiation-induced migration (Steinle
et al., 2011). Additionally, ClC-3 anion channels were identi-
fied as downstream targets of radiation-induced CaMKII activity
(Huber, 2013). This suggests on the one hand motor function
(i.e., volume decrease) of radiation-induced BK and ClC-3 cur-
rents, on the other hand, it points to a signaling function of BK
channels in the programming of radiation-stimulated glioblas-
toma migration (Figure 2). Similar to the situation in migrating
glioblastoma cells, radiation-induced plasma membrane K+ cur-
rents and downstream CaMKII activation have been defined as
key signaling events in cell cycle control of irradiated leukemia
cells as introduced in the following paragraphs.
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FIGURE 2 | Ionizing radiation (IR)-induced activation of BK K+ channels
results in evasion of glioblastoma cells from radiation stress. Activation
of BK channels occurs upstream of CaMKII and ClC-3 Cl− channels. The
Na+/K+/2Cl− cotransporter accumulates Cl− above its electrochemical
equilibrium. Cl− is used as osmolyte for volume decrease.
DNA REPAIR
Survival of irradiated tumor cells critically depends on DNA
repair. This involves cell cycle arrest, elevated energy consump-
tion, chromatin relaxation, and formation of repair complexes
at the site of DNA damage. Recent in vitro observations suggest
that radiation-induced ion transports may contribute to these
processes in an indirect manner.
Cell cycle control
Survival of irradiated human leukemia cells depends on Ca2+
signaling. Radiation reportedly stimulates Ca2+ entry through
TRPV5/6-like channels and subsequently activates CaMKII,
which in turn fosters G1/S transition, S progression and accumu-
lation in G2 phase of the cell cycle (Heise et al., 2010). Moreover,
Ca2+ signaling in human leukemia cells has been demonstrated
to be tightly regulated by voltage-gated Kv3.4 K+ channels
and translates into G2/M cell cycle arrest by CaMKII-mediated
inhibitory phosphorylation of the phosphatase cdc25B resulting
in inactivation of the mitosis promoting factor and G2/M arrest.
Radiation activates Kv3.4 currents without changing the surface
expression of the channel protein. Most importantly, inhibition of
Kv3.4 by tetraethylammonium and blood-depressing substance-
1 and substance-2 or silencing of the Kv3.4 channels by RNA
interference prevents TRPV5/6-mediated Ca2+ entry, CaMKII
activation, as well as cdc25B inactivation which results in release
from radiation-induced G2/M arrest, increased apoptosis, and
decreased clonogenic survival. Thus, targeting of Kv3.4 radiosen-
sitizes the leukemia cells demonstrating the pivotal role of this
channel in cell cycle arrest required for DNA repair (Palme et al.,
2013). Similar results have been obtained in prostate cancer cells,
where TRPV6 inhibition by capsaicin resulted in radiosensitiza-
tion (Klotz et al., 2011).
Glucose fueling and chromatin relaxation
In addition to cell cycle control, radiation-induced ion trans-
ports are proposed to improve glucose fueling of irradiated tumor
cells. Fast proliferating tumor cells have a high metabolism at
low external glucose and oxygen concentration in the usually
chronically under-perfused growing tumor tissue. At the same
time, many tumor cells cover their high energy requirements
by anaerobic glycolysis with low ATP yield per metabolized
glucose even under normoxic conditions. To sustain sufficient
glucose fueling, tumor cells may up-regulate the Na+/glucose co-
transporter (SGLT). SGLTs are capable to take up glucose into
the tumor cell even against a high chemical gradient (Ganapathy
et al., 2009). Several tumor entities such as colorectal, pancre-
atic, lung, head and neck, prostate, kidney, cervical, mammary,
and bladder cancer as well as chondrosarcomas and leukemia
have indeed been shown to up-regulate SGLTs (Nelson and
Falk, 1993; Ishikawa et al., 2001; Helmke et al., 2004; Casneuf
et al., 2008; Weihua et al., 2008; Yu et al., 2008; Leiprecht
et al., 2011; Wright et al., 2011). The inwardly directed Na+
gradient and the voltage across the plasma membrane drive
the electrogenic SGLT-generated glucose transport into the cell.
The membrane voltage is tightly regulated by the activity of
voltage gated K+ channels which counteract SGLT-mediated
depolarization.
Ionizing radiation has been demonstrated to activate EGF
receptors (Dittmann et al., 2009). In addition, SGLT1 report-
edly is in complex with and under the direct control of
the EGF receptor (Weihua et al., 2008) suggesting radiation-
induced SGLT1 modifications. As a matter of fact, ionizing
radiation stimulates a long lasting EGFR-dependent and SGLT-
mediated glucose uptake in A549 lung adenocarcinoma and
head and neck squamous carcinoma cell lines (but not in
non-transformed fibroblasts) as shown by 3H-glucose uptake
and patch-clamp, current clamp recordings (Huber et al.,
2012). In the latter experiments, radiation-induced and SGLT-
mediated depolarization of membrane potential was preceded
by a transient hyperpolarization of the plasma membrane
indicative of radiation-induced K+ channel activation (Huber
et al., 2012). Such radiation-induced increase in K+ chan-
nel activity has been reported for several tumor cell lines
including A549 lung adenocarcinoma cells (Kuo et al., 1993).
In this cell line, radiation at doses between 0.1 and 6 Gy
stimulates the activity of voltage gated K+ channels within
5min, which gradually declines thereafter. It is tempting to
speculate that this radiation-stimulated K+ channel activ-
ity counteracts the depolarization of the membrane poten-
tial caused by the SGLT activity shortly after radiation and
sustains the driving force for Na+-coupled glucose uptake
(Huber et al., 2012).
Ionizing radiation may lead to necrotic as well as apop-
totic cell death depending on cell type, dose, and fractiona-
tion (Verheij, 2008). In particular, necrotic cell death may be
associated with ATP depletion (Dorn, 2013). Increased SGLT
activity in irradiated tumor cells might contribute to ATP replen-
ishment counteracting necrotic cell death. Such function has
been suggested in irradiated A549 cells by experiments analyz-
ing cellular ATP concentrations, chromatin remodeling, residual
DNA damage, and clonogenic survival of irradiated tumor cells
(Dittmann et al., 2013). The data demonstrate that radiation
of A549 lung adenocarcinoma cells leads to a transient intra-
cellular ATP depletion and to histone H3 modifications crucial
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for both chromatin remodeling and DNA repair in response to
irradiation.
Importantly, recovery from radiation-induced ATP cri-
sis was EGFR/SGLT-dependent and associated with improved
DNA-repair and increased clonogenic cell survival. The block-
ade of either EGFR or SGLT inhibited ATP level recovery and
histone H3 modifications. Vice versa, inhibition of the acetyl-
transferase TIP60, which is essential for histone H3 modification,
prevented chromatin remodeling as well as ATP crisis (Dittmann
et al., 2013). Together, these data suggest that radiation-associated
interactions between SGLT1 and EGFR result in increased glucose
uptake, which counteracts the ATP crisis in tumor cells caused
by chromatin remodeling. Importantly, the blockade of recovery
from ATP crisis by SGLT1 inhibition may radio-sensitize tumor
cells as demonstrated in lung adenocarcinoma and head and neck
squamous carcinoma cell lines (Huber et al., 2012; Dittmann
et al., 2013).
Formation of repair complexes
In addition to SGLT-generated glucose uptake, radiation-induced
electrosignaling via transient receptor potential melastatin 2
(TRPM2) and vanilloid 1 (TRPV1) cation channels, has been
shown to stimulate Ataxia telangiectasia mutated (ATM) kinase
activation, histone 2AX (H2AX) phosphorylation, and γH2AX
focus formation in A549 lung adenocarcinoma cells, processes
required to recruit further repair proteins to the DNA double
strand break (Masumoto et al., 2013). Furthermore, radiation-
induced TRPM2 induces ATP release and P2Y signaling in A549
cells (Masumoto et al., 2013). Radiation-stimulated and P2X7
receptor- and gap junction hemichannel connexin43-mediated
ATP release has been suggested to signal in a paracrine man-
ner to unirradiated bystander cells in the B16 melanoma model
(Ohshima et al., 2012).
Combined, these recent data indicate that ion transports may
regulate processes that mediate intrinsic radioresistance. The
investigation of ion transports in radiobiology is at its very begin-
ning and the few data available are mostly phenomenological in
nature. The molecular mechanisms that underlie, e.g., regula-
tion of DNA repair by ion transports are ill-defined. Nevertheless,
the data prove functional significance of ion transports and
electrosignaling for the survival of irradiated tumor cells
and might have translational implications for radiotherapy in
the future.
Similar to intrinsic radioresistance, the function of ion
transports in hypoxia resistance and associated hypoxic radiore-
sistance of tumor cells is not well-defined. The following para-
graphs give a summary of what is known about mitochondrial
transports and hypoxia resistance of normal tissue and how these
findings might also apply for tumor cells.
MITOCHONDRIAL UNCOUPLING AND RESISTANCE TO HYPOXIA,
CHEMO-, AND RADIOTHERAPY
Intermittent hypoxia is a common feature of vascularized solid
tumors. The pathophysiologial aspects of hypoxia and reoxy-
genation are well-known from ischemia-reperfusion injuries
observed in normal tissue. Reoxygenation-associated produc-
tion of reactive oxygen species (ROS) is a major cause of
the hypoxia/reoxygenation injury after myocardial, hepatic,
intestinal, cerebral, renal and other ischemia and mitochondria
have been identified as one of the main sources of ROS forma-
tion herein (Li and Jackson, 2002). Mitochondrial ROS formation
mutually interacts with hypoxia/reoxygenation-associated cellu-
lar Ca2+ overload. Brief hypoxic periods induce an adaptation
to hypoxia in several tissues which lowers ischemia-reperfusion
injuries of subsequent ischemic insults (so-called ischemic pre-
conditioning). Similar adaptations which involve alterations in
mitochondrial ion transport have been proposed to confer
hypoxia resistance of tumor cells.
Mitochondrial ROS formation
Activity and efficacy of the mitochondrial respiration chain
are fine-tuned by the dependence of the ATP synthase (com-
plex V) on the membrane potential !"m, by the ATP/ADP
ratio, as well as by reversible phosphorylation of the com-
plexes I and IV (Figure 3) (Kadenbach, 2003). It is suggested
that under physiological conditions (high ATP/ADP ratios),
the membrane potential !"m is kept low [around −100
to −150mV (Kadenbach, 2003)]. The efficacy of the respira-
tory chain at low !"m is high. At higher ATP demand or
decreasing cellular ATP levels, cytochrome c oxidase (complex
IV) is relieved from ATP blockade and !"m increases. High
!"m values (up to −180mV), however, lower the efficacy
of cytochrome c oxidase (Kadenbach, 2003) and increase the
probability of single electron leakage at complex I and III to
molecular oxygen resulting in an increased O2·− production
(Figure 3) (Korshunov et al., 1997; Skulachev, 1998; Kadenbach,
2003).
The respiratory chain is also regulated by the cytosolic
([Ca2+]i) and mitochondrial matrix free Ca2+ concentration
([Ca2+]m) in a complexmanner (for review see Pizzo et al., 2012).
The phosphatases that dephosphorylate (and thereby switch-off)
the NADH oxidase and that relieve the ATP blockade of complex
IV are inhibited by [Ca2+]m and activated by [Ca2+]i, respectively
(Figure 3). As a consequence, increase in [Ca2+]m and [Ca2+]i
results in a higher!"m and a concurrently increased production
of reactive oxygen species (Kadenbach, 2003).
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FIGURE 3 | Mitochondrial ROS formation in dependence on !"m (I, II,
III, and IV, electron transport complexes I, II, III, and IV; Q: semiquinone
radical; cyt C: cytochrome C). Ca2+ and the ATP/ADP ratio regulate the
electron chain at complexes I and IV.
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Hypoxia decreases the activity of the mitochondrial man-
ganese superoxide dismutase (Mn-SOD) and of the cytochrome
c oxidase. Depletion of the final electron acceptor, however,
increases the formation of O2·− during reoxygenation by the
enhanced leakage of single electrons from more proximal com-
plexes of the respiration chain (for review see Li and Jackson,
2002; Sack, 2006). Lowered O2·−-detoxifying capability com-
bined with simultaneous elevated O2·− production results in a
highly elevated O2·− concentration which, e.g., in hepatocytes
increases 15-fold within 15min of reoxygenation (Caraceni et al.,
1995).
Hypoxia/reoxygenation-associated Ca2+ overload
Hypoxia-associated energy depletion and the concomitant
impairment of plasma membrane Na+ and Ca2+ pump activity
lead to a decline of the chemical Na+, Ca2+ and K+ gradi-
ents across the plasma membrane and to the depolarization
of the plasma membrane potential. In parallel, increased lactic
acid fermentation during hypoxia increases the cytosolic proton
concentration and lowers the intracellular pH. The proton extru-
sion machinery that is already active during hypoxia becomes
massively activated during reoxygenation and restores a phys-
iological pH by wash-out of lactic acid and activation of the
sodium/hydrogen exchanger and sodium/bicarbonate symporter.
The latter, Na+-coupled transports, in turn, further increase the
cytosolic Na+ concentration to a level, where the low affinity
high capacity sodium/calcium exchanger in the plasma mem-
brane starts to operate in the reverse mode (i.e., to extrude Na+
at the expense of Ca2+ uptake). At that time, reoxygenation-
mediated oxidative stress (see above) stimulates further Ca2+
entry through Ca2+-permeable channels in the plasma mem-
brane and the release of Ca2+ from the endoplasmic reticulum
resulting in an abrupt rise in [Ca2+]i during the first minutes of
reoxygenation. Cytosolic Ca2+ is buffered by !"m-driven and
uniporter-mediated Ca2+ uptake into the mitochondrial matrix
which increases [Ca2+]m. Elevated [Ca2+]m and [Ca2+]i val-
ues, in turn, signal back to the respiratory chain by further
increasing !"m (see above). Exceeding the Ca2+ threshold con-
centration in the matrix, [Ca2+]m activates the permeability
transition pore which leads to breakdown of !"m, swelling of
the mitochondrial matrix and eventually release of cytochrome
c from the intermembrane space into the cytosol (Crompton,
1999; Rasola and Bernardi, 2011). By reversing the ATP syn-
thase activity, into the ATPase proton pump mode, the F0/F1
complex in the inner mitochondrial delays the break-down of
!"m at the expense of ATP hydrolysis. In addition to this
ATP depletion, the loss of cytochrome c and the concurrent
decline of the final electron acceptor (cytochrome c oxidase
of complex IV) further increases the formation of O2·− by
more proximal complexes. The pivotal role of membrane trans-
ports in this process is illustrated by the fact that inhibition
of the sodium/hydrogen antiporter in the plasma membrane,
the Ca2+ uniporter in the inner mitochondrial membrane, or
Ca2+ channels in the endoplasmic reticulum (ER) decreases the
hypoxia/reoxygenation injury in vitro (for review see Crompton,
1999; Li and Jackson, 2002; Sack, 2006; Yellon and Hausenloy,
2007).
Ischemic pre-conditioning
Cells can also adapt to repetitive periods of hypoxia. This
so-called ischemic preconditioning has been demonstrated in
the myocardium where it reduces ischemia-caused infarct size,
myocardial stunning, and incidence of cardiac arrhythmias
(Gross and Peart, 2003). Since mitochondrial ROS forma-
tion increases with increasing !"m (Korshunov et al., 1997;
Skulachev, 1998; Kadenbach, 2003) lowering of the mitochon-
drial !"m is proposed to be a key adaptation event in ischemic
preconditioning (Sack, 2006). Lowering of !"m reduces not
only mitochondrial O2·− production but also the mitochon-
drial Ca2+ overload during reoxygenation (Gross and Peart, 2003;
Prasad et al., 2009). The hypoxic preconditioning-associated
reduction of !"m is in part achieved by up-regulation of ATP-
sensitive (mitoKATP) and Ca2+-activated (mitoKCa) K+ chan-
nels in the inner mitochondrial membrane which short-circuit
!"m (Murata et al., 2001; Gross and Peart, 2003; Prasad et al.,
2009; Singh et al., 2012; Szabo et al., 2012). The uncoupling
proteins-2 and -3 (UCP-2, -3) constitute two further proteins
that have been suggested to play a role in counteracting cardiac
hypoxia/reoxygenation injury and in hypoxic preconditioning in
heart and brain (Mcleod et al., 2005; Sack, 2006; Ozcan et al.,
2013). Activation of these proteins results in a modest depo-
larization of !"m by maximally 15mV (Fink et al., 2002).
High expression of UCP-3 has also been demonstrated in skele-
tal muscle where it suppresses mitochondrial oxidant emission
during fatty acid-supported respiration (Anderson et al., 2007).
Accordingly, overexpression of UCP-3 in cultured human muscle
cells lowers!"m, raises the ATP/ADP ratio, and favors fatty acid
vs. glucose oxidation (Garcia-Martinez et al., 2001). Conversely,
knockdown of UCP-3 increased the coupling between electron
and proton transfer across the inner mitochondrial membrane
and ROS production (Vidal-Puig et al., 2000; Talbot and Brand,
2005). UCP-3 protein is robustly up-regulated in chondrocytes
(Watanabe et al., 2008) and skeletal muscle during hypoxia and
the absence of UCP-3 exacerbates hypoxia-induced ROS (Lu and
Sack, 2008). UCP-3 is not constitutively active. O2·− has been
demonstrated to stimulate the activity of UCP-3 in skeletal mus-
cle suggesting that UCP-3 is the effector of a feed back loop which
restricts overshooting ROS production (Echtay et al., 2002).
Mitochondrial uncoupling in tumor cells
Recent studies suggest that UCPs are upregulated in a number of
aggressive human cancers. In particular, over-expression of UCP2
has been reported in leukemia as well as in breast, colorectal, ovar-
ian, bladder, esophagus, testicular, kidney, pancreatic, lung, and
prostate cancer (Ayyasamy et al., 2011; Su et al., 2012). In human
colon cancer, UCP2 mRNA and protein expression reportedly
is increased by factor of 3–4 as compared to peritumoral nor-
mal epithelium. In addition, UCP2 expression gradually increases
during the colon adenoma-carcinoma sequence (Horimoto et al.,
2004) and is higher in clinical stages III and IV colon cancer than
in stage I and II (Kuai et al., 2010). Similarly, UCP4 expression
has been shown to correlate with lymph node metastases in breast
cancer (Gonidi et al., 2011) and UCP1 expression in prostate can-
cer with disease progression from primary to bone metastatic
cancers (Zhau et al., 2011). Moreover, postmenopausal breast
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tumors with low estrogen receptor (ER) alpha to ER beta ratios
that associate with higher UCP5 expression and higher oxidative
defense have a poor prognosis (Sastre-Serra et al., 2013). Finally,
ectopic expression of UCP2 in MCF7 breast cancer cells has been
demonstrated to enhance proliferation, migration and matrigel
invasion in vitro and to promote tumor growth in vivo (Ayyasamy
et al., 2011). Together, these observations suggest that UCPs may
contribute to the malignant progression of tumor cells.
In addition to malignant progression, UCPsmay alter the ther-
apy sensitivity of tumor cells. In specimens of human ovarian
cancers carboplatin/paclitaxel-resistant cancers showed decreased
UCP2 protein abundances as compared to the sensitive ones
(Pons et al., 2012). Likewise, progression-free and overall survival
of patients with inoperable lung cancer who received cisplatin-
based chemotherapy was higher when tumors expressed high
levels of UCP2 as compared to tumors with low UCP2 levels (Su
et al., 2012). A possible explanation of the latter observation is
that especially in lung tumors with mutated p53, cisplatin elicits
oxidative stress that induces pro-survival signaling. High UCP2
expression, however, diminishes cisplatin-evoked oxidative stress
and, in turn, decreases the pro-survival signals (Su et al., 2012).
In lung cancer cell lines with wildtype p53, in contrast, down-
regulation of UCP2 results in significantly increased paclitaxel-
induced cell death (Su et al., 2012). Similarly, overexpression
of UCP2 in a human colon cancer cell line has been shown to
blunt topoisomerase I inhibitor CPT-11-induced accumulation
of reactive oxygen species and apoptosis in vitro and to con-
fer CPT-11 resistance of tumor xenografts (Derdak et al., 2008).
In addition, in pancreatic adenocarcinoma, non-small cell lung
adenocarcinoma, and bladder carcinoma cell lines IC50 values
of the anticancer drug gemcitabine increase with intrinsic UCP2
mRNA abundance. Furthermore, UCP2 overexpression strongly
decreases gemcitabine-induced mitochondrial superoxide forma-
tion and protects cancer cells from apoptosis (Dalla Pozza et al.,
2012). Finally, metabolic changes including UCP2 up-regulation
and UCP2-mediated uncoupling of oxidative phosphorylation
have been demonstrated in multidrug-resistant subclones of var-
ious tumor cell lines (Harper et al., 2002). Similarly, in acute
myeloid leukemia cells, UCP2 up-regulation has been shown to
foster the Warburg effect (i.e., anaerobic glycolysis in the absence
of respiratory impairment) (Samudio et al., 2008).
UCP2 expression is stimulated by co-culturing of these
leukemia cells with bone marrow-derived mesenchymal stro-
mal cells (Samudio et al., 2008). Other stimuli of UCP expres-
sion/activity are hydrogen peroxide as shown for UCP5 in colon
cancer cells (Santandreu et al., 2009) and gemcitabine chemother-
apy as reported for UCP2 in pancreatic, lung and bladder cancer
cell lines (Dalla Pozza et al., 2012). Collectively, these data sug-
gest that tumor cells may acquire resistance to chemotherapy
by up-regulation of UCPs and lowering of the therapy-evoked
mitochondrial formation of reactive oxygen species (Robbins and
Zhao, 2011).
Accordingly, experimental targeting of UCPs has been demon-
strated to sensitize tumor cells to chemotherapy in vitro. For
instance, genipin-induced inhibition or glutathionylation of
UCP2 sensitizes drug-resistant leukemia subclones to chemother-
apy with menadione, doxorubicin, or epirubicin (Mailloux
et al., 2010; Pfefferle et al., 2012). Likewise, UCP2 inhibi-
tion by genipin or UCP2 mRNA silencing strongly enhances
gemcitabine-induced mitochondrial superoxide generation and
apoptotic cell death of pancreatic, lung and bladder cancer cell
lines (Dalla Pozza et al., 2012). Moreover, UCP2 inhibition
has been reported to trigger reactive oxygen species-dependent
nuclear translocation of GAPDH and autophagic cell death in
pancreatic adenocarcinoma cells (Dando et al., 2013) Together,
this suggests that targeting UCPsmight be a promising strategy to
overcome resistance to anti-cancer therapies in the clinic. Notably,
in an acute myeloid leukemia cell line, the cytotoxicity of cisplatin
has been proposed to be in part mediated by cisplatin-dependent
down-regulation of UCPs (Samudio et al., 2008) suggesting that
established chemotherapy regimes already may co-target UCPs.
It is tempting to speculate that UCPs may also confer resis-
tance to radiotherapy. One could hypothesize that UCPs adapt
the tumor cells to a “relatively radioprotected” hypoxic microen-
vironment by decreasing hypoxia-associated mitochondrial for-
mation of reactive oxygen species. Such UCP function in hypoxia
resistance has been demonstrated for a lung adenocarcinoma
cell line (Deng et al., 2012). Notably, radiation induces up-
regulation of UCP2 expression as shown in colon carcinoma cells
(Sreekumar et al., 2001) and in a radiosensitive subclone of B cell
lymphoma (Voehringer et al., 2000). On the one hand, this UCP2
up-regulationmight facilitate radiation-induced apoptosis induc-
tion by accelerating the break-down of !"m as proposed by the
authors of these studies. On the other hand, radiation-induced
UCP2 upregulation might be radioprotective by lowering the
radiation-induced burden of reactive oxygen species. As a matter
of fact, multi-resistant subclones of leukemia cells show higher
UCP2 protein expression, lower !"m, lower radiation induced
formation of reactive oxygen species and decreased DNA damage
as compared to their parental sensitive cells (Harper et al., 2002).
In summary, UCPs suppress the formation of O2·−, a byprod-
uct of the mitochondrial respiration chain and a major source
of oxidative stress. In some cancers UCPs in particular UCP2
are highly upregulated and may contribute to the reprogram-
ming of the cell metabolism that results in chemoresistance (for
review see Baffy, 2010; Baffy et al., 2011) or even radioresis-
tance. Moreover, recent studies imply that UCP2 may repress
p53-mediated apoptosis providing a potential new mechanism
of how UCP2 contributes to cancer development (Robbins and
Zhao, 2011).
Together, these observations suggest that ion transport pro-
cesses are critically involved in evasion from radiation stress,
and intrinsic or hypoxic radioresistance. Since ion transport-
mediated radioresistance might underlie failure of radiotherapy,
concepts which combine ion transport targeting with radiother-
apy hold promise for new therapy strategies in the future. A
summary of how ion transport can be harnessed for anticancer
therapy and how these therapy strategies might be combined with
radiotherapy is given in the next paragraphs.
TARGETING ION TRANSPORTS IN RADIOTHERAPY
An important reason for the study of ion transports in the context
of radiotherapy is the possible translation of the acquired knowl-
edge into anti-cancer therapy. Many pharmacological modulators
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of ion transports are already in clinical use or currently tested in
clinical trials (Wulff and Castle, 2010). Moreover, tumors often
over-express certain types of transport proteins.
These proteins such as the transient receptor melastatin 8
(TRPM8) non-selective cation channel in prostate cancer have
been used in clinical trials as tumor-associated antigen for
anti-tumor vaccination (Fuessel et al., 2006). Tumor promot-
ing inflammation and anti-tumor immune effects are evolving
fields of preclinical and clinical research (Hanahan andWeinberg,
2011). Preclinical evidence supports the thesis that tumors have
to develop immune-evading capacities in order to grow into
macroscopic, clinically detectable lesions (Koebel et al., 2007;
Teng et al., 2008). Possible mechanisms are the secretion of
cytokines and chemokines by cancer and tumor stroma cells
(Vianello et al., 2006; Shields et al., 2010), the priming of infiltrat-
ing T-lymphocytes toward immunosuppressive regulatory T-cells
and the recruitment of myeloid-derived suppressor cells and
tumor-associated macrophages (Tanchot et al., 2013; Oleinika
et al., 2013). Irradiation of tumors has been shown to impair
on the one hand the immunosuppressive action of the tumor
and on the other to induce so-called “immunogenic” cell death
within the tumor with translocation of calreticulin to the plasma
membrane, release of HMGB1 or ATP (Formenti and Demaria,
2013). Preclinical studies showed a synergistic effect of irradia-
tion and several immunotherapeutic approaches such as dendritic
cell injection (Finkelstein et al., 2012), anti-CTLA-4-antibody
(Grosso and Jure-Kunkel, 2013), and vaccines (Chakraborty et al.,
2004). Interestingly, for combination with anti-CTLA-4 antibody
a synergistic effect could only be demonstrated for fraction-
ated but not for single-dose irradiation (Demaria and Formenti,
2012).
In addition, over-expressed transport proteins in tumors can
be harnessed to target drugs, cytokines, or radioactivity to the
tumor cells (Hartung et al., 2011). One example is the specific
surface expression of ClC-3 Cl− channels by glioblastoma (and
other tumor entities) which suggests ClC-3 as an excellent and
highly specific target for anti-glioblastoma therapy. Chlorotoxin
which is a 36 amino acid-long peptide from the venom of the
scorpion Leiurus quinquestriatus has been found to inhibit ClC-
3 and to preferentially bind to the cell surface of a variety of
human malignancies. This specificity probably comes from the
highly affine binding of chlorotoxin to a lipid raft-anchored
complex of matrix metalloproteinase-2, membrane type-I MMP,
and transmembrane inhibitor of metalloproteinase-2, as well as
ClC-3 (Veiseh et al., 2007). Ongoing clinical trials successfully
used 131I-labeled chlorotoxin as glioblastoma-specific PET-tracer
(Hockaday et al., 2005) and for targeted radiation of glioblas-
toma cells (Mamelak and Jacoby, 2007). Due to the low surface
expression of ClC-3 in normal tissue, chlorotoxin exhibits little
or no affinity to normal cells (Lyons et al., 2002). If the in vitro
and mouse data on radiation-stimulated glioblastoma migration
reflect indeed the in vivo situation in glioblastoma patients, a
clinical setting might be envisaged in which radiation-induced
glioblastoma spreading is prevented by combining radiotherapy
with chlorotoxin blockade of ClC-3 channels.
CONCLUDING REMARKS
Interdisciplinary approaches linking radiobiology with physiol-
ogy brought about the first peaces of evidence suggesting a
functional significance of ion transport processes for the sur-
vival of irradiated tumor cells. The few reports published up
to now on this topic are confined to phenomena occurring in
the plasma membrane due to the methodological restrictions
of studying these processes in the membranes of mitochondria,
endoplasmic reticulum, or nuclear envelope. Intracellular mem-
brane transports, however, might similarly impact tumor cell
radiosensitivity. This is suggested by the notion that intracellular
Cl− channel CLIC1 protein expression regulates radiosensitivity
in laryngeal cancer cells (Kim et al., 2010). However, the molec-
ular mechanisms underlying, e.g., radiation-induced transport
modifications, or downstream signaling events are far from being
understood. Despite all these limitations, our current knowledge
already clearly indicates that the observed transport processes
may be crucial for the survival of the tumor and, thus, are worth-
while to spend further and more effort in this field which might
lead to new strategies for cancer treatment in the future.
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Abstract Aberrant ion channel expression in the plasma
membrane is characteristic for many tumor entities and has
been attributed to neoplastic transformation, tumor progres-
sion, metastasis, and therapy resistance. The present study
aimed to define the function of these “oncogenic” channels
for radioresistance of leukemia cells. Chronic myeloid leu-
kemia cells were irradiated (0–6 Gy X ray), ion channel
expression and activity, Ca2+- and protein signaling, cell
cycle progression, and cell survival were assessed by quan-
titative reverse transcriptase-polymerase chain reaction,
patch-clamp recording, fura-2 Ca2+-imaging, immunoblot-
ting, flow cytometry, and clonogenic survival assays, re-
spectively. Ionizing radiation-induced G2/M arrest was
preceded by activation of Kv3.4-like voltage-gated potassium
channels. Channel activation in turn resulted in enhanced Ca2+
entry and subsequent activation of Ca2+/calmodulin-depen-
dent kinase-II, and inactivation of the phosphatase cdc25B
and the cyclin-dependent kinase cdc2. Accordingly, channel
inhibition by tetraethylammonium and blood-depressing
substance-1 and substance-2 or downregulation by RNA in-
terference led to release from radiation-induced G2/M arrest,
increased apoptosis, and decreased clonogenic survival.
Together, these findings indicate the functional significance
of voltage-gated K+ channels for the radioresistance of mye-
loid leukemia cells.
Keywords K562 human erythroid leukemia cells . Primary
chronic myeloid leukemia cells . Patch-clamp whole-cell
recording . Ion channels . Calcium signaling . Cell cycle
Introduction
Cell cycle progression of proliferating cells requires Ca2+
signals to enter and accomplish the S and the M phase of the
cycle [58, 60]. Fast-proliferating tumor cells have been
postulated to remodel their Ca2+ signalosome. For instance,
many tumor entities such as prostate cancer [34], breast
cancer [9], and primary chronic myeloid leukemia (CML)
[53] upregulate TRPV5/6 Ca2+-permeable channels. In ad-
dition, many tumor entities are endowed with K+ channels
that are different from those of normal cells [30]. K+
channel-mediated changes of the membrane potential direct-
ly participate in the generation of cytosolic Ca2+ signals by
modulating the activity of voltage-dependent Ca2+ entry
pathways and/or altering the electrochemical driving force
for both, Ca2+ entry through channels, and Ca2+ extrusion
via Na/Ca antiport. Among those “oncogenic” K+ channels
[24] that are upregulated by tumor cells are human ether-à-
gogo-related (hERG) [3] and further voltage-gated Kv chan-
nels [22, 46], or two-pore domain K+ channels such as
TASK-3 [33, 47] and TREK-1 [62]. In particular, hERG
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channels are reportedly overexpressed in leukemias where
they promote cell proliferation [36, 49, 50, 55].
Previously, we reported that survival of erythroleukemic
K562 cells treated with ionizing radiation (IR) critically de-
pends onCa2+ signaling [39]. Specifically, IR stimulates Ca2+-
entry through TRPV5/6-like channels and subsequent activa-
tion of Ca2+/calmodulin-dependent kinase-II (CaMKII),
which in turn fosters G1/S transition, S progression, and
accumulation in G2 phase of the cell cycle, resulting in an
increased survival of these leukemia cells [21]. Besides
TRPV5/6, IR reportedly activates K+ channels in A549 lung
adenocarcinoma cells [25, 31] and in glioblastoma cell lines
[59]. IR-induced K+ channel activity has been proposed to
contribute to the stress response in these tumor cells by im-
proving energy supply [25] or inducing stress evasion [59].
The present study, therefore, tested for an involvement of K+
channels in the stress response of irradiated leukemia cells. To
this end, K562 cells which were originally isolated from a
patient with CML [39] and primary CML cells were subjected
to ionizing radiation. Afterward, K+ channel activity, Ca2+-
and biochemical signaling, cell cycle control, and cell survival
were analyzed by whole-cell patch clamp recording,
ratiometric Ca2+ imaging and immunoblotting, flow cytome-
try, and colony-forming assays, respectively. Our data suggest
that ionizing radiation activates Kv3.4 voltage-gated Kv chan-
nels, which in turn, via activation of CaMKII isoforms, leads
to inactivation of cdc25B and consequently to inactivation of
the mitosis-promoting factor, resulting in G2/M cell cycle
arrest. Inhibition or experimental downregulation of Kv3.4
overrides G2/M cell cycle arrest and decreases the survival
of the leukemia cells.
Materials and methods
Cell culture Primary CML cells from patients were isolated
by density gradient centrifugation after obtaining informed
consent in accordance with the Helsinki protocol, and the
study was performed according to the guidelines of the local
ethics committee. Primary CML cells and K562 human
erythroleukemia cells were cultivated in RPMI 1640 medi-
um containing L-glutamine (Gibco, Karlsruhe, Germany)
supplemented with 10 % fetal calf serum (FCS) and peni-
cillin (100 U/ml)/streptomycin (100 μg/ml). Ionizing X-ray
radiation (IR, single dose of 1–6 Gy) was applied by using a
linear accelerator (LINAC SL25 Philips) at a dose rate of
4 Gy/min at room temperature. Following irradiation, cells
were post-incubated in supplemented RPMI 1640 medium for
1–48 h (patch-clamp, fura-2 Ca2+-imaging, flow cytometry)
and 2 weeks (colony formation).
Patch-clamp recording K562, K562 cells transfected with
Kv3.4 siRNA or nontargeting RNA (1 μM each, 48–72 h
after transfection, see below), and primary CML cells were
irradiated with 0, 1, or 5 Gy. Whole-cell currents were
evoked by 11–33 voltage pulses (700 ms each) from
−50 mV holding potential (−65 and −52 mVafter correcting
the liquid junction potential in NaCl and Na-D-gluconate
bath solution, respectively) to voltages between −100 mV
(−115 and −102 mV, respectively) and +60 mV (+45 mV),
+80 mV (+78 mV), or +100 mV (+85 mV) delivered in 5–
20-mV increments. Peak current values were analyzed 1–5 h
post-IR. The liquid junction potentials between the pipette
and the bath solutions were estimated according to Barry
and Lynch [5], and data were corrected for the estimated
liquid junction potentials. Membrane potential was recorded
in the whole-cell 0 pA current-clamp mode. Cells were
superfused at 37 °C temperature with NaCl solution (in
millimolars—125 NaCl, 32 N-2-hydroxyethylpiperazine-N-
2-ethanesulfonic acid (HEPES), 5 KCl, 5 D-glucose, 1
MgCl2, 1 CaCl2, titrated with NaOH to pH 7.4). Upon
GΩ-seal formation and entry into the whole-cell recording
mode, cells were recorded with NaCl bath solution, KCl
bath solution (in millimolars—130 KCl, 32 HEPES, 5 D-
glucose, 1 MgCl2, 1 CaCl2, titrated with KOH to pH 7.4), or
Na-D-gluconate bath solution (in millimolars—150 Na-D-
gluconate, 10 HEPES, 1 Ca-D-gluconate2, titrated with
NaOH to pH 7.4). The K-D-gluconate pipette solution
contained (in millimolars)—140 K-D-gluconate, 5 HEPES,
5 MgCl2, 1 K2-EGTA, 1 K2-ATP, titrated with KOH to
pH 7.4. To inhibit Kv3.4 currents, blood-depressing sub-
stance 2 (BDS-II, Sigma, Taufkirchen, Germany) was added
at a concentration of 2 μM to the NaCl bath solution.
Quantitative RT-PCR Messenger RNAs of irradiated K562
cells (0 and 5 Gy, 2 h post-IR) were isolated (Qiagen RNA
extraction kit, Hilden, Germany) and reversely transcribed
in cDNA (RT2 First Strand Kit, SABiosciences, Qiagen). K+
channel-specific fragments were amplified by the use of a
polymerase chain reaction (PCR) array (SABiosciences
#PAHS-036F, Qiagen, Hilden, Germany) and a Roche
Light Cycler 480. Ct (threshold cycle) values of the PCR
amplifications were normalized to that of a housekeeper.
Western blotting Irradiated K562 and primary CML cells
(0 and 5 Gy, 2–6 h post-IR) were lysed in a buffer
(containing in millimolars—50 HEPES pH 7.5, 150 NaCl, 1
EDTA, 10 sodium pyrophosphate, 10 NaF, 2 Na3VO4, 1
phenylmethylsulfonylfluorid additionally containing 1 % tri-
ton X-100, 5 μg/ml aprotinin, 5 μg/ml leupeptin, and 3 μg/ml
pepstatin) and separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) under reduc-
ing condition. In some experiments, cells were pre-incubated
(0.5 h), irradiated, and post-incubated (6 h) in the presence of
the Kv channel inhibitor tetraethylammonium (TEA, 0 or
3 mM) or the CaMKII inhibitor KN-93 (0 or 30 μM).
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Surface proteins of irradiated (0 and 5 Gy, 2 h post-IR) K562
cells were enriched by the use of a cell surface protein isola-
tion kit (Pierce, Rockford, IL, USA) according to the supplied
protocol and separated by SDS-PAGE under reducing condi-
tion. Segregated proteins were electro-transferred onto PVDF
membranes (Roth, Karlsruhe, Germany). Blots were blocked
in TBS buffer containing 0.05 % Tween 20 and 5 % non-fat
dry milk for 1 h at room temperature. The membrane was
incubated overnight at 4°C with the following primary anti-
bodies: rabbit anti-phospho-CaMKII (Thr286) antibody (Cell
Signaling #3361, New England Biolabs, Frankfurt, Germany,
1:1,000), rabbit anti-CaMKII (pan) antibody (Cell Signaling
#3362, 1:1,000), rabbit anti-phospho-cdc25B (Ser187) anti-
body (Epitomics #T1162, Biomol Hamburg, Germany,
1:1,000), rabbit anti-cdc25B antibody (Cell Signaling #9525,
1:1,000), rabbit-anti Kv3.4 (Alomone, # APC-019, Jerusalem,
Israel, 1:200), or rabbit anti-Na/K-ATPase (α1-subunit) anti-
body (cell signaling #3010, 1:1,000). Antibody binding was
detected with a horseradish peroxidase-linked goat anti-rabbit
or horse anti-mouse IgG antibody (Cell Signaling #7074 and
#7076, respectively; 1:1,000–1:2,000 dilution in TBS–
Tween/5% milk) incubated for 1 h at room temperature and
enhanced chemiluminescence (ECLWestern blotting analysis
system, GE Healthcare/Amersham-Biosciences, Freiburg,
Germany). Equal gel loading was verified by an antibody
against β-actin (mouse anti-β-actin antibody, clone AC-74,
Sigma #A2228 1:20,000). Where indicated, protein levels
were quantified by densitometry using ImageJ software
(ImageJ 1.40 g NIH, USA).
Fura-2 Ca2+ imaging Fluorescence measurements were
performed using an inverted phase-contrast microscope
(Axiovert 100; Zeiss, Oberkochen, Germany). Fluorescence
was evoked by a filter wheel (Visitron Systems, Puchheim,
Germany)-mediated alternative excitation at 340/26 or
387/11 nm (AHF, Analysentechnik, Tübingen, Germany).
Excitation and emission light was deflected by a dichroic
mirror (409/LP nm beamsplitter, AHF) into the objective
(Fluar ×40/1.30 oil; Zeiss) and transmitted to the camera
(Visitron Systems), respectively. Emitted fluorescence inten-
sity was recorded at 587/35 nm (AHF). Excitation was con-
trolled and data acquired by Metafluor computer software
(Universal Imaging, Downingtown, PA, USA). The
340/380-nm fluorescence ratio was used as a measure of
cytosolic free Ca2+ concentration ([Ca2+]i), the slope of the
increase in the 340/380 nm-ratio as a measure of Ca2+ entry
into the cells. The cells were irradiated (0 or 5 Gy) and loaded
with fura-2/AM (2 μM for 30min at 37 °C;Molecular Probes,
Goettingen, Germany) in supplemented RPMI medium.
[Ca2+]i was determined 2–3 h post-IR at 37 °C during
superfusion with NaCl solution, during extracellular Ca2+
removal in EGTA-buffered NaCl solution (in millimolars—
125 NaCl, 32 HEPES, 5 KCl, 5 D-glucose, 1 MgCl2, 0.5
EGTA, titrated with NaOH to pH 7.4), and Ca2+ re-addition
in NaCl solution additionally containing TEA or, for control,
NaCl (3 mM each).
Transfection with siRNA K562 cells were cultured at a low
density to ensure log phase growth. For transfection, cells (3×
106) were resuspended in 300 μl RPMI 1640 without phenol
red. After adding siRNAs (1 μM), cells were electroporated at
340 V for 5 ms, using an EPI2500 electroporator (Fischer,
Heidelberg, Germany). Immediately after transfection, cells
were re-suspended in pre-warmed medium and continued to
be cultured. Transfection efficiency and viability was deter-
mined by transfecting the cells with 400 nM green fluores-
cence siGLO siRNA followed by propidium iodide exclusion
dye and flow cytometric analysis. Kv3.4 ON-TARGET
SMARTpool, siCONTROL NON-TARGETING pool, and
siGLO siRNA were purchased from Dharmacon (Chicago,
IL, USA). Downregulation of Kv3.4 was controlled by immu-
noblotting (data not shown) and patch-clamp recording.
Flow cytometry K562 cells were pre-incubated (30 min),
irradiated (0 or 5 Gy), and incubated for further 24 or 48 h
in supplemented RPMI 1640 medium additionally
containing either TEA or NaCl (3 mM each), or blood-
depressing substance-1 (BDS-I) (0 or 5 μM, Sigma). In
further experiments, K562 cells were irradiated (0 or 5 Gy)
24 h after transfection with either Kv3.4 or non-targeting
siRNA and grown for 48 h in supplemented RPMI 1640
medium. For cell cycle analysis, cells were permeabilized
and stained (30 min at room temperature) with propidium
iodide (PI) solution (containing 0.1% Na-citrate, 0.1% triton
X-100, 10 μg/ml PI in phosphate-buffered saline, PBS), and
the DNA amount was analyzed by flow cytometry (FACS
Calibur, Becton Dickinson, Heidelberg, Germany, 488 nm
excitation wavelength) in fluorescence channel FL-3 (linear
scale, >670 nm emission wavelength). In parallel, cells with
degraded DNAwere defined by the subG1 population of the
PI histogram recorded in fluorescence channel FL-2 (loga-
rithmic scale, 564–606 nm emission wavelength). For de-
termination of phosphatidylserine exposure (which results
from break-down of the phospholipids asymmetry of the
plasma membrane) and (secondary) necrosis, cells were
resuspended in NaCl solution containing annexin V fluos
(1:80 dilution; BD Biosciences, Heidelberg, Germany) and
PI (10 μg/ml). After 30 min of staining, annexin-V binding
and PI staining were measured by flow cytometry in fluo-
rescence channels FL-1 (515–545 nm emission wavelength)
and FL-3, respectively. Data were analyzed with the FCS
Express 3 software (De Novo Software, Los Angeles, CA,
USA).
BrdU incorporation To test for DNA synthesis/repair by
bromodeoxyuridine (BrdU) incorporation, the cells were
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resuspended in supplemented RPMI 1640 medium containing
BrdU (20 μM) and TEA or NaCl (3 mM each), irradiated with
0 or 5 Gy, post-incubated for 8 h at 37 °C, washed, and fixed
with 70% ethanol and consecutively treated with RNase A
(0.1 mg/ml in PBS for 10 min at 37 °C), pepsin (0.5 mg/ml in
0.05 N HCl for 10 min at 37 °C), and 2 N HCl (for 10 min at
room temperature). For immunolabelling, cells were incubat-
ed (30 min at room temperature) with a monoclonal mouse
anti-BrdU antibody (1:67 dilution in PBS/1 % bovine serum
albumin (BSA), Becton Dickinson, Pharmingen, Freiburg,
Germany) and post-incubated (30 min at room temperature)
with a fluoresceinisothiocyanat-conjugated rabbit anti-mouse
IgG antibody (1:100 in PBS/1 % BSA, DAKO, Hamburg,
Germany). Thereafter, cells were stained (15 min at 4 °C) with
PI solution (25 μg/ml PI and 20 μg/ml RNAse A in PBS/1%
BSA). BrdU- and PI-specific fluorescence was analyzed by
flow cytometry in fluorescence channels FL-1 and FL-3,
respectively.
Colony-formation assay To test for clonogenic survival,
cultures of K562 cells were diluted to 100 or 200 cells/ml
with supplemented RPMI 1640 medium additionally
containing TEA (3 mM) or, for control, NaCl (3 mM), and
seeded out in six-well plates (5 ml/well). In a second series
of experiments, 100 cells were seeded in 96-well plates in
200 μl supplemented RPMI 1640 medium additionally
containing BDS-I (0 or 5 μM) or BDS-II (0 or 5 μM).
Thereafter, cells of both experimental series were irradiated
(0–5 Gy) and grown for 2 weeks. In further experiments,
K562 cells were seeded 48 h after transfection with either
Kv3.4 or non-targeting siRNA in supplemented RPMI 1640
medium, irradiated (0–6 Gy), and grown for 2 weeks. K562
cells formed round colonies that adhered to the bottom. The
plating efficiency was defined by dividing the number of
colonies by the number of plated cells. Survival fraction was
calculated by dividing the plating efficiency of the treated
cells by that of the untreated controls.
Results
To test for IR-induced changes in ion channel activity,
irradiated (0, 1, or 5 Gy) K562 cells were recorded with
the patch-clamp technique in whole-cell mode using phys-
iological intra- (i.e., pipette) and extracellular (i.e., bath)
solutions. K562 cells exhibited a membrane potential of
around −50 mV (Fig. 1a, b) which tended to hyperpolarize
upon irradiation with 5 Gy (Fig. 1a, b). This slight hyper-
polarization was accompanied by a change in whole-cell
currents (Fig. 1c). In particular, IR (5 Gy) induced within
1–3 h an increase in outward current (Fig. 1c, right) that
showed fast voltage-dependent activation (time constant Τ≈
1 ms at +25 mV), time-dependent inactivation at voltages
more positive than 0 mV (Τ≈40 ms at +25 mV). The IR-
stimulated current fraction (ΔI, grey curve in Fig. 1d) was
K+-selective as deduced from a reversal potential of the
current voltage relationship (I/V curve) that was close to
K+ equilibrium potential (EK=−89 mV). Together, K+-se-
lectivity, voltage-dependent activation, and time-dependent
inactivation (Fig. 1c, right) classify the IR-induced current
as voltage-gated Kv current. The peak current densities
(Fig. 1e, left) and peak current conductances (Fig. 1e, right)
of individual control (0 Gy), 1 Gy-, and 5 Gy-irradiated
K562 cells show the dependence of the Kv current on the
IR dose. To closer define the gating behavior, an extended
pulse protocol (Fig. 1f, insert) was applied to irradiated
(5 Gy) K562 cells. From the recorded currents (Fig. 1f),
the voltage-gated current fraction (Ivolt, Fig. 1g) was isolated
by subtracting the “non-gating,” linear current fraction, and
the normalized conductance (Gvolt/Gvolt max; Fig. 1h) was
calculated. As shown for the mean curve in Fig. 1g, a half-
maximal voltage of activation of V1/2=−44±5 mV (n=5)
Fig. 1 IR stimulates voltage-gated (Kv) K
+ channels in K562 cells. a,
b Membrane voltage of control (black line in a and open circles in b,
n=12) and irradiated (5 Gy) K562 cells (1.7±0.2 h post-IR, red line in
a and closed triangles in b, n=8) recorded in current-clamp mode with
K-D-gluconate pipette combined with NaCl (a, b) and KCl bath solu-
tion (a). Red marks in b indicate the median voltages (p=0.06, two-
tailed t test) c Current tracings from a control K562 cell (0 Gy, first
tracings) and cells irradiated with 1 Gy (second tracings) or 5 Gy
(third tracings). Records were obtained with K-D-gluconate pipette and
Na-D-gluconate bath solution. The insert shows the holding potential
and the applied voltage pulse protocol. Applied voltages refer to the
cytoplasmic face of the membrane with respect to the extracellular
space. In the current tracings, the individual current sweeps recorded at
the different voltages are superimposed. Outward currents, defined as
flow of positive charge (here: K+) from the cytoplasmic to the extra-
cellular membrane face, are positive currents and depicted as upward
deflections of the original current tracings. The zero current value is
indicated by the red line. d Relationships between mean peak current
densities and voltage (±SE, n=9–26) of control (0 Gy) and irradiated
K562 cells (5 Gy, 2.8±0.4 h post-IR) recorded as in (c, first and third
tracings). The grey curve (ΔI) resulted from subtracting the mean
current densities of the 0 Gy- from the 5 Gy-irradiated cells. e Densities
of the peak outward current (left) and conductance (right) of control
K562 cells (0 Gy, open circles) and cells irradiated with 1 Gy (closed
diamonds) or 5 Gy (closed triangles). Peak currents were analyzed at
0 mV and conductances between −40 and 0 mV. Shown are individual
cells (n=7–26) and the median value (red line) recorded as in c 3.2±
0.6 h and 2.8±0.4 h post-IR with 0 Gy and 5 Gy, respectively. Asterisk
indicates significant difference (p≤0.05), Kruskal–Wallis test (non-
parametric ANOVA). f Relationships between mean normalized peak
current and voltage (±SE, n=5) of irradiated K562 cells (5 Gy, 1.8±0.6 h
post-IR) recorded with the indicated pulse protocol with K-D-gluconate in
the pipette and NaCl in the bath. g Mean current voltage relationship of
the voltage-gated-current fraction (±SE, n=5) isolated from the record-
ings shown in f by subtracting the linear current fraction. h Rela-
tionship between mean normalized conductance (Gvolt/Gvolt max, ±SE,
n=5), and the voltage as calculated from the data in g. The
Boltzmann fit of the mean normalized conductances is indicated by
the red line, the half-maximal voltage of activation (V1/2) by the vertical
blue line

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was deduced by fitting the individual normalized conduc-
tance voltage relationship with the Boltzmann equation.
To narrow down potential molecular correlates of the IR-
induced Kv current, K
+ channel mRNA abundance of irra-
diated (0 and 5 Gy) K562 cells was analyzed 2 h post-IR by
a quantitative reverse transcriptase-polymerase chain reac-
tion (RT-PCR) micro-array. As shown in Fig. 2a, transcripts
specific for KCNH2 (hERG), KCNN4 (KCa3.1), KCNC4
(Kv3.4), and KCNQ4 (KvLQT4) could be identified. The
latter two channel types have biophysical signatures similar
to the IR-stimulated current of the present study. IR induced
a decrease in hERG-, Kv3.4-, and KvLQT4 mRNA abun-
dance (compare open and closed bars in Fig. 2a). In addition
to the mRNA, Kv3.4 protein could be detected in total cell
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lysates (Fig. 2b) and in enriched surface proteins (Fig. 2c)
by immunoblotting. Two Kv3.4 immunoreactive bands (50
and 70 kDa) were suggestive of Kv3.4 splice isoforms as
previously described [63]. On the cell surface of K562 cells,
only the 50 kDa protein was detectable (Fig. 2c). IR did not
alter the abundance of Kv3.4-immunoreactive total (Fig. 2a)
or surface protein (Fig. 2c). Together, these data suggest that
the IR-stimulated Kv current did not result from a change in
(surface) expression of the channels.
In order to estimate whether IR-induced Kv current activa-
tion is peculiar to the K562 leukemia model or a more general
phenomenon, Kv3.4 protein abundance and function was an-
alyzed in primary CML cells upon IR with 0 or 5 Gy. Primary
CML cells exhibited Kv3.4 protein (70 kDa) expression,
which was not altered 2 h post-IR (Fig. 3a). Kv channel
activity, in contrast, was stimulated by IR within 1–3 h post-
IR (Fig. 3b, c) suggesting that IR-induced Kv channel activa-
tion is a general phenomenon and not restricted to K562 cells.
The Kv current fraction of primary CML cells activated very
fast (time constants of Τ=6±1 ms, 3±0.5 ms, 1±0.3 s, and
0.6±0.1 ms after stepping the voltage from −65 mV to −35,
−15, +5, and +25mV, respectively) with a V1/2 for activation of
−48±2 mV (n=5, data not shown). Notably, Kv current inac-
tivation in irradiated primary CML cells was faster (Τ=13±
7 ms at 25 mV) than that in irradiated K562 cells (see above).
K+ channels participate in the generation of cytosolic
Ca2+ signals. The effect of IR-induced K+ channel activity
on Ca2+ entry was tested in K562 cells by Fura-2 Ca2+-
imaging. K+ channels were inhibited by the Kv channel
blocker tetraethylammonium (TEA, 3 mM), which exerts
an inhibitory potency among the identified K+ channels of
Kv3.4 (IC50=0.3 mM [52])>KvLQT4 (IC50=3.0 mM [20])
>>hERG1 (IC50=46 mM [11]) and KCa3.1 (Kd=30 mM
[38]). IR (5 Gy) stimulated the Ca2+ entry upon removal and
re-addition of external Ca2+ (Fig. 4a). Importantly, TEA
abolished the IR-induced Ca2+ entry (compare first and third
bars in Fig. 4b). Surprisingly, TEA stimulated the Ca2+-
entry in unirradiated cells (compare first and second bars
in Fig. 4b), a phenomenon which was not further studied.
Ca2+/calmodulin-dependent kinase II (CaMKII) isoforms
are reportedly activated in K562 cells by IR-stimulated Ca2+
signaling [21]. In the present study, K+ channel blockade by
TEA (3 mM) as well as the kinase inhibitor KN-93 (30 μM)
alleviated IR (5 Gy)-induced CaMKII activation as
evidenced by decreased auto-phosphorylation at Thr286
(Fig. 4c, d). Phosphorylation of the phosphatase cdc25B at
Ser187 has been demonstrated to decrease cdc25 activity
[10]. Since cdc25 isoforms are reported downstream targets
of CaMKII (see “Discussion”), cdc25B phosphorylation at
Ser187 was assessed in irradiated K562 cells. IR increased
phosphorylation of cdc25B at Ser187 in a KN-93- and TEA-
sensitive manner (Fig. 4e). Active cdc25B reportedly de-
phosphorylates and thereby activates cdc2, a subunit of the
mitosis-promoting factor. In line with the observed KN-93
and TEA-mediated attenuation of the IR-mediated cdc25B
inhibition, KN93 and TEA also decreased the IR-stimulated
inhibitory phosphorylation of cdc2 at Tyr15 (Fig. 4f).
Together, these data suggest that IR induces K+-channel-
regulated Ca2+ signals which inhibit the mitosis-promoting
factor via activation of CaMKII isoforms and subsequent
inactivation of cdc25B. Blockage of the voltage-gated K+
channels and the CaMKII isoforms by TEA and KN-93,
respectively, attenuates the IR-induced inhibition of the
mitosis-promoting factor.
Next, the effect of voltage-gated K+ channel inhibition on
the cell cycle was studied in irradiated (0 and 5 Gy) K562
cells by flow cytometry. Within 48 h, IR (5 Gy) induced a
redistribution of the cells from G1 to G2 phase of the cell
cycle, which is indicative of an IR-induced accumulation in
G2/M arrest (Fig. 5, black histograms in A and open bars in
B). In line with the observed Kv channel blocker-mediated
disinhibition of the mitosis-promoting factor (Fig. 4f), TEA
(3 mM) blunted the IR-induced accumulation in G2 (Fig. 5,
red histograms in A and closed bars in B). In theory, this
TEA effect might be also a consequence of a putative TEA-
mediated block of the previously reported [21] IR-
stimulated G1/S transition and S progression. To exclude
this possibility, incorporation of the thymidine analogue
bromodeoxyuridine (BrdU) was measured in irradiated (0
or 5 Gy) K562 cells. As shown in Fig. 6, TEA even pro-
moted the G1/S transition within the first 8 h post-IR.
Fig. 2 IR does not affect Kv3.4 (KCNC4) mRNA protein or surface
expression. a Mean housekeeper-normalized K+ channel mRNA abun-
dance (±SE, n=3) as determined in control (open bars) and irradiated
K562 cells (2 h post-IR) by quantitative RT-PCR array. The insert
shows the Kv3.4 (KCNC4) mRNA abundance in higher power. b, c
Immunoblots of total lysates (b) and surface proteins (c) of control
(0 Gy) and irradiated K562 cells (5 Gy, 2 h post-IR) probed against
Kv3.4 (upper blots). For loading control, β-actin (b) and Na/K-ATPase
α-subunit (c) immunoblots were performed
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Fig. 3 Primary chronic myeloid leukemia (CML) cells express Kv3.4
protein and activate voltage-gated K+ channels upon irradiation. a
Immunoblots of total lysates from control (0 Gy) and irradiated CML
cells (5 Gy, 2 h post-IR) probed against Kv3.4 (top) and for loading
control against β-actin (bottom). b Current tracings from a control
(0 Gy, first tracings) and an irradiated CML cell (5 Gy, second
tracings). Records were obtained with K-D-gluconate pipette and Na-
D-gluconate bath solution. c Conductance density of control (0 Gy,
open circles) and irradiated CML cells (5 Gy, closed triangles). Con-
ductances were calculated for the peak outward current between 0 and
40 mV voltage. Shown are individual cells (n=5–11) and the median
value (red line) recorded as in b 1.8±0.2 h post-IR with 0 and 5 Gy.
Asterisk indicates significant difference (p≤0.05), two-tailed t test
Fig. 4 Kv channels stimulate Ca
2+ entry, CaMKII activity, cdc25B,
and cdc2 phosphorylation in irradiated K562 cells. a Time course of
the mean ratio between the 340 and the 380 nm excited fura-2 fluo-
rescence as a measure of the cytosolic free Ca2+ concentration. Ratios
were recorded 80 min post-irradiation with 0 Gy (open circles; n=25)
or 5 Gy (closed triangles n=34) during removal and re-addition of
external Ca2+. b Mean slope of ratio increase upon Ca2+ re-addition.
Slopes for the linear course of ratio increase upon Ca2+ re-addition (as
indicated by blue and red lines in a) were calculated for K562 cells 1–3
post-irradiation with 0 and 5 Gy. Cells were irradiated and post-incu-
bated in the absence (open bars) or presence (closed bars) of the Kv
channel blocker tetraethylammonium (TEA, 3 mM). Given are means
±SE (n=102–378, *** indicates p≤0.001, ANOVA). c Immunoblots
showing the abundance of phosphorylated (Thr286, upper panel) and
total CaMKII isoforms (lower panel) of K562 lysed 6 h after irradiation
with 0 and 5 Gy. Cells were irradiated and post-incubated in the absence
or presence of the CaMKII inhibitor KN-93 (30 μM) or TEA (3 mM). d
Mean (±SE, n=3 lysates) protein abundance of phospho-CaMKII
(Thr286) analyzed and normalized to that of the 5 Gy-irradiated cells
which were irradiated and post-incubated in the absence of KN-93 and
TEA as in (c). e, f Immunoblots probed against phospho-cdc25B
(Ser187), cdc25B, phospho-cdc2 (Tyr15), or ß-actin. Numbers (ratio) in
(c, e, f) indicate the normalized ratio between the densitometry values of
the band in the upper and lower plot
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Together, these experiments suggest that inhibition of the Kv
channels by TEA results in an override of the G2/M arrest in
irradiated cells.
Finally, the involvement of the Kv channels in survival of
irradiated K562 cells was determined. To this end, break-
down of the phospholipid asymmetry across the plasma
membrane and clonogenic survival of irradiated (0 or
5 Gy) K562 cells was assessed in the presence or absence
of TEA by annexin V binding in flow cytometry and colony
formation assays, respectively. TEA augmented the IR-induced
breakdown of the phospholipid asymmetry (Fig. 7a, b) and
decreased clonogenic survival of K562 cells (Fig. 7c), strongly
suggesting that Kv channel targeting radiosensitizes K562 leu-
kemia cells. Besides radiosensitization, TEA decreased the
plating efficacy of unirradiated K562 cells (from 0.4 to 0.08)
suggesting a cytotoxic effect of TEA also in unirradiated cells.
Since TEA inhibits also KvLQT4 (albeit with much lower
efficacy) and potentially also other yet unidentified K+
channels in K562 cells, the effects of the more Kv3.4-spe-
cific inhibitors BDS-I and BDS-II [14, 65] were tested on
radiation-induced whole-cell current, on cell cycle control,
cell death, and clonogenic survival in irradiated (0 or 5 Gy)
K562 cells. BDS-II (2 μM) inhibited in irradiated K562
cells a current fraction that resembled the irradiation-
induced current (grey curve in Fig. 1d) in K+ selectivity
and voltage-dependent activation (Fig. 8a, b). Similar to
TEA, BDS-I (5 μM) decreased the number of irradiated
cells accumulating 48 h post-IR in the G2 phase of cell cycle
(Fig. 8c, right). In contrast to TEA, BDS-I significantly
decreased and increased the number of unirradiated cells
residing in the G1 and S phase of cell cycle, respectively
(Fig. 8c, left and middle). In addition, BDS-1 induced cell
death which was more pronounced in irradiated cells
(Fig. 8d). Moreover, BDS-1 and BDS-2 (5 μM) decreased
the clonogenic survival of irradiated K562 cells (without
decreasing the plating efficiencies). Together, the data indi-
cate a radiosensitizing effect of the more specific Kv3.4
inhibitors BDS-I and BDS-II. Like TEA, BDS-I exhibited
cytotoxicity also in unirradiated cells.
In a last series of experiments, Kv3.4 was downregulated
in K562 cells by RNA interference, and whole-cell currents,
cell cycle, cell death, and clonogenic survival were deter-
mined in irradiated (0 or 5 Gy) K562 cells. Kv3.4 silencing
decreased whole-cell currents of irradiated cells (Fig. 9a, b).
The downregulated current fraction (ΔI, grey curve in
Fig. 9b) was similar to the radiation-stimulated current frac-
tion (grey curve in Fig. 1d) and the BDS-II-sensitive current
fraction of irradiated K562 cells (grey curve in Fig. 8b)
suggesting Kv3.4 channels generated at significant part of
the radiation-stimulated BDS-II-sensitive currents in K562
cells. Like TEA (Fig. 5) and BDS-I (Fig. 8c) treatment,
Kv3.4 silencing increased the percentage of irradiated cells
that accumulated in the G2 phase of the cell cycle 48 h post-
IR (Fig. 9c, d). Like TEA- (Fig. 7a, b) and BDS-I treatment
(Fig. 8d), Kv3.4 silencing increased cell death in the irradi-
ated cells as revealed by the higher number of cells with
Fig. 5 Increase in Kv channel
activity induces G2/M arrest in
irradiated K562 cells. a
Histograms of propidium
iodide-stained K562 cells
(Nicoletti protocol) recorded by
flow cytometry 48 h post-IR
with 0 Gy (left) or 5 Gy (right).
Cells were pre-incubated
(0.5 h), irradiated, and post-
incubated in the absence
(control, black line) or presence
of TEA (3 mM, red line). b
Mean percentage (n=6) of 0 Gy
(control, first and second bars)
and 5 Gy- irradiated cells (third
and fourth bars) residing in G1
(upper line), S (middle line), or
G2 phase of cell cycle (lower
line) recorded as in (a) 48 h
post-IR. *** indicates p≤0.001,
ANOVA
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degraded DNA (subG1 fraction, Fig. 9c, e). Finally, Kv3.4
silencing decreased clonogenic survival of irradiated K562
cells (Fig. 9f). The effect of Kv3.4 silencing was not as
pronounced as treatment with the Kv3.4 inhibitors TEA or
BDS-1 and BDS-II hinting to a significant residual activity
of Kv3.4 in the silenced cells. Together, these data on cell
cycling and survival suggest that Kv channels including
Kv3.4 indeed control cell cycle and foster survival of irra-
diated K562 cells.
Discussion
Aberrant ion channel expression is a hallmark of cancer
cells. “Oncogenic” channels [24] have been shown to par-
ticipate in multiple processes of tumor biology. They regu-
late cell proliferation, malignant progression, invasion and
metastasis, adaptation to the microenvironment, and tumor
neovascularization (for review, see [4, 6, 12, 17, 24, 32, 35].
In particular, voltage-gated K+ channels such as shaker-
(Kv1.x), shaw- (Kv3.x), or shal-related (Kv4.x) channels
have been reported to promote cell proliferation of breast
[27], colon [57], gastric [29], lung [28], ovarian [67], and
squamous head and neck cancer [44], as well as
leiomyosarcoma [8]. Similarly, hERG (Kv11.1) voltage-
gated K+ channels are upregulated in many tumor entities
[3] including leukemia where they regulate cell cycle and
cell proliferation [36]. In line with this observation, hERG
mRNAwas most abundant among the four K+ channel types
identified in K562 cells in the present study.
Similarly to K562, hERG protein is highly abundant and
functional in the primary CML cells used in this study (own
unpublished results). Further common features of K562 and
the primary cells are the reported radiation-induced Ca2+
entry [21] and the radiation-induced Kv channel activation
observed in the present study. Together, these suggest that
K562 can be used as CML cell model to study regulation of
radiation-induced Ca2+ signaling by Kv channels.
The present study identified a functional significance of
Kv3.4 for the survival of irradiated K562 cells. Reported
biophysical features of Kv3.4 channels comprise (1) high
voltage of activation when heterologously expressed, (2) a
shift of the activation voltage to highly negative values
(half-maximal voltage of activation, V1/2=−44 mV) when
Fig. 7 Inhibition of Kv channels by TEA radiosensitizes K562 cells. a
Histograms showing annexin V-binding to K562 cells which were
irradiated (0 Gy, left and 5 Gy, right) and post-incubated (24 h) in
the absence (black line) or presence (red line) of TEA (3 mM) before
recording by flow cytometry. b Mean percentage of annexin V-binding
cells (±SE, n=12) 24 h post-IR with 0 (first and second bars) and 5 Gy
(third and fourth bars). Cells were irradiated and post-incubated in the
absence (control, open bars) or presence of TEA (3 mM, closed tri-
angles). c Mean survival fraction (±SE, n=3) of irradiated (0, 1, 3, or
5 Gy) K562 cells. Cells were irradiated and post-incubated in the
absence (control, open bars) or presence of TEA (3 mM, closed tri-
angles). Mean plating efficiencies were 0.4 and 0.08 for the non-
irradiated control and TEA-treated group, respectively. Asterisk indi-
cates p≤0.05, Kruskal–Wallis test (nonparametric ANOVA)
Fig. 6 Inhibition of Kv channels fosters radiation-induced G1/S tran-
sition. a Dot plots showing the DNA-synthesis by bromdesoxyuridin
(BrdU) incorporation and DNA amount by propidium iodide (PI)
staining after incubation for 8 h in the absence (top) and presence of
TEA (3 mM, bottom) following irradiation with 5 Gy. BrdU-positive
cells in S-phase of cell cycle are outlined in turquoise, cells which
reside in G1 and G2 and which did not accumulate BrdU (low BrdU)
are outlined in violet and yellow, respectively. The BrdU-positive cells
(high BrdU) in G1 and G2 are indicated by the red and grey boxes,
respectively. b Mean percentage (±SE) of control (0 Gy) and irradiated
(5 Gy) cells residing in the G1 low BrdU, S, or G2 high BrdU,
population as defined in (a). Shown is a representative experiment
performed in triplicates, * indicates p≤0.05, ANOVA
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coexpressed with MinK-related peptide 2 (MiRP2, KCNE3),
(3) very fast activation, and (4) fast inactivation, as well as
sensitivity to BDS-II with IC50s of 0.3 μM (Kv3.4) and
7 μM (Kv3.4/MiRP2) [1]. Similarly to Kv3.4/MiRP2, the
Kv3.4 currents of K562 cells and the Kv currents of primary
CML cells observed in the present study exhibited mean
V1/2s of −44 and −48 mV, respectively. In addition, Kv
currents of the irradiated primary CML cells activated and
inactivated fast with time constants reported for Kv3.4
Fig. 9 Kv3.4 RNA interference overrides G2/M arrest in irradiated K562
cells. a, b Current tracings (a) and mean (±SE) current densities voltage
relationships (b) recorded from irradiated K562 cells (5 Gy, 2.1±0.4 and
2.1±0.3 h post-IR, respectively) pre-treated either with non-targeting RNA
(nt, a left and b open circles, n=11) or Kv3.4 siRNA (si, a right and b
closed triangles, n=9). Records were obtained as in Fig. 8a, b with K-D-
gluconate pipette and NaCl bath solution. The grey curve in b indicates the
current fraction ΔI that was sensitive to Kv3.4 downregulation. c Histo-
grams of propidium iodide-stained K562 cells (Nicoletti protocol)
recorded by flow cytometry 48 h post-IR with 0 Gy (left) or 5 Gy (right).
Cells were transfected with non-targeting (nt, black line) or Kv3.4 siRNA
(si, red line) 24 h prior to IR. dNormalized percentage of cells treated with
non-targeting RNA (nt, open bars) or Kv3.4 siRNA (si, closed bars)
residing in G1 (left), S (middle), and G2 (right) phase of cell cycle,
respectively, 48 h post-IR with 0 or 5 Gy (recorded as in (c)). eNormalized
percentage of dead cells (subG1 population) treated with non-targeting
RNA (nt, open bar) or Kv3.4 siRNA (si, closed bar) 48 h post-IR with 0 or
5 Gy (recorded as in (c)). f Mean survival fraction (±SE, n=10–14) of
irradiated (0, 2, 4, or 6 Gy) MOCK-, non-targeting RNA-, and Kv3.4
siRNA (si, closed triangles)-transfected K562 cells. Data from MOCK-
(n=4) and non-targeting RNA-transfected cells (n=10) did not differ and
were pooled (nt, open circles). Mean plating efficiencies were 0.4 and 0.5
for the MOCK-/non-targeting RNA-, and Kv3.4 siRNA-transfected cells,
respectively. Asterisk indicates p≤0.05, ANOVA
Fig. 8 Kv3.4 inhibitors BDS-I and BDS-II mimic the effect of TEA. a,
b Current tracings (a) and mean (±SE, n=3) normalized current density
voltage relationships (b) recorded in paired experiments from irradiat-
ed K562 cells (5 Gy, 2.6±0.8 h post-IR) with Na-D-gluconate pipette-
and NaCl bath solution before (control, a, left and b, open circles) and
after application of BDS-II (2 μM, a right and b closed triangles) to
the bath solution. The grey curve in b shows the BDS-II-sensitive
current fraction ΔI. c Mean percentage of cells (±SE, n=4–15) treated
with BDS-I (0 and 5 μM) residing in G1 (left), S (middle), and G2
(right) phase of cell cycle, respectively, 48 h post-IR with 0 or 5 Gy. d
Mean percentage (±SE, n=4–15) of dead cells (subG1 population)
treated with BDS-1 (0 or 5 μM) 48 h post-IR.*, **, and *** indicate
p≤0.05, p≤0.01, and p≤0.001, respectively, ANOVA. e Mean survival
fraction (±SE, n=3–9) of irradiated (0, 2, or 4 Gy) BDS-1 or BDS-2 (0
or 5 μM, each)-treated cells. Mean plating efficiencies were 0.09, 0.19,
and 0.14 for control, BDS-1-, and BDS-2-treated cells, respectively
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channels [65]. The Kv3.4 currents in irradiated K562 cells,
however, inactivated slower (compare Figs. 1c (right) with
3b (right)). Alternative splicing and alternative transcription
start sites have been reported for mammalian Kv3.4 channels
[63]. In particular, variant Kv3.4d lacks N-terminal amino
acids which might be involved in the N-terminal “ball and
chain” inactivation. In K562 cells, only surface expression
of an about 50 kDa Kv3.4-immunoreactive protein could be
detected (see Fig. 2c) while primary CML cells expressed
only the 70 kDa Kv3.4 full-length protein. Moreover, protein
kinase C-dependent posphorylation of NH2-terminal serines
S8, S9, S15, and S21 has been shown to slow down Kv3.4
inactivation [7]. It is therefore tempting to speculate that
the difference in inactivation kinetics between the primary
CML and the K562 cell line might reflect either expres-
sion of different isoforms, or different phosphorylation
states of the Kv3.4 channels. The present study did not
directly test for Kv3.4 function in primary CML cells. The
similarities between the Kv currents of the primary CML
cells and heterelogously expressed Kv3.4/MirP2 channels
[1] suggest that, likewise K562, Kv3.4 contributed to the
Kv currents of irradiated primary CML cells. To which
extent the Kv channel beta subunit MirP2 participated in
the Kv currents of both leukemia cell models was not analyzed
in the present study.
The irradiation-induced increase in Kv3.4 channel activity
was accompanied by a slight hyperpolarization of the mem-
brane potential (Fig. 1a, b) suggesting Kv3.4 as a modulator of
the membrane potential in K562 cells. Kv3.4-mediated hyper-
polarization of the plasma membrane has been postulated to
contribute to G1 progression and G2/M transition in prolifer-
ation of vascular smooth muscle cells [45]. Kv3.4 might exert
similar cell cycle regulatory functions in unirradiated K562
cells as suggested by BDS-I-induced modifications of cell
cycle progression (see Fig. 8c). Besides regulating cell prolif-
eration, Kv3.4 channels are participating in the stress response
of human leukemia cells. This is evident from the present
study which discloses a functional significance of Kv3.4 chan-
nels for the induction of G2/M cell cycle arrest and clonogenic
survival of irradiated leukemia cells.
Irradiation stimulated, in the present study, the Kv3.4 cur-
rents in K562 without increasing the surface expression of the
channel protein indicating radiation-induced modifications of
the Kv3.4 channel itself or of a putative beta subunit, and/or of
the membrane lipid environment of the channel complexes. In
this context, irradiation has been reported to result in mem-
brane lipid peroxidation with subsequent activation of tyro-
sine kinases [15]. Moreover, tyrosine phosphorylation of
shaker Kv channels [19] and protein kinase C-dependent
phosphorylation of MirP2 have been shown to alter voltage-
dependence of Kv channel activation [2].
In the present study, irradiation-induced Kv channel acti-
vation stimulated Ca2+ entry (see Fig. 4a, b) probably
through TRPV5/6 channels. The latter are co-activated in
K562 and primary CML cells upon irradiation [21].
Irradiation-induced modulation of Kv and TRPV5/6 chan-
nels participates in the generation of Ca2+ signals that in turn
activate CaMKII isoforms, as deduced from the increased
autophosphorylation at Thr286 of this kinase (see Fig. 4c, d
and [21]). CaMKII isoforms link biochemical signaling to
the Ca2+ signalosome and exert multiple functions in cell
cycle controls. CaMKII activity results in proteasomal deg-
radation of p27 in colon adenocarcinoma [37], in decreased
expression of p21 in osteosarcoma [66], and breast cancer [18]
and increased expression of cyclin D1 in breast cancer [61].
Conversely, over-expression of the endogeneous CaMKII
inhibitory proteins hCaMKIINalpha and hCaMKIINbeta in
human colon adenocarcinoma [64] and ovarian cancer cells
[40], respectively, stabilizes p27 or upregulates p21 and
downregulates cyclin A, cyclin D1, cyclin E, and Cdk2.
Thus, by upregulating cyclin D1 and downregulating the cell
cycle inhibitors p21 and p27, CaMKII activity leads to disin-
hibition of the cyclin-Cdk4 and cyclin-Cdk2 complexes, and
thus promotes G1/S transition and S-G2/M cell cycle progres-
sion. Later on, in cell cycle, CaMKII directly activates cdc25c,
triggering G2/M cell cycle transition [48, 56]. Moreover,
CaMKII is required for centrosome duplication [43] and
maintenance of the spindle bipolarity during mitosis [23].
Finally, CaMKII regulates M phase exit [13]. In primary
CML cells and CML cell lines, cell proliferation specifically
depends on activation of the CaMKIIγ isoforms, and CML
cells undergoing terminal differentiation or growth arrest dis-
play a marked reduction of CaMKIIγ autophosphorylation
[54].
In addition to its cell cycle-promoting functions, CaMKII
isoforms may also suppress cell cycle progression by inhi-
bition of cdc25c [26], by stabilization of p53 [16], by
impairing nuclear translocation of nuclear factor of activated
T cells [41], or by inhibiting S phase DNA replication [42].
Moreover, CaMKII induces G2/M arrest when transiently
expressed in a constitutively active form [51]. Thus,
CaMKII isoforms appear to interfere with cell cycle control
in a complex manner at multiple pathways.
As demonstrated in the present study, IR-induced G2/M
cell cycle arrest of K562 cells is, at least in part, mediated by
CaMKII-dependent inactivation of the phosphatase cdc25B
and the mitosis-promoting factor. Most importantly, Kv
channel inhibition attenuated CaMKII activation and subse-
quent inactivation of cdc25B and the mitosis promoting
factor, and overrode G2/M cell cycle arrest, increased cell
death, and decreased clonogenic survival. This suggests
both, that Kv channels, in particular, Kv3.4 channels,
are key regulators in the stress response of irradiated
leukemia cells and that Kv channels might be attractive
new targets to overcome therapy resistance of leukemia
cells.
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 2 
Abstract 
 
K+ channels crosstalk with biochemical signaling cascades and regulate virtually all cellular 
processes by adjusting intracellular K+ concentration, generating membrane potential, 
mediating cell volume changes, contributing to Ca2+ signaling, and by directly interacting 
within molecular complexes with e.g., membrane receptors and downstream effectors. 
Importantly, tumor cells exhibit aberrant expression and activity patterns of K+ channels. The 
upregulation of highly “oncogenic” K+ channels such as the Ca2+-activated IK channel may 
drive neoplastic transformation, malignant progression, metastasis, or therapy resistance of 
tumor cells. In particular, ionizing radiation in doses used for fractionated radiotherapy in the 
clinic has been shown to activate K+ channels. Radiogenic K+ channel activity, in turn, 
contributes to the DNA damage response and promotes survival of the irradiated tumor cells. 
Tumor-specific overexpression of certain K+ channel types together with the fact that 
pharmacological K+ channel modulators are already in clinical use or well tolerated in clinical 
trials suggests that K+ channel targeting alone or in combination with radiotherapy might 
become a promising new strategy of anti-cancer therapy. The present article aims to review 
our current knowledge on K+ channel signaling in irradiated tumor cells. Moreover, it 
provides new data on molecular mechanisms of radiogenic K+ channel activation and 
downstream signaling events. 
 
 
 
 
Key words. Oncochannels, fractionated radiation therapy, electrosignaling, Ca2+ signalosome, 
patch-clamp recording, fura-2 Ca2+ imaging 
 3 
Introduction 
 
Radiotherapy belongs to the standard therapy protocol of many tumor entities. About 50% of 
all tumor patients undergo radiotherapy often neoadjuvant or adjuvant to surgery and/or 
combined with chemotherapy (Delaney et al. 2005). Radiation protocols frequently comprise 
fractionated therapy regimes with single fractions of sublethal radiation doses. Besides 
damaging the DNA, such doses of ionizing radiation trigger a plethora of cellular signaling 
events, which in concert with DNA repair mechanisms contribute to the cellular stress 
response. 
 
Radioresistance of tumor cells often results in failure of local tumor control, metastasis or 
tumor recurrence. Unexpectedly, ion channels/transporters in the plasma membrane (Stegen et 
al. 2015), in the inner mitochondrial membrane (Braun et al. 2015; Huang et al. 2015), or in 
the nucleus/cytoplasma (Kim et al. 2010) have been demonstrated to regulate radioresistance. 
Specifically, K+ channels in leukemia (Klumpp et al. 2016; Palme et al. 2013), lung 
adenocarninoma (Gibhardt et al. 2015; Huber et al. 2012; Roth et al. 2015) and glioblastoma 
cells (Huang et al.; Stegen et al. 2015; Steinle et al. 2011) are reportedly stimulated by 
ionizing radiation and exert functions in metabolisms, cell cycle, pro-survival signaling, or 
stress evasion that improve survival of the irradiated tumor cells. Moreover, preliminary 
clinical data might hint to a prognostic value of tumor-associated K+ channels for clinical 
outcome. In particular, in glioblastoma, a primary brain tumor which is treated with surgery 
and adjuvant fractionated radiochemotherapy (Stupp et al. 2009), high expression of Ca2+-
activated intermediate conductance IK (KCa3.1, KCNN4) K+ channels (Stegen et al. 2015; 
Turner et al. 2014) or mitochondrial mKATP K+ channels (Huang et al.) in the tumors has been 
linked to poor prognosis of the patients.  
 
K+ channels such as EAG1 are getting more and more in the focus of oncologists due to their 
pivotal functions in tumor biology (for review see (Pardo and Stühmer 2008) and (Pardo and 
Stühmer 2014)). However, worldwide, only a handful of groups including our one works on 
K+ channel function in irradiated tumor cells. Hence, the available data are very limited and 
primarily derived from human leukemia or glioblastoma cell lines. The present study aims to 
give an update of our current knowledge about the functional significance and the signaling 
upstream and downstream of radiation-induced K+ channel activation. In addition, new data 
on radiogenic K+ channel signaling will be presented. Previous review articles of our group on 
this topic focus on “oncogenic functions” of ion channels (Huber 2013), on the biophysics of 
radiogenic modulation of membrane transports and strategies to radiosensitize tumor cells by 
targeting these transports (Huber et al. 2013), and on the functional significance of ion 
channels for intrinsic and acquired radioresistance (Huber et al. 2015). 
 
 
1 Functional significance of radiogenic K+ channel activity 
 
1.1 Glucose uptake. Many tumor cells metabolize glucose by anaerobic glycolysis and lactic 
acid fermentation rather than by mitochondrial respiration. This so-called Warburg effect 
entails high cellular glucose consumption. Low glucose availability in the tumor cell 
microenvironment of poorly perfused solid tumors, in addition, forces the tumor cells to 
upregulate highly efficient glucose fuelling pathways in the plasma membrane. Tumor cells 
have been shown to aberrantly express Na+-coupled glucose contransporters (SGLTs) which 
harness the inwardly directed electrochemical Na+-gradient to take up glucose even against 
high chemical glucose gradients. Previous work of our group disclosed that irradiated A549 
lung adenocarcinoma cells massively increase their SGLT activity in the plasma membrane 
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(Huber et al. 2012). Notably, elevated Na+-coupled glucose uptake is preceded by radiogenic 
K+ channel activation (Roth et al. 2015) and hyperpolarization of the plasma membrane 
(Huber et al. 2012), most probably to maintain the electrochemical driving force for Na+ and 
to sustain glucose uptake. The latter is required to counteract the cellular energy crises of 
DNA-damaged cells and to provide carbohydrates for acetyl-CoA synthesis needed for 
histone acetylation and DNA decondensation as prerequisite for DNA repair (Dittmann et al. 
2013). 
 
1.2 Cell cycle control. Cells arrest their cell cycle upon radiogenic DNA damage to prevent 
entering of mitosis with unfixed DNA double strand breaks. During this arrest cell cycle is 
halted at several points including G1/S transition, S phase and G2/M transition until DNA 
damages are repaired. Cellular sensors of DNA damage such as ataxia-telangiectasia-and-
rad3-related (ATR)-dependent or -independent activation of checkpoint kinases (Chks) and 
ataxia-telangiectasia-mutated (ATM)-dependent stabilization of p53 arrest the cell cycle via 
phosphorylation of the phosphatase cdc25 and upregulation of the cyclin-dependent kinase 
inhibitor p21, respectively. Proteasomal degradation of phosphorylated cdc25 and 
upregulation of p21, in turn, prevent the formation of or inhibit the cyclin-dependent kinase 
complexes. Radiogenic electrosignaling by K+ channels have been demonstrated by our group 
to crosstalk with this biochemical signaling. Specifically, radiogenic Kv3.4 and IK K+ channel 
activity in chronic myeloid leukemia (Palme et al. 2013) and glioblastoma (Stegen et al. 2015) 
cell lines, respectively, has been identified to be required for G2/M cell cycle arrest.  
 
1.3 Radioresistance. In our studies, pharmacological inhibition of Kv3.4 and IK channels did 
override cell cycle arrest in both tumor entities resulting in entering mitosis despite residual 
DNA damages (Palme et al. 2013; Stegen et al. 2015). Moreover, IK channel blockade 
delayed repair of DNA double strand breaks in irradiated glioblastoma cells (Stegen et al. 
2015). Premature re-entry of irradiated cells into mitosis, however, is expected to drive the 
cells in mitotic catastrophe and to decrease the percentage of irradiated tumor cells that 
maintain their clonogenicity. As a matter of fact, pharmacological inhibition of Kv3.4 
channels in leukemia cells with TEA, BDS-1, or BDS-2 and IK channels in glioblastoma cells 
with TRAM-34 radiosensitized these cells as evident from colony formation assays (Palme et 
al. 2013; Stegen et al. 2015). Importantly, stable knock-down of IK in irradiated glioblastoma 
cells decreased clonogenic survival and, at the same time, abolished the effect of 
pharmacological IK channel targeting, indicating the K+ channel specificity of TRAM-34 
(Stegen et al. 2015). Vice versa, experimental overexpression of IK channels in a human 
gliobastoma cell line with low basal IK channel expression rendered the tumor cells 
radioresistant and sensitive against IK channel blockade by TRAM-34 (Fig. 1). Further in 
vitro evidence for a radioresistance-conferring function of IK channels in glioblastoma has 
been reported by others (Liu et al. 2010). 
 
Beside cell cycle control, mitochondrial mtKATP K+ channels have been demonstrated by a 
recent report (Huang et al. 2015) to suppress apoptotic cell death in irradiated glioblastoma 
cells. Knockdown or pharmacological blockage of mtKATP increased apoptotic death and 
decreased clonogenic survival of irradiated glioblastoma cells, while opening of mtKATP with 
diazoxide suppressed apoptosis and rendered the cells radioresistant. 
 
1.4 Migration and metastasis. Fractionated radiotherapy which applies sublethal single doses 
of usually 2 Gy may induce migration and metastasis of tumor cells (for review see (Huber et 
al. 2013)). Specifically, glioblastoma cells responded in our transfilter chemotaxis 
experiments to ionizing radiation within 1-2 hours with an almost doubling of migration 
velocity (Steinle et al. 2011). At least in theory, this radiogenic hypermigration 
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fractionated radiation therapy (which usually applies a cumulative dose of 60 Gy in 30 
fractions á 2 Gy during 6 weeks) might promote evasion of clonogenic glioblastoma cells 
from the target volume of the radiation beam. 
 
Brain infiltration of glioblastoma cells employs Ca2+-activated BK (SLO1, KCNMA1) K+ 
channels which are reportedly required for cell volume decrease during squeezing of 
glioblastoma cells through smallest interstitial spaces (Sontheimer 2008). Similar to BK, IK 
K+ channels have been shown to contribute to the serum- (Catacuzzeno et al. 2011; 
Catacuzzeno et al. 2012), bradykinin- (Cuddapah et al. 2013) and chemokine-induced 
glioblastoma cell migration (D'Alessandro et al. 2013) in vitro and brain infiltration by 
xenografted human glioblastoma cells in orthotopic mouse models (D'Alessandro et al. 2013). 
 
Most importantly, radiogenic BK (Steinle et al. 2011) and IK channel activation (Stegen et al. 
2015) are involved in radiogenic hypermigration since BK channel blockade by inhibitors 
such as paxilline abrogates radiogenic hypermigration of glioblastoma cells in vitro and BK as 
well as IK channel inhibition slows down radiogenic hyperinfiltration of the brain in an 
orthotopic glioblastoma mouse model (Edalat et al., own unpublished observation). Thus, 
these results suggest a pivotal function of the Ca2+-activated K+ channel for radiogenic 
glioblastoma spreading which - in the worst scenario - might contribute to evasion from the 
target volume of radiotherapy and tumor relapse.  
 
1.5 Maintenance of “stemness”. One might speculate that radiogenic hypermigration might 
foster homing of glioblastoma cells to perivascular cancer “stem cell” niches (Pajonk and 
Vlashi 2013). The subsequent reciprocal interaction between endothelial and glioblastoma 
cells (Rao et al. 2012) within these niches has been demonstrated to induce/maintain 
“stemness” in glioblastoma cells (Anido et al. 2010; Pietras et al. 2014). Cancer “stem cells”, 
in turn, have been proposed to be more radioresistant than the bulk tumor mass of 
“differentiated” tumor cells (Pajonk et al. 2010). In this context, a previous report showed that 
xenografted CD133+ (prominin-1) stem-like subpopulations of glioblastoma cells exhibited a 
higher radioresistance than xenografted CD133- cells while radiosensitivity of both 
subpopulations did not differ in vitro (Jamal et al. 2012). This clearly indicates a function of 
the brain microenvironment for radioresistance. 
 
Ionizing radiation has been demonstrated to select cancer “stem”-like cells or even to induce 
transition of “differentiated” to “stem”-like tumor cells in glioblastoma (Kim et al. 2011; 
Tamura et al. 2013) and other tumor entities (Lagadec et al. 2012; Pajonk et al. 2010). 
Noteworthily, up-regulation of “stemness” markers in glioblastoma is reportedly associated 
with over-expression of IK channels (Ruggieri et al. 2012 and Fig. 2A-C). Moreover, 
glioblastoma “stem” cells have been proposed to be highly migratory and to be primarily 
responsible for brain infiltration (Liu et al. 2006a; Nakada et al. 2013). Most importantly, 
stem cell migration highly depends on IK channels (Ruggieri et al. 2012). Along those lines, 
IK channels reportedly contribute to the migration of neuronal precursor cells into the 
olfactory bulb of mouse brain (Turner and Sontheimer 2014). 
 
In summary, K+ channels might be required for maintenance of “stemness” of tumor cells and 
radiogenic K+ channel activity exerts various pro-survival functions. The identified signaling 
pathways underlying radiogenic K+ channel activation will be described in the next 
paragraphs. 
 
 
 
 6 
 
 
2 Upstream signaling  
 
2.1 Radiogenic expression of K+ channels. Cells receiving fractionated irradiation with 
sublethal single doses partially recover between the fractions. This recovery is more 
pronounced in normal tissue than in most tumor entities and, therefore, contributes to the 
normal tissue protection in radiotherapy. As a consequence of partial recovery between the 
radiation fractions, cell survival after a certain cumulative total dose of fractionated irradiation 
is much higher than after a corresponding single dose as shown here in the U251 glioblastoma 
model (Fig. 2A). Therefore, radiation doses that are assumed to be ablative have to 
accumulate, e.g. in the case of glioblastoma, within 6 weeks of fractionated radiotherapy. 
During this time period, however, tumor cells may acquire radioresistance, e.g., by radiation-
induced overexpression of the genes involved in DNA repair and cell cycle control (Shimura 
2011). In our experiments, 5 fractions of 2 Gy led to a 2-3 fold upregulation of the mRNAs 
encoding for the proposed “stem”cell marker CD133 (Fig. 2B) and IK (Fig. 2C) in U251 
glioblastoma cells. In accordance to elevation of IK mRNA abundance, fractionated radiation 
induced an increase in plasma membrane IK K+ currents (Fig. 2D-G). Hence, fractionated 
radiation may alter the expression of K+ channels in tumor cells. 
 
2.2 The HIF-1α/SDF-1/CXCR4 axis. Ionizing radiation induces expression and stabilization of 
the transcription factor hypoxia-inducible-factor-1α (HIF-1α) in several tumor entities. 
Subsequent gene regulation by HIF-1α has been demonstrated to trigger a metabolic switch 
from oxidative phosphorylation to anaerobic glycolysis and lactic acid fermentation 
(Dittmann et al. 2015; Lall et al. 2014), to stimulate angiogenesis (Zagzag et al. 2006), to 
recruit bone marrow-derived cells resulting in vasculogenesis (Kioi et al. 2010), to induce 
malignant progression (Kim et al. 2014) and radioresistance (Zhang et al. 2011). Accordingly, 
HIF-1α overexpression by malignant melanoma or locally advanced squamous cell head-and-
neck cancer has been shown to be associated with poor prognosis (Giatromanolaki et al. 2003; 
Koukourakis et al. 2002) 
 
Radiogenic HIF-1α stabilization may be mediated by hypoxia resulting from the decay of the 
radiosensitive tumor vasculature, by destabilization of prolyl hydroxylases-2 and HIF-1α-
specific E3-ligase (Kim et al. 2014), by S-nitrosylation of the protein via NO release from 
tumor-associated macrophages (Li et al. 2007). In addition, upregulation of HIF-1α protein 
expression via complex formation of HIF-1α mRNA with the nuclear epithelial-growth-
factor-receptor (EGFR) has been reported (Dittmann et al. 2015). The latter translocates in 
irradiated cells from the plasma membrane to the nucleus (Dittmann et al. 2009). 
 
The chemokine SDF-1 (stromal cell-derived factor-1, CXCL12) (Kioi et al. 2010) and its 
receptor CXCR4 (Zagzag et al. 2006) belong to the HIF-1α target genes. In accordance to 
radiogenic HIF-1α upregulation/stabilization, ionizing radiation has been shown to induce the 
expression of SDF-1 in different tumor entities including glioblastoma (Kioi et al. 2010; 
Kozin et al. 2010; Tabatabai et al. 2006; Wang et al. 2013) as well as in normal brain tissue 
(Zhou et al. 2013). Notably, upregulation of SDF-1 secretion and CXCR4 expression has been 
proposed to be associated with “stemness” in A549 lung adenocarcinoma cells (Jung et al. 
2013). Similarly, glioblastoma “stem” cells markedly upregulate and (Liu et al. 2006a) 
depend on CXCR4 (Barone et al. 2014). Moreover, formation of the perivascular 
glioblastoma stem cell niches and reciprocal signaling between glioblastoma stem cells and 
endothelial cells depend on SDF-1/CXCR4 (Rao et al. 2012; Richardson 2015). 
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In our yet unpublished experiments, irradiated cells released SDF-1 in the culture medium and 
conditioned medium from irradiated cells stimulated BK and IK channel activity and 
migration of glioblastoma cells in a CXCR4-dependent manner (Edalat et al., unpublished). 
Like conditioned medium, SDF-1 triggers K+ channel activity (Edalat et al, own unpublished 
observations) and IK channel-dependent migration of glioblastoma cells (Sciaccaluga et al. 
2010). Taken together, it can be concluded that radiogenic HIF-1α stabilization, subsequent 
SDF-1 formation/secretion and auto-/paracrine SDF-1/CXCR4 signaling contributes to 
radiogenic IK and BK channel activation in cancer cells. 
 
2.3. Reactive oxygen species (ROS). The majority of radiation energy is absorbed by cellular 
water molecules resulting in the formation of the short-lived, highly reactive hydroxyl radicals 
(for review see (Huber et al. 2013)). Hydroxyl radical-mediated lipid peroxidation has been 
demonstrated to trigger src kinase activity and translocation of EGFR to the nucleus 
(Dittmann et al. 2009). Nuclear EGFR, in turn, facilitates HIF-1α signaling (see above). In 
addition, in A549 lung adenocarcinoma cells transfected with reporters of hydrogen peroxide 
and of glutathione redox potential, ionizing radiation reportedly induces a rapid rise in 
hydrogen peroxide concentration as a function of both, hydrogen peroxide formation and 
glutathione buffering capacity (Gibhardt et al. 2015). Hydrogen peroxide signaling stimulates 
Ca2+ entry and eventually activation of IK K+ channels (Gibhardt et al. 2015; Roth et al. 
2015). 
 
2.4 Upstream Ca2+ signaling. Reactive oxygen species and ionizing radiation have been 
demonstrated to activate Ca2+-permeable cation channels of the transient receptor potential 
(TRP) family such as TRPC6 (Foller et al. 2008) in red blood cells and TRPV5/6 (Heise et al. 
2010) as well as TRPM2 (Klumpp et al. 2016) in leukemia cells. Own, yet unpublished data 
suggest radiogenic up-regulation and activation of the cold receptor TRPM8 in glioblastoma 
cells (Klumpp et al, unpublished). Glioblastoma cells highly overexpress the cold receptor 
TRPM8 (Alptekin et al. 2015) and stimulation of TRPM8 with the cooling agent icilin has 
been shown to induce BK K+ channel activation and migration of glioblastoma cells via 
increase in intracellular Ca2+ (Wondergem and Bartley 2009). 
 
In addition to Ca2+ influx, ionizing radiation may stimulate Ca2+ store release via upregulation 
of SDF-1 (see above) and CXCR4-mediated formation of inositol-trisphosphate (Haribabu et 
al. 1997). Remarkably, the Ca2+-activated BK channels have been demonstrated to 
accumulate in lipid rafts which are directly linked to inositol 1,4,5-triphosphate receptors in 
the ER (Weaver et al. 2007). 
 
Furthermore, the Ca2+ effector proteins such as the Ca2+-dependent tyrosine kinase Pyk-2 
(protein-tyrosine-kinase-2β or focal-adhesion-kinase-2) (Ling et al. 2004) and the 
serine/threonine kinase CaMKII (Liu et al. 2006b) reportedly may modulate the function of 
BK channels. In our experiments, Pyk-2 became activated and phosphorylated in irradiated 
glioblastoma cells (Fig. 3A) and contributed to radiogenic BK channel activation (Fig. 3B, C) 
and migration (Fig. 3D, E).  
 
Combined, these data suggest that several radiation-induced pathways converge to Ca2+ 
signaling which either directly or via Ca2+-regulated kinases may alter K+ channel activity. K+ 
channel activity, however, may modulate Ca2+ signaling as described in the next paragraph. 
 
 
3 Downstream signaling 
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3.1 Downstream Ca2+ signaling. Entry of the divalent cation Ca2+ depolarizes the plasma 
membrane, which diminishes the inwardly directed electrochemical gradient for Ca2+. In 
addition, some Ca2+ entry pathways, such as the highly Ca2+-selective TRPV6 channels 
exhibit strong inward rectification (Voets et al. 2003), i.e., an over-proportional decline of the 
Ca2+ current with depolarizing membrane potential. K+ channels may form molecular 
complexes with Ca2+ channels as reported for, e.g., mast cells where store-operated Ca2+ 
(ORAI1)- and IK K+ channels have been demonstrated to physically interact (Duffy et al. 
2015). By stabilizing the plasma membrane, voltage-gated or Ca2+-activated K+ channels 
counteract Ca2+ entry-mediated membrane depolarization, maintain the conductivity of the 
Ca2+ entry and/or the Ca2+ driving force and, thus, directly modulate Ca2+ signaling. For 
example, voltage-gated Kv3.1 channels have been demonstrated by our group to be required 
for radiation-induced Ca2+ entry in leukemia cells (Palme et al. 2013).  
 
Another example is given by our fura-2 Ca2+ imaging experiments (Fig. 4) where we tested 
the effect of BK and IK K+ channel blockers on steady state cytosolic free Ca2+ concentration 
of irradiated (0 or 2 Gy) T98G glioblastoma cells. T98G cells responded very 
heterogeneously to the two blockers. IK channel inhibitor TRAM-34 decreased cytosolic free 
Ca2+ concentration in about half of the cells (Fig. 4 A) while eliciting strong Ca2+ oscillations 
in the other half (data not shown). The response to the BK channel inhibitor paxilline ranged 
from no change to an instantaneous and long-lasting rise in cytosolic free Ca2+ concentration 
(Fig. 4. B). The latter was unexpected and might hint either to yet unknown off-target effects 
of paxilline or an speculative effect induced by the blockage of mitochondrial BK channels, or 
to Ca2+-entry pathways of the plasma membrane that are activated upon BK blockade-
associated membrane depolarization. Candidates for such pathways in glioblastoma cells are 
voltage-gated Ca2+ channels or strongly outwardly rectifying cation channels such as TRPM8 
(Yudin and Rohacs 2012). Importantly, the effect of both K+ channel blockers was more 
pronounced in irradiated than in control T98G cells (compare open circles and closed 
triangles in Fig. 4A, B) which points to the specific function of IK and BK channels in 
radiogenic Ca2+ signaling. 
 
K+ channel activity may impact on Ca2+ signaling in a complex and mutually interacting 
manner (for review see (Berridge et al. 2000)). Spatiotemporal and reciprocal 
activation/deactivation of K+ and Ca2+-permeable channels may generate complex Ca2+ 
signals such as Ca2+ oscillations. In dependence on frequency, amplitude and duration, Ca2+ 
oscillations trigger activation of a vast variety of different Ca2+ effector proteins in a highly 
specific manner. The CaMKIIs are such Ca2+ effector proteins (Bayer and Schulman 2001) 
that reportedly become activated in irradiated tumor cells. 
 
3.2 Activation of CaMKII kinases. The CaMKII isoforms are encoded by four genes and 
expressed in multiple splice variants, which differ in Ca2+ sensitivity and cytoplasma/nuclear 
distribution. Upon binding of Ca2+/calmodulin, CaMKII kinases become autophosphorylated 
and remain active in a Ca2+ independent manner until dephosphorylation. Hence, CaMKII 
kinases translate short-lived Ca2+ signals in long-lasting biochemical signaling. In our 
previous studies ionizing irradiation led to CaMKII phosphorylation in leukemia (Palme et al. 
2013) and glioblastoma cells (Steinle et al. 2011) in a K+ channel-dependent manner. Albeit 
increasing cytosolic free Ca2+ (see Fig. 4), inhibition of BK channels by paxilline prevented 
radiogenic CaMKII activation in glioblastoma cells (Steinle et al. 2011) suggesting complex 
radiation-induced Ca2+ signaling involved in CaMKII activation that requires BK channels. 
Another piece of evidence for such a sequence of signaling events came from the observation 
that CaMKII inhibition with KN-93 mimics the effect of BK channel blockade with paxilline 
on radiogenic hypermigration (Steinle et al. 2011). Similarly to BK, blockage of Kv3.4 
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channels in leukemia cells blunted radiogenic CaMKII activation (Palme et al. 2013). 
CaMKII kinases have been reported to regulate ion channels/transporters. Among those are 
BK channels (Liu et al. 2006b) (see above) hinting to a further possible Ca2+-BK-feedback 
regulation in glioblastoma. Another CaMKII target is the ClC-3 Cl- channel/Cl--proton 
antiporter.  
 
3.3 ClC-3 Cl- channel/Cl--proton antiporter. ClC-3 Cl- channels/Cl--proton antiporters reside 
in intracellular membranes where they contribute to acidification of endosomes/lysosmes by 
utilizing the V-ATPase-generated outwardly directed proton gradient to transport Cl- into the 
endosomes/lysosomes (Stauber et al. 2012). Under oxidative stress, however, ClC-3 may be 
trafficked to the plasma membrane as shown in leukemia cells (Kasinathan et al. 2007). In 
glioblastoma, ClC-3 channels/antiporters colocalize with BK channels to lipid rafts in the 
plasma membrane (Sontheimer 2008), generate an anion current in whole-cell patch-clamp 
experiments, are activated by CaMKII (Cuddapah and Sontheimer 2010), and are required for 
cytoplasmic condensation during mitotic cell rounding (Cuddapah et al. 2012) and 
bradykinin-induced migration (Cuddapah et al. 2013). 
 
In our experiments on glioblastoma cells, CAMKII and ClC-3 were found to co-
immunoprecipitate (Fig. 5A). BK channel inhibition by paxilline that prevented CaMKII 
activation in irradiated cells also blocked radiogenic anion channel activation (Fig. 5B-F). 
Although not shown directly, one might speculate that radiogenic BK channel activity induces 
ClC-3 activity via modulation of the Ca2+ signaling and subsequent CaMKII activation.  
 
3.4 The cdc25/cdc-2 axis. In addition to modulating ion channels, CaMKII isoforms have 
been demonstrated to be essential for regulating G2/M cell cycle transition (for review see 
(Skelding et al. 2011)). As reported by our group, radiation-induced G2/M cell cycle arrest of 
leukemia cells is, at least in part, mediated by CaMKII-dependent proteasomal degradation of 
cdc25B. Since function of the mitosis promoting factor cdc2 requires cdc25B phosphatase 
activity, radiogenic CaMKII activation results in inhibition of cdc2 and G2/M arrest. Most 
importantly, in our experiments Kv3.4 channel inhibition in irradiated leukemia cells 
compromised CaMKII activation, degradation of cdc25B, and inhibition of cdc2, and 
overrode G2/M cell cycle arrest which resulted in increased cell death, and decreased 
clonogenic survival (Palme et al. 2013). 
 
3.5 Activation of the MAP kinase pathway. Glioblastoma cells reportedly overexpress 
mitochondrial KATP channels that are required for radiogenic formation of reactive oxygen 
species (Huang et al. 2015). This KATP-mediated redox signaling, in turn, confers 
radioresistance as demonstrated in vitro and in an ectopic glioblastoma mouse model. 
Radioresistance is most probably mediated by suppression of apoptosis and induced by ROS-
mediated activation of the MAP kinase kinase MEK (Huang et al. 2015).  
 
Together, these studies demonstrate a close interaction of radiogenic electrosignaling by K+ 
channels in plasma and inner mitochondrial membrane with biochemical signaling proteins of 
the CaMKII/cdc25/cdc2 or the MAP kinase pathways. 
 
 
Concluding Remarks 
 
Radiation-induced activation of plasma membrane K+ channels might be a common 
phenomenon in tumor cells. In glioblastoma, leukemia and lung carcinoma cell lines, 
radiogenic K+ channel activity reportedly contributes to radioresistance. The underlying 
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molecular mechanisms of K+ channel activation and the K+ channel functions are largely ill-
defined. Radiation-induced cellular lesions may converge to Ca2+ signaling upstream of K+ 
channel activation. This upstream signaling may involve HIF-1α stabilization, auto-/paracrine 
chemokine signaling and Ca2+ store release, activation of Ca2+-permeable TRP channels, 
and/or Ca2+-regulated kinases. Radiogenic K+ channel activation may modulate the Ca2+ and 
redox signaling which modify the activity of biochemical signaling. In this context, activation 
of CaMKII kinase isoforms seems to be a key event of the signaling downstream of 
radiogenic K+ channel activation. Since CaMKII may also act upstream and Ca2+ up- and 
downstream of K+ channels, radiogenic electrosignaling by K+ channels may be fine-tuned by 
several feed-back loops. 
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Figures and Legends  
 
 
 
 
Fig. 1. Upregulation of the Ca2+-activated IK K+ channels induces radioresistance in human 
U251 glioblastoma cells. A. IK and MSI1 (Musashi-1) mRNA abundances in T98G, WK1, 
and nt- or MSI1si RNA-transfected U251 cells. MSI1 and IK mRNA abundance negatively 
correlated (correlation quotient of liner fit R2 = 0.8). MSI1 knockdown was associated with 
IK upregulation. B. Mean survival fractions (± SE, n = 24) of non-targeting (nt)- (black) or 
MSI1 (Musashi-1) siRNA-transfected U251 cells after irradiation with 0, 2, 4, or 6 Gy and 
combined treatment with the IK inhibitor TRAM-34 (10 µM, filled triangles) or vehicle alone 
(0.1% DMSO, open circles) as determined by delayed plating colony formation assay. C. 
Mean (± SE) plating efficacies and D. survival fractions after irradiation with 2 Gy (data from 
(B). * indicates p ≤ 0.05, two tailed Welch-corrected t-test in (A) and ANOVA in (D). MSI1 
knockdown induced radioresistance of U251 cells and rendered the cells sensitive to TRAM-
34. 
 
The human WK1 and T98G glioblastoma cell lines were grown in RPMI-1640/10% FCS 
medium and the U251 cells in DMEM (4500 mg glucose/l)/10% FCS medium. Exponentially 
growing U251 cells were reversely transfected with stealth MSI1 siRNAs (HSS106732, -33, -
34, #1299001, Thermo Fischer Scientific, Waltham, MA, U.S.A) or nt siRNA (Silencer® 
Select Negative Control No. 1 siRNA, #4390844, Ambion™, Thermo Fischer Scientific). 
Detached cells (250.000 in 2.5 ml RPMI-1640/10% FCS and DMEM (4500 mg 
glucose/l)/10% FCS medium, respectively) were added to 500 µl of pre-incubated (20 
min/RT) Opti-MEM medium containing RNAiMAX lipofectamine (6 µl, Invitrogen Life 
Technologies, Carlsbad, CA, USA) and siRNA (25 nM final concentration). Messenger RNAs 
were isolated (Qiagen RNA extraction kit, Hilden, Germany) from parental T98G and WK1 
cells and from nt- or MSI1 siRNA-transfected U251 cells (48 h-72 h after transfection) and 
reversely transcribed in cDNA (Transcriptor First Strand cDNA Synthesis Kit, Roche). IK K+ 
channel, MSI1 (Musashi-1) as well as housekeeper β-actin (ACTB)-, pyruvate dehydrogenase 
beta (PDHB)-, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-specific fragments 
were amplified by the use of SYBR Green-based quantitative real-time PCR (QT00003780, 
QT00025389, QT00095431, QT00031227, and QT01192646 QuantiTect Primer Assay and 
QuantiFast SYBR Green PCR Kit, Qiagen) in a Roche LightCycler 480 Instrument (Roche, 
Mannheim, Germany). To test for clonogenic survival, U251 cells were transfected with nt or 
MSI1 siRNA. After 24 h, cells were irradiated (0, 2, 4 or 6 Gy) with 6 MV photons by using a 
linear accelerator (LINAC SL25 Philips) at a dose rate of 4 Gy/min at room temperature in 
DMEM (4500 mg glucose/l)/10% FCS medium additionally containing TRAM-34 (1-[(2-
Chlorophenyl)diphenylmethyl]-1H-pyrazole, 10 µM, Sigma-Aldrich, Taufkirchen, Germany) 
or vehicle alone (0.1% DMSO). After further 24 h of incubation with the inhibitor/vehicle, 
cells were detached, 1000-3000 cells were re-seeded in inhibitor-free medium on 6-well plates 
 17 
and grown for further 2-3 weeks. The plating efficiency was defined by dividing the number 
of colonies by the number of plated cells. Survival fractions as calculated by dividing the 
plating efficiency of the irradiated cells by those of the unirradiated controls were fitted by the 
use of the linear quadratic equation. 
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Fig. 2. Fractionated irradiation induces/selects glioblastoma cells with high IK K+ channel 
expression. A. Mean (± SE, n = 36-48) survival fractions of fractionated irradiated U251 cells 
(4 x 2 Gy plus 1 x 0, 2, 4, or 6 Gy, red triangles) as plotted against the cumulative dose (red 
numbers). For comparison, the survival fractions of U251 cells (black circles) irradiated with 
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a single dose (black numbers) already shown in Fig. 1B are given. B-C. Housekeeper-
normalized CD133 (B) and IK (C) mRNA abundances in 5 x 0 Gy- (open bars) and 5 x 2 Gy-
irradiated (closed bars) U251 glioblastoma cells. D. Patch-clamp recording of macroscopic 
on-cell (cell-attached) currents from semiconfluent U251 cells with KCl and NaCl in pipette 
and bath solution, respectively. Depicted is the applied voltage pulse protocol. E. 
Macroscopic on-cell current tracings recorded from control (5 x 0 Gy, left) and fractionated 
irradiated (5 x 2 Gy, right) U251 cells. Shown are representative patches that exhibit BK 
(prominent upward current deflections at depolarizing voltages) and IK K+ channel activity or 
only IK channel activity in the upper and lower line, respectively (only voltage pulses to -96, -
46, + 4 +54, and +104 mV are shown as indicated by the red square pulses in A). F. 
Dependence of the mean macroscopic on-cell currents (± SE) on holding potential in control 
(5 x 0 Gy, open circles) and fractionated irradiated (5 x 2 Gy, closed triangles) U251 cells. G. 
Mean conductance (as calculated for the inward currents in C between-96 mV and +4 mV 
voltage as indicated by the grey lines) of 5 x 0 Gy- (open bar) and 5 x 2 Gy-irradiated (closed 
bar) U251 cells. *, ** and *** indicate p ≤ 0.05, p ≤ 0.01 and p ≤ 0.001, respectively, two 
tailed (Welch-corrected) t-test. 
 
For colony formation assay, U251 cells were irradiated with 2 Gy on days 1, 2, 3, 4, and 
finally irradiated with 0, 2, 4, or 6 Gy on day 5. On day 6, defined number of cells were 
reseeded as described in legend to Fig. 1. Survival fractions were fitted by the use of the linear 
quadratic equation. For RT-PCR, U251 cells were fractionated irradiated on five consecutive 
days with 5 x 0 Gy or 5 x 2 Gy. Twenty-four hours after the last radiation fraction, mRNA 
was isolated and CD133 (prominin-1, QT00075586 QuantiTect Primer Assay, Qiagen), IK 
and housekeepers mRNA abundances were determined as described in legend to Fig. 1. For 
patch-clamp recording, semiconfluent U251 cells were irradiated with 5 daily fractions of 0 
Gy or 2 Gy (T98G). One day after the last fraction, on-cell currents were evoked by 41 
voltage square pulses (700 ms each) from 4 mV holding potential to voltages between -96 mV 
and +104 mV delivered in 5 mV increments. Voltages were corrected for the estimated liquid 
junction potentials (Barry and Lynch 1991). Cells were superfused at 37°C with NaCl 
solution (in mM: 125 NaCl, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid 
(HEPES), 5 KCl, 5 D-glucose, 1 MgCl2, 1 CaCl2, titrated with NaOH to pH 7.4). The pipette 
solution contained (in mM) 130 KCl, 32 HEPES, 5 D-glucose, 1 MgCl2, 1 CaCl2, titrated 
with KOH to pH 7.4.  
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Fig. 3. Radiogenic activation of the Ca2+-dependent tyrosine kinase Pyk-2 increases BK K+ 
channel activity and cell migration in glioblastoma cells. A. Immunoblot probed against 
phospho-(Tyr402)-Pyk-2 (top), total Pyk-2 (middle) and for loading control against β-actin 
(bottom). Lysates were from an irradiated T98G cell 1 h after irradiation with 0 Gy (left) or 2 
Gy (right). B. Irradiated T98G cells (0 or 2 Gy, 2-4 h after irradiation) were recorded with the 
patch-clamp technique applying the whole-cell mode using K-gluconate in the pipette and 
NaCl in the bath. The voltage-clamp pulse protocol is depicted. C. Whole-cell current tracings 
of a 0 Gy- (upper line) and a 2 Gy (lower line)-irradiated T98G cell recorded before (1st 
tracings), during application of the Pyk-2 inhibitor PF431396 (1 µM; 2nd tracings), after wash-
out (3rd tracings), and after administration of the BK blocker paxilline (5 µM, 4th tracings). D. 
Dependence of the mean (± SE, n = 7-8) whole-cell current densities of 0 Gy (left)- and 2 Gy 
(right)-irradiated T98G cells on voltage. Records were obtained before (open circles) or 
during administration of PF431396 (closed triangles, recording as shown in B, C). E. Mean (± 
SE, n = 7-8) PF431396-sensitive current density fractions as calculated by subtracting the 
current densities of (D) recorded with PF431396 from those obtained under control condition. 
F. Mean (± SE, n = 7-8) conductance densities (as calculated for the outward currents in D 
between +44 mV and +84 mV voltage as indicated by the grey lines) of 0 Gy- (left) and 2 Gy-
irradiated (right) T98G cells recorded in the absence (open bars) or presence (closed bars) of 
PF431396. G-H. Mean (± SE, n = 3-4) impedance (G) as measure of transfilter migration and 
(H) mean migration velocity (calculated from the data in (G, grey lines) for the first 0.5 h of 
transfilter migration) of T98G cells irradiated with 0 Gy (open circles/bars) or 2 Gy (closed 
triangle/bars) and recorded in the absence (black symbols/bars) or presence of PF431396 (1 
µM, red symbols/bars. * indicates p ≤ 0.05, two tailed paired t-test in (D, right) two tailed 
Welch-corrected t-test in (E) and ANOVA in (H). 
 
For immunoblotting, whole protein lysates were prepared from semiconfluent irradiated (0 or 
2 Gy, 1 h after irradiation) T98G cells, proteins were separated by SDS-PAGE and blotted as 
described (Wolfsperger et al. 2016). Blot membranes were blocked (TBS-Tween/5% milk) 
and probed overnight at 4°C against Pyk-2 (rabbit polyclonal anti-Pyk-2 antibody, #3292S 
Cell Signaling Merck-Millipore, Darmstadt, Germany, 1:1000 in TBS-Tween/5% milk), 
phospho-Pyk2 (rabbit polyclonal anti-phospho (Tyr402)-Pyk-2 antibody, #3291S Cell 
Signaling, 1:1000 in TBS-Tween/5% milk) and β-actin (mouse anti-β-actin antibody, clone 
AC-74, Sigma #A2228 1:20,000 in TBS-Tween/5% milk). Antibody binding was detected 
with a horseradish peroxidase-linked goat anti-rabbit or horse anti-mouse IgG antibody (# 
7074 and #7076, respectively; 1:2000 dilution in TBS-Tween/5% milk, Cell Signaling) 
incubated for 1 h at room temperature and enhanced chemoluminescence (ECL Western 
blotting analysis system, GE Healthcare/Amersham-Biosciences, Freiburg, Germany). Whole-
cell currents were evoked by 11 voltage square pulses (700 ms each) from -66 mV holding 
potential to voltages between -116 mV and +84 mV delivered in 20 mV increments. 
Semiconfluent irradiated T98G cells were superfused at 37°C with NaCl solution (see legends 
to Fig. 2) additionally containing PF431396 (0 or 1 µM), paxilline (0 or 5 µM), and DMSO (0 
or 0.1 %). The K-D-gluconate pipette solution contained (in mM): 140 K-D-gluconate, 5 
HEPES, 5 MgCl2, 1 K2-EGTA, 1 K2-ATP, titrated with KOH to pH 7.4. For transfilter 
migration, the lower and upper chamber of a CIM-Plate 16 (Roche) were filled with 160 µl 
(lower chamber) and 100 µl (upper chamber) of RPMI-1640 medium containing 5% and 1% 
FCS, respectively, equilibrated at 37°C and 5% CO2 for 30-60 min. The upper and lower 
chamber additionally contained PF431396 (0 or 1 µM in 0.1% DMSO, Sigma-Aldrich). 
Irradiated (0 or 2 Gy) T98G cells (40.000) in RPMI-1640/1% FCS were added to the upper 
chamber. After sedimentation and adherence of the cells (2-3 h after irradiation), migration 
was analyzed in real-time by measuring the impedance increase between electrodes which 
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cover the lower surface of the filter membrane and the reference electrode in the lower 
chamber.  
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Fig. 4. K+ channel activity modulates Ca2+ signaling in glioblastoma cells. A-B. Mean (± SE, 
n = 24-32 in A and 10-50 in B) fura-2 fluorescence 340/380 nm ratio as measure of cytosolic 
free Ca2+ concentration. Ratios were recorded in 0 Gy (open circles) or 2 Gy (closed 
triangles)-irradiated semiconfluent T98G cells at 37°C before and during superfusion of the 
IK K+ channel blocker TRAM-34 (10 µM in 0.1% DMSO, A) or before, during, and after 
(wash-out) superfusion of the BK K+ channel blocker paxilline (2 µM in 0.1% DMSO, B). 
The insert in (A) shows the immunofluorescence micrograph of fura-2-loaded T98G cells.) 
 
Fura-2 ratiometric Ca2+ imaging was performed as described (Klumpp et al. 2016). 
Semiconfluent T98G cells were superfused at 37 °C with NaCl solution (see legend to Fig. 2) 
additionally containing the IK K+ channel inhibitor TRAM-34 (0 or 10 µM in 0.1% DMSO) 
or the BK channel blocker paxilline (0 or 2 µM in 0.1% DMSO). 
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Fig. 5. Radiogenic activation of plasma membrane Cl- channels in glioblastoma cells depends 
on BK K+-channels . A. Immunoprecipitation (IP) of CaMKII isoforms co-
immunoprecipitates ClC-3 Cl- channels/Cl--proton antiporters in T98Gglioblastoma cells. 
Immunoblots of proteins immunoprecipitated with anti-CaMKII antibody (left lanes) or the 
respective IgG isotype control (right lanes) probed against CaMKII (upper blot) and ClC-3 
(lower blot). B. Whole-cell currents of irradiated T98G cells (0 or 2 Gy) were recorded with 
the impermeable cation N methyl-D-glucamine+ (NMDG+) in bath and pipette solution to 
isolate Cl--currents. Cells were irradiated and post-incubated for 3-5 h in cell culture medium 
containing the BK K+ channel blocker paxilline (0 or 5 µM in 0.1% DMSO) before recording 
of the whole-cell currents in the absence of paxilline. Shown is the applied voltage-clamp 
pulse protocol. C. Whole-cell current tracings of a 0 Gy- (1st and 3rd tracings) and a 2 Gy (2nd 
and 4th tracings)-irradiated T98G cell preincubated with vehicle alone (left) or with paxilline 
(right). D. Mean (± SE, n = 9-27) conductance densities (as calculated for the outward 
currents between -13 mV and +67 mV) of 0 Gy- (left) and 2 Gy-irradiated (right) T98G cells 
irradiated and post-incubated in the absence (open bars) or presence (closed bars) of paxilline. 
E. Whole-cell current tracings of a 2 Gy-irradiated vehicle-control cells recorded before (left), 
during (middle), and after (wash-out, right) superfusion of the anion channel blocker 5-nitro-
2-[(3-phenylpropyl)amino]benzoic acid (NPPB, 50 µM). F. Mean (± SE, n = 7-17) NPPB-
sensitive conductance densities (∆GNPPB) of 0 Gy- (left) and 2 Gy-irradiated (right) T98G 
cells irradiated and post-incubated in the absence (open bars) or presence (closed bars) of 
paxilline. *, and ** indicate p ≤ 0.05 and p ≤ 0.01, respectively ANOVA. 
 
For immunopreciptation, cells were lysed and protein (1.6 mg in 800 µl) was precipitated with 
5 µg of rabbit polyclonal anti-CaMKII (pan) antibody (3362S, Cell Signaling) or the same 
amount of rabit IgG isotype antibody (#12-370, Millipore) as described (Wolfsperger et al. 
2016). For immunoblotting (non-reducing SDS-PAGE) rabbit polyclonal anti-ClC-3 antibody 
(ACL-001, Alamone Labs, 1:500 in TBS-Tween/5% milk) and rabbit polyclonal anti-CaMKII 
(pan) antibody (3362S, Cell Signaling) were used. For patch-clamp recording, T98G cells 
were irradiated (0 or 2 Gy) and postincubated for 3-5 h in the presence of paxilline (0 or 5 µM 
in 0.1% DMSO). Whole-currents were evoked by 9 square pulses to voltages from -93 mV to 
+67 mV delivered in 20 mV increments from a holding potential of  
-23 mV. A pipette solution containing (in mM) 140 NMDG-Cl (pH 7.4), 40 mannitol, 10 
HEPES/NMDG (pH 7.4), 1 MgCl2, 1 Mg-ATP, 0.5 EGTA, was combined with a bath 
solution containing 180 NMDG-Cl (pH 7.4), 10 HEPES/NMDG (pH 7.4), 1 CaCl2, 1 MgCl2 
additionally containing NPPB (0 or 50 µM in 0.1% DMSO, Sigma). 
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Abstract 
 
BACKGROUND: TRPM8 is a Ca2+-permeable nonselective cation channel belonging to the 
melastatin sub-group of the transient receptor potential (TRP) family. TRPM8 is aberrantly 
overexpressed in a variety of tumor entities including glioblastoma multiforme where it 
reportedly may contribute to cancerogenesis, tumor spreading and metastasis, adaptation to 
hypoxia, or therapy resistance. The present study aimed to disclose the functional significance 
of TRPM8 in glioma cells in particular upon cell injury by ionizing radiation. 
METHODS: TRPM8 channels were stimulated in human glioblastoma cell lines 
pharmacologically by the cold simulating agents menthol and icilin or inhibited with BCTC or 
2-APB. In addition, down- and upregulation of TRPM8 was performed by RNA interference. 
Glioblastoma cells were irradiated with 0-6 Gy 6 MV photons and TRPM8 channel activity, 
Ca2+ signaling, cell migration, clonogenic survival, apoptotic cell death, and cell cycle control 
were determined by patch-clamp on-cell recording, fura-2 Ca2+ imaging, transfilter migration 
or wound healing assay, colony formation assay, and flow cytometry, respectively. Moreover, 
the TCGA data base was queried to expose a dependence of glioma patient survival on 
TRPM8 mRNA abundance. 
RESULTS: TRPM8 channels were required for glioblastoma cell migration and DNA 
damage response. TRPM8-knock-down slowed-down cell migration, impaired cell cycle 
regulation, induced apoptotic cell death, and radiosensitized glioblastoma cells. Finally, high 
TRPM8 abundance in low grade glioma associated with poor patient outcome. 
CONCLUSIONS: Combined, our data suggest that TRPM8 channels contribute to 
malignancy and therapy resistance of glioma and might, therefore, a promising target of future 
strategies of anti-glioma therapy. 
 
Key words: Radiotherapy, Ca2+-permeable nonselective cation channel, melastatin family of 
transient-receptor-potential channels, BK Ca2+-activated K+ channels, patch-clamp recording, 
transfilter migration, wound healing assay, colony formation assay, CaspACE, propidium 
iodide, EdU incorporation 
 3 
Background 
 
The melastatin family member 8 (M8) of the transient receptor potential (TRP) nonselective 
cation channels has been originally identified as a cancer-associated gene in prostate 
carcinoma [1]. Meanwhile, there is increasing evidence that many tumor entities such as 
glioblastoma multiforme [2] highly overexpress TRPM8 channels. Aberrantly expressed 
TRPM8 channels have been proposed to contribute to epithelial-mesenchymal-transition and 
metastasis of breast cancer [3], growth and metastasis of pancreatic adenocarcinoma [4], 
adaptation to hypoxia of prostate cancer [5], metastasis and chemotherapy resistance of 
osteosarcoma [6], poor prognosis of urothelial carcinoma [7], cancerogenesis of colon 
carcinoma [8], and migration of glioblastoma cells [9, 10]. Besides these malignancy-
associated functions, TRPM8 reportedly suppresses survival of melanoma cells [11]. In 
addition, TRPM8 is highly upregulated in an early, differentiated stage but downregulated 
during malignant progression of prostate cancer [1, 12, 13] which might suggest that TRPM8 
rather suppresses than promotes malignant progression in these tumor entities. Moreover, 
overexpression of TRPM8 in glioblastoma has been associated with better clinical outcome 
[2] again pointing rather to a tumor-suppressing function of TRPM8.  
 
While in normal skin and peripheral neurons TRPM8 functions as a cold sensor (for review 
see [14]), the functions of TRPM8 in non-temperature-sensing organs such as normal prostate 
epithelium are not well defined. Reportedly, TRPM8 acts as an ionotropic testosterone 
receptor in the plasma membrane of prostate epithelium [15, 16] or osmosensor in peripheral 
neurons [17]. Similarly poorly understood are the mechanisms leading to upregulation of 
TRPM8 in cancer cells. In prostate cancer, TRPM8 gene [13] and surface expression [18] are 
up-regulated by androgens, in breast cancer by estrogens [19]. 
 
Glioblastoma multiforme infiltrates the brain in a diffuse and net-like manner which confines 
complete surgical resection and adequate coverage by radiotherapy of the tumor. The highly 
migrating behavior of glioblastoma cells together with a high intrinsic resistance to radio- and 
chemotherapy, most probably accounts for therapy failure and bad prognosis of glioblastoma 
patients (for review see [20]). Glioblastoma migration is reportedly motorized by a local cell 
volume increase and decrease at the lamellipodium and the opposite cell pole which extrudes 
the leading edge and retracts the cell rear, respectively. Ca2+-activated IK and BK channels 
exert a key role in this process pointing to a pivotal function of Ca2+ signaling for 
programming of migration (for review see [21]). Moreover, ionizing radiation at doses used 
for single fractions of fractionated radiotherapy in the clinic has been shown to induce Ca2+ 
signals that are sufficient to activate BK and IK K+ channels and to induce migration of 
glioblastoma cells [22-24]. In addition, radiation-induced activation of IK channels has been 
demonstrated to be required for cell cycle arrest and DNA repair since inhibition of IK 
radiosensitizes glioblastoma cells [23]. 
 
Activation of TRPM8 channels by menthol reportedly stimulates BK channel activity and 
migration of glioblastoma cells [9, 10] suggesting that TRPM8 functions as Ca2+ entry 
pathway in glioblastoma cells. Therefore, the present study aimed to define in vitro the 
functional significance of TRPM8 for the Ca2+ signaling in glioblastoma cells involved on the 
one hand in cell migration and chemotaxis and on the other in the stress response to DNA 
damage by ionizing radiation. Our data strongly suggest that TRPM8 contributes to both, 
migration and radioresistance of glioblastoma cells. 
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Methods 
 
Cell Culture. Human WK1, T98G, U373, A172, U-87MG, and DBTRG glioblastoma cells 
were grown in 10% fetal calf serum (FCS)-supplemented RPMI-1640 medium, human U251 
glioblastoma cells in DMEM (4500 mg glucose/l)/10% FCS medium. Exponential growing 
T98G, U251 and U-87MG-Katushka cells were irradiated with 6 MV photons (IR, single dose 
of 0, 2, 4 and 6 Gy) or five daily fractions of 0 or 2 Gy (fractionated IR) by using a linear 
accelerator (LINAC SL25 Philips) at a dose rate of 4 Gy/min at room temperature. Following 
IR, cells were post-incubated in the respective cell culture media for 1.5-3 h (fura-2 Ca2+-
imaging), 24 h (RT-PCR, CaspACE flow cytometry), 48 h (flow cytometry, Nicoletti 
protocol), 54 h (EdU incorporation), or 2-3 weeks (colony formation assay). 
 
Querying The-Cancer-Genome-Atlas (TGCA) data sets. Via the cBIOportal Web resource 
[25, 26], the provisional Glioblastoma-Multiforme and Lower-Grade-Glioma TCGA 
databases (http://cancergenome.nih.gov/) were queried for TRPM8 mRNA abundance of the 
tumor specimens and progression free and overall survival of the glioma patients. Statistical 
analysis was performed with log-rank test. To assess TRPM8- , CXCR4- and IK mRNA 
abundances in low grade and high grade gliomas, RNA sequencing data (Illumina HiSeq 2000 
RNA Sequencing platform) were received from the file TCGA_KIRC_exp_HiSeqV2-2015-
02-24, downloaded on 2015-10-20 via the Cancer Genomics Browser. The file contained 
log2(x+1)-transformed data for n (low grade ) and N (high grade) gliomas on 20,530 genes. 
Here, x are RSEM (RNA-Seq by Expectation Maximization) expression estimates, which 
were normalized to set the upper quartile count at 1000 (for details, vide 
http://cancergenome.nih.gov/ and https://genome-cancer.soe.ucsc.edu/proj/site/hgHeatmap. 
 
Patch-clamp recording. On-cell currents of semi-confluent T98G cells were elicited by 41 
voltage square pulses (700 ms each) delivered in 5 mV increments from 0 mV holding 
potential to voltages between -100 mV and +100 mV. Voltages refer to the intracellular face 
of the plasma membrane. Flow of positive charge out of the cells (or the counter flow of 
anions) is defined as positive current and depicted as upward deflection of the current 
tracings. Cells were superfused at 37°C. with NaCl solution (in mM: 125 NaCl, 32 N-2-
hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), 5 KCl, 5 D-glucose, 1 MgCl2, 1 
CaCl2, titrated with NaOH to pH 7.4). This NaCl solution was also used for the pipette 
solution further containing 0 or 10 µM icilin (in 0.1% DMSO). Macroscopic on-cell currents 
were analyzed by averaging the currents between 100 and 700 ms of each square pulse. 
 
Transfection. Exponentially growing U251 and T98G cells were reversely transfected with 
stealth siRNAs (Thermo Fischer Scientific, Waltham, MA, U.S.A) specific for TRPM8 
(HSS128188, HSS128189, HSS128190) and MSI1 (Musashi-1, HSS106732, HSS106733, 
HSS106734), or with nt siRNA (Silencer® Select Negative Control No. 1 siRNA, #4390844, 
Ambion™, Thermo Fischer Scientific). Detached T98G and U251 cells (250.000 in 2.5 ml 
RPMI-1640/10% FCS and DMEM (4500 mg glucose/l)/10% FCS medium, respectively) 
were added to 500 µl of pre-incubated (20 min/RT) Opti-MEM medium containing 
RNAiMAX lipofectamine (6 µl, Invitrogen Life Technologies, Carlsbad, CA, USA) and 
siRNA (25 nM final concentration).  
 
Migration assays. For cell migration during wound healing, control (T98G, U-87MG) and 
TRPM8- or nt siRNA-treated (T98G) glioblastoma cells were plated in 35 mm dishes 
(120.000 cells per insert) with culture inserts (Ibidi, Martinsried, Germany). After monolayer 
formation, cells were pretreated (30 min) with TRPM8 activator icilin or inhibitor N-(4-tert-
butylphenyl)-4-(3-chloropyridin-2-yl)piperazine-1-carboxamide (BCTC, both 0 or 10 µM in 
 5 
0.1% DMSO) in phenol red-free 20 mM HEPES (pH 7.4)-supplemented RPMI-1640 medium. 
Migration assay was started by removing the inserts to create a wound of approximately 500 
µm in width. Thereafter (0 -18 h), 3 fields of the wound were photographed with an inverse 
light microscope every 30 min (Axio Observer.Z1, 10x, Zeiss, Jena). For each field 5 cells 
were tracked (Manual Tracking, ImageJ) and the velocity was calculated. 
 
For transfilter migration, the lower and upper chamber of a CIM-Plate 16 (Roche, Mannheim, 
Germany) were filled with 160 µl (lower chamber) and 100 µl (upper chamber) of RPMI-
1640 medium containing 5% and 1% FCS, respectively, equilibrated at 37°C and 5% CO2 for 
30-60 min. After CO2 equilibration and resetting the impedance to zero, 100 µl of cell 
suspension containing 40.000 of control (U251 or T98G) or TRPM8- or nt siRNA-treated 
(T98G) cells in RPMI-1640/1% FCS were added to the upper chamber. After sedimentation 
and adherence of the cells (2-3 h after IR), migration was analyzed. The upper and lower 
chamber additionally contained icilin, 2-aminoethoxydiphenyl borate (2-APB) and BCTC (all 
0 or 10 µM in 0.1% DMSO). Transfilter migration was assessed by measuring the electrical 
impedance increase between electrodes which cover the lower surface of the filter membrane 
(i.e., the bottom of the upper chamber) and the reference electrode at the bottom of the lower 
chamber. Upon transfilter migration, cells adhere to the electrode at the lower surface of the 
filter membrane and, thereby, increase the impedance. 
 
Quantitative RT-PCR. Messenger RNAs of WK1, T98G, U373, A172, U-87MG, DBTRG and 
U251 cells, of fractionated irradiated (5 x 0 Gy or 5 x 2 Gy) T98G, U251 and U-87MG cells 
(24 h after the last IR fraction), as well as of TRPM8 siRNA-, MSI1 siRNA- or nt siRNA-
transfected U251 and T98G cells (48-72 h after transfection) were isolated (Qiagen RNA 
extraction kit, Hilden, Germany) and reversely transcribed in cDNA (Transcriptor First Strand 
cDNA Synthesis Kit, Roche, Mannheim, Germany). TRPM8-, TRPV1-, TRPV2-, TRPC6-, 
and housekeeper glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-specific fragments 
were amplified by the use of SYBR Green-based quantitative real-time PCR (QT00038906, 
QT00046109, QT00035987, QT00037660, and QT00079247 QuantiTect Primer Assay and 
QuantiFast SYBR® Green PCR Kit, Qiagen) in a Roche LightCycler Instrument. Abundances 
of the individual mRNAs were normalized to the GAPDH housekeeper mRNA. 
 
Colony formation assay. To test for clonogenic survival, TRPM8-, MSI1-, or nt siRNA-
transfected U251 and T98G cells (24 h (MSI1) and 48 h (TRPM8)) were irradiated (0, 2, 4 or 
6 Gy) in the respective cell culture media. Twenty-four h after IR, 400 and 600 (T98G) or 
1200 (U251) cells were re-seeded on 6-well plates and grown for further 2-3 weeks. The 
plating efficiency was defined by dividing the number of colonies by the number of plated 
cells. Survival fractions as calculated by dividing the plating efficiency of the irradiated cells 
by those of the unirradiated controls were fitted by the use of the linear quadratic equation. 
 
Fura-2 fluorescence imaging of free[Ca2+]i. Fluorescence measurements were performed at 
37°C using an inverted phase-contrast microscope (Axiovert 100; Zeiss, Oberkochen, 
Germany). Fluorescence was evoked by a filter wheel (Visitron Systems, Puchheim, 
Germany)-mediated alternative excitation at 340/26 or 387/11 nm (AHF, Analysentechnik, 
Tübingen, Germany). Excitation and emission light was deflected by a dichroic mirror 
(409/LP nm beam splitter, AHF) into the objective (Fluar x40/1.30 oil; Zeiss) and transmitted 
to the camera (Visitron Systems), respectively. Emitted fluorescence intensity was recorded at 
587/35 nm (AHF). Excitation was controlled and data acquired by Metafluor computer 
software (Universal Imaging, Downingtown, PA, USA). The 340/380-nm fluorescence ratio 
was used as a measure of cytosolic free Ca2+ concentration (free[Ca2+]i). Irradiated (0 or 2 Gy, 
1.5-3 h after IR) T98G cells and TRPM8- , MSI1- or nt siRNA-transfected U251 cells (24 h 
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(MSI1) and 48 h (TRPM8)) were incubated with fura-2/AM (2 µM for 30 min at 37°C; 
Molecular Probes, Goettingen, Germany) in RPMI-1640/10% FCS and DMEM/10% FCS 
medium, respectively. In irradiated T98G cells, fura-2 fluorescence ratios were measured 
during superfusion with EGTA-buffered Ca2+-free NaCl (in mM: 125 NaCl, 32 HEPES, 5 
KCl, 5 D-glucose, 1 MgCl2, 0.5 EGTA, titrated with NaOH to pH 7.4) solution and upon 
wash-in of Ca2+ in NaCl ringer (in mM: 125 NaCl, 32 HEPES, 5 KCl, 5 D-glucose, 1 MgCl2, 2 
CaCl2, titrated with NaOH to pH 7.4) additionally containing menthol (100 µM). In 
transfected U251 cells, steady state free[Ca2+]i was recorded in Ca2+-containing NaCl solution 
before and during superfusion of icilin (10 µM). 
 
Flow cytometry. To determine the caspase activity after irradiation T98G and U251 cells were 
transfected with TRPM8- or nt-siRNA, irradiated (48 h after transfection, 0 or 4 Gy) and 
incubated for further 24 h in the respective cell culture media. CaspACE TM FITC-VAD-FMK 
In Situ Marker was added directly to the medium (5 µM) and incubated for 30 min at room 
temperature. CaspaACE-specific fluorescence was measured by flow cytometry (FACS 
Calibur, Becton Dickinson, Heidelberg, Germany, 488 nm excitation wavelength) in 
fluorescence channel FL-1 (log scale, 515-545 nm emission wavelength).  
 
For cell cycle analysis, irradiated TRPM8- or nt-siRNA transfected T98G and U251 cells (0 
or 4 Gy, 48 h afer IR and 96 h after transfection) were permeabilized and stained (30 min at 
room temperature) with propidium iodide (PI) according to the Nicoletti protocol (containing 
0.1% Na-citrate, 0.1% triton X-100, 10 µg/ml PI in phosphate-buffered saline, PBS), and the 
DNA amount was analyzed by flow cytometry in fluorescence channel FL-3 (>670 nm, linear 
scale). Data were analyzed with the FCS Express 3 software (De Novo Software, Los 
Angeles, CA, USA). 
 
For EdU incorporation, , irradiated TRPM8- or nt-siRNA transfected T98G and U251 cells (0 
or 4 Gy, 48 h afer IR and 96 h after transfection) were incubated for further 6 h in the 
respective cell culture media additionally containing the base analogon 5-ethynyl-2’-
deoxyuridine (EdU, 5 µM). EdU incorporation was analyzed by the use of a EdU flow 
cytometry kit (BCK-FC488, baseklick, Tutzing, Germany) after fixing the cells and co-
staining the DNA with propidium iodide (PI, Sigma-Aldrich) according the manufacturer’s 
instructions. EdU- PI specific fluorescence were recorded by flow cytometry in fluorescence 
channel FL-1 (log scale) and FL-3 (linear scale), respectively.  
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Results 
 
Glioma overexpress TRPM8. Glioblastoma reportedly upregulate TRPM8 channels [2]. The 
present study queried The-Cancer-Genome-Atlas (TCGA) to expose the dependence of 
TRPM8 mRNA abundance on disease-free (DS) and overall survival (OS) of low grade 
glioma and glioblastoma patients. Moreover, TCGA TRPM8 mRNA abundances were 
compared between low grade glioma and glioblastoma and associated with those of the Ca2+-
activated IK K+ channel and the chemokine receptor CXCR4. IK [23] and CXCR4 [27, 28] 
have been associated with therapy resistance and poor prognosis in glioblastoma. As a result, 
high TRPM8 mRNA abundance in low grade glioma was associated with shorter DS and OS 
of the patients (p ≤ 0.0000001, log rank test, Fig. 1A, B). In particular, low grade glioma 
without mutations in isocitrate dehydrogenas-1 (IDH1) exhibit significant higher TRPM8 
mRNA abundance as compared to low grade glioma with IDH1 mutations (Fig. 1C). In 
glioblastoma specimens (n = 528), in contrast, which exhibited TRPM8 upregulation similarly 
to the low grade gliomas without IDH1 mutations (Fig. 1C), no dependence of patient DS or 
OS on TRPM8 mRNA abundance was evident (data not shown). However, TRPM8 mRNA 
expression by the glioblastoma specimens seemed to be weakly but significantly (p ≤ 0.05) 
associated with that of CXCR4 and moderately associated with that of IK (p ≤ 0.01). The 
associations with these proposed malignancy markers were in particular higher (reaching 
Pearson coefficients of 0.33 and 0.51 for CXCR4 and IK, respectively) in glioblastoma 
patients treated with the standard therapy protocol [29] (Fig. 1D). 
 
TRPM8 generates a Ca2+ entry pathway and promotes cell migration. We started our 
experiments by determining the TRPM8 mRNA expression in different human glioblastoma 
cell lines by real time RT-PCR. Among TRPV1 and -V2 mRNA (Fig. 1E), TRPM8 mRNA 
could be detected in human glioblastoma lines at different abundances (Fig. 1F). Cell lines 
with relatively high (U251 and U-87MG) and low (T98G) TRPM8 mRNA abundance were 
chosen for further studies. First, we tested for functional expression of TRPM8 by on-cell 
patch-clamp recording. 
 
To this end, glioblastoma cells were stimulated with the TRPM8 agonist icilin and activation 
of the Ca2+-activated BK K+-channels was used as a surrogate marker for TRPM8-mediated 
Ca2+ entry into the cells. As shown in Fig. 2A-D, icilin induced a macroscopic outward 
current in T98G cells when recorded with NaCl in pipette and bath solution. This current was 
generated by channels with a unitary conductance of about ~200 pS (Figs. 3A-C). The 
negative reversal potential of the current amplitude which can be extrapolated from the 
current amplitude-voltage relationship in Fig 3C indicated K+ selectivity of the 200 pS 
channels. Under control conditions, channel activity occurred at depolarized voltages (Fig 3A, 
D) and open probability increased with increasing positive clamp-voltage (Fig 3D, open 
circles). The high unitary conductance, the K+-selectivity, and the typical voltage-dependence 
proved the channels as BK K+ channels. 
 
Icilin induced channel activity already at negative voltages (Fig 3B), a left shift of the open 
probability voltage relationship (Fig 3D, closed triangles) and changed the mean voltage of 
activation from +30 mV (control) to -15 mV clamp-voltage (Fig 4E). Stimulation by icilin did 
not affect the unitary conductance of the channels (Fig 3F). Together, these data indicate 
icilin-induced activation of Ca2+-dependent BK K+ channels suggestive of functional 
expression of TRPM8 channels in the plasma membrane of T98G cells. 
 
Experimental TRPM8-upregulation and TRPM8 knock-down. In U251 cells, transfection with 
siRNA specific for the mRNA-binding protein MSI1 (Musashi-1) was paralleled by an 
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increase in TRPM8 mRNA abundance (Fig.4A), a phenomenon which could not be defined 
mechanistically. Nevertheless, MSI1 knock-down was harnessed for experimental 
upregulation of TRPM8 in further functional studies. In addition, U251 and T98G were 
transfected with TRPM8 siRNA which reduced TRPM8 mRNA abundance by more than 
(U251) and below (T98G) 50% (Fig. 4B, C). In U251 cells, the functional significance of 
TRPM8 up- and downregulation for icilin-stimulated Ca2+ entry was confirmed by fura-2 
Ca2+ imaging. TRPM8 upregulation and knock-down significantly in- and decreased menthol 
(100 µM)-induced rise in intracellular free Ca2+ concentration indicating both, effectiveness 
of the transfection protocols and functional expression of TRPM8 in the plasma membrane of 
glioblastoma cells (Fig. 4D, E). 
 
TRPM8 promotes cell migration. TRPM8 agonists have been reported previously to stimulate 
migration of glioblastoma cells [9, 10]. Therefore, we tesed in our glioblastoma models 
whether cell migration and chemotaxis depend on TRPM8 channel activity. As shown in Fig. 
5A-D, TRPM8 activation by icilin tended to increase (U-87MG) or significantly (T98G) 
increased the migration speed in wound healing assays while TRPM8 inhibition by BCTC (U-
87MG and T98G) or downregulation by RNA interference (T98G) significantly reduced the 
migration velocity. Similarly, TRPM8 channel activation by icilin tended to increase and 
TRPM8 channel inhibition by 2-APB and BCTC or downregulation by RNA interference 
significantly decreased transfilter chemotaxis as induced by a fetal calf serum (FCS) gradient 
(Fig. 5E-H). Combined, these data clearly indicated a cell migration-stimulating role of 
TRPM8 channels in the human glioblastoma lines. 
 
Ionizing radiation induces TRPM8 upregulation. In order to characterize any function of 
TRPM8 for radioresistance, T98G and U251 glioblastoma cells were fractionated irradiated 
with single doses of 2 Gy photons as used in the standard radiotherapy of glioblastoma 
patients. Radiation-induced changes in expression and function of TRPM8 were assessed by 
real time PCR and fura-2 Ca2+ imaging, respectively. As shown in Fig. 6A-D, fractionated 
irradiation (5 x 2 Gy) induced a significant increase in TRPM8 mRNA abundance in T98G 
and U251 cells and a not quite significant increase in U-87MG cells. The latter cell line 
showed highest basal TRPM8 mRNA abundance (see Fig. 1F). Moreover, a single dose (2Gy) 
of ionizing radiation already evoked within 2 h an increase in menthol-stimulated Ca2+ influx 
into T98G cells as recorded by fura-2 imaging applying a Ca2+-depletion/repletion protocol 
(Fig. 6E, F). Together, these data suggest that ionizing radiation may stimulate TRPM8 
expression and function in glioblastoma cells. 
 
TRPM8 confers radioresistance. To discriminate, whether this radiation-induced TRPM8 
stimulation is an epiphenomenon of DNA damage response or has functional significance for 
the survival of irradiated glioblastoma cells, TRPM8 was knocked-down in U251 and T98G 
cells by RNA silencing. Moreover, TRPM8 was upregulated in U251 cells by MSII knock-
down (see Fig. 4). Cells with unchanged (non-targeting siRNA) and down-regulated TRPM8 
activity (U251, T98G) as well as up-regulated TRPM8 expression (U251) were then tested for 
clonogenic survival and radioresistance in colony formation assays. For the latter, 0 - 6 Gy-
irradiated cells were delayed-plated 24 h after irradiation. Notably, TRPM8 knock-down 
radaisensitized both glioblastoma lines (Fig. 7A, B). In particular, TRPM8 knock-down 
diminished the survival fraction at 2 Gy by some 30% in U251 (Fig. 7C) and 10% in T98G 
cells (Fig. 7D). Moreover, TRPM8 knock-down lowered the plating efficiency of U251 and 
T98G cells by 30% (Fig. 7E) and 60% (Fig. 7F), respectively. Vice versa, TRPM8-
upregulated U251 cells (MSI1 knock-down) exhibited higher radioresistance (Fig. 7A, C) but 
lower plating efficiency (Fig. 7E) than non-targeting siRNA-transfected U251 control cells. In 
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summary, these experiments strongly suggest a pivotal function of TRPM8 channels for the 
clonogenicity and radioresistance of glioblastoma cells. 
 
TRPM8 knock-down results in caspase activation. To test whether TRPM8 activity is required 
for cell survival, caspase activity was determined upon TRPM8 knock-down in T98G and 
U251 cells 24 h after irradiation with 0 or 4 Gy by measuring the active-caspase-dependent 
caspACE fluorescence intensity in flow cytometry (Fig. 8A). TRPM8 knock-down increased 
the fraction of cells with detectable caspase activity by a factor of three in both cell lines (Fig. 
8B, C) suggesting a survival function of TRPM8. Importantly, effects of irradiation and 
TRPM8 knock-down on caspase activation were only (T98G, Fig. 8B) or not even (U251, 
Fig. 8C) additive suggesting that further mechanisms probably underlie the observed TRPM8-
conferred radioresistance (see Fig. 7). We, therefore, characterized the effect of TRPM8 
knock-down in irradiated T98G and U251 on cell cycle control as analyzed 48 h after 
irradiation. 
 
TRPM8 function is required for S phase progression and mitosis. To this end, the cellular 
DNA content was measured in permeabilized glioblastoma cells by flow cytometry using the 
fluorescence dye propidium iodide (Nicoletti protocol, Fig. 9A). In both cell lines, irradiation 
increased the G2 and S and decreased the G1 population (compare 1st and 2nd bars of the first 
three diagrams in Fig 5B, C). Combined, these results suggest a radiation-induced S- and 
G2/M arrest in both glioblastoma cell lines. 
 
Although not always reaching significance, TRPM8 knock-down exerted in both glioblastoma 
lines similar effects on cell cycle: TRPM8 knock-down showed the tendency to augment both, 
the radiation-induced rise of the G2 and the shrinkage of the G1 population. At the same time, 
TRPM8 knock-down blunted (U251) or abolished (T98G) the radiation-induced accumulation 
in S phase (Fig. 9B, C, first three diagrams) and increased the hyper G population exclusively 
(U251) or in a pronounced manner (T98G) in irradiated cells (Fig. 9B, C, last diagrams). The 
hyper G population presents cells with elevated DNA content. An increase in this population, 
therefore, hints to an impairment of mitosis or cytokinesis upon TRPM8 knock-down. Such 
impairment might be consistent with the observed pronounced increase in G2 and decrease in 
G1 population that was associated with TRPM8 knock-down. To directly test for a function of 
TRPM8 for the re-entry in mitosis and cell division upon radiation-induced cell cycle arrest, 
T98G and U251 cells were irradiated (0 or 4 Gy) and post-incubated for 48 h. Thereafter, 5-
ethynyl-2′-deoxyuridine (EdU) was incubated for 8 h before EdU incorporation into the DNA 
and DNA content was determined by flow cytometry (Fig. 10A). 
 
Irradiation (1st and 2nd bars in Fig. 10B, C) resulted in both cell lines in an increase in EdU-
negative S and G2 phase cells and in a decrease of EdU-negative G1 cells (Fig. 10B, C, 1st-3rd 
diagrams) while having no effect on the S and G2 phase cells that incorporated EdU (Fig. 
10B, C, 4th-5th diagrams). The latter observation suggests that G1/S transition and S phase 
progression (i.e., DNA replication) seemed to be restored to levels of unirradiated cells 
already 48-56 h after irradiation with 4 Gy. In both cell lines TRPM8 knock-down further 
increased the EdU-negative S and G2 phase cells and decreased the EdU-negative G1 
population mostly in both, irradiated and unirradiated cells (compare 1st with 3rd and 2nd with 
4th bars in Fig. 10B, C, 1st-3rd diagrams). This parallel increase and decrease in EdU-negative 
G2 and G1 population, respectively, again (see Fig. 9) points to a role of TRPM8 in mitosis. 
Moreover, the TRPM8 knock-down-associated increase in EdU-negative S cells hints to an 
additional function of TRPM8 in S phase progression. 
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Consistent with elevated EdU negative populations, TRPM8 knock-down diminished the 
EdU-positive S and G2 populations (Fig. 10B, C, 4th and 5th diagrams). Computing the ratio 
between EdU-positive and EdU-negative cells revealed that irradiation alone did not alter this 
ratio in U251 and T98G cells (compare 1st and 2nd bar in Fig. 10D, E) again pointing to a 
restored DNA replication 48-56 h after irradiation. TRPM8 knock-down, in contrast, 
decreased the ratio between EdU-positive and EdU-negative cells (compare 1st and 3rd bars in 
Fig. 10D, E). In U251, but not in T98G cells, combined irradiation and TRPM8 knock-down 
further decreased this ratio (compare 3rd and 4th bar in Fig. 10D, E). In summary, these data 
suggest a functional significance of TRPM8 channels in cell cycle control of unirradiated 
glioblastoma cells. At least in U251 cells, TRPM8 knock-down increased the hyperG 
population specifically in irradiated cells (see Fig. 9 B, 4th diagram) and exerted supra-
additive effects with irradiation on EdU incorporation into the DNA (see Fig. 10D) further 
suggesting TRPM8 function in the cell cycle management of irradiated cells. 
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Discussion 
 
The present study confirms previous data showing that TRPM8 channels constitute a Ca2+ 
entry pathway in glioblastoma cells and that TRPM8 channel activity stimulates glioblastoma 
cell migration. The new findings of our study are that ionizing radiation in doses used in the 
clinic for fractionated radiation therapy of glioblastoma patients induces upregulation of 
TRPM8 and that elevated TRPM8 channel function, in turn, confers radioresistance. The 
latter might result from the observed dependence of cell cycle control during DNA damage 
response on TRPM8-mediated Ca2+ signaling. 
 
Radiation-induced Ca2+ signaling. In addition to glioblastoma, chronic myeloid and T cell 
leukemia cells have been reported to respond to ionizing radiation with Ca2+ signaling that 
utilizes Ca2+-permeable TRP channels [30, 31]. These TRP channels have been suggested to 
regulate cell cycle progression and contribute to survival in concert with voltage-gated Kv3.4 
[32] or Ca2+-activated IK K+ channels [31]. By re- or hyperpolarizing the plasma membrane, 
voltage-gated or Ca2+-activated K+ channels counteract Ca2+ entry-generated membrane 
depolarization. By doing so, these K+ channels maintain locally in close vicinity to a Ca2+ 
entry pathway a high inwardly directed electrochemical Ca2+ gradient across the plasma 
membrane and regulate the activity of voltage-gated or voltage-dependent Ca2+ entry 
pathways. Therefore, these K+ channels are important players of the Ca2+-signalosome (for 
review see [20]). 
 
Interaction between TRPM8, IK and BK channels. In glioblastoma, ionizing radiation has 
been shown to activate BK [22] and IK Ca2+-activated K+ channels [23]. Activities of both 
channels signal back to Ca2+ or biochemical signaling. For instance, radiation-induced BK 
electrosignaling has been demonstrated to be pivotal for the activation of downstream Ca2+ 
effector proteins such as the Ca2+/calmodulin kinase-II isoforms and glioblastoma cell 
migration [22]. Radiation-induced IK electrosignaling, on the other hand, is reportedly 
required for cell cycle control, DNA damage repair and clonogenic survival [23]. Since 
TRPM8 function - as suggested by the present study - seems to be needed for both, migration 
and survival of irradiated cells it is tempting to speculate that IK and BK closely interact with 
TRPM8 in glioblastoma cells. The cation permeability of the strongly outwardly rectifying 
TRPM8 channels (for review see [14]) decreases with hyperpolarizing voltages. Therefore, a 
plausible scenario might be that IK and BK channel activities hyperpolarize the plasma 
membrane and shut down TRPM8 channel-mediated Ca2+ influx. Decrease of Ca2+ influx, 
however, deactivates the Ca2+-activated BK and IK channels resulting in membrane re-
depolarization. Depolarization again increases TRPM8-mediated Ca2+-entry and reactivation 
of the K+ channels. Thus, reciprocal and interdependent activity of IK, BK, and TRPM8 may 
generate membrane voltage and Ca2+ oscillations specifically recognized by certain Ca2+ 
effector proteins such as CaMKII isoforms (for review see [20]). CaMKIIs reportedly regulate 
glioblastoma cell migration [22, 33, 34] and mitosis [35]. 
 
TRPM8 activation in glioblastoma cells. In brain tumors, TRPM8 channels are not exposed to 
low temperature. In addition, our experimental settings (e.g, migration, colony formation 
assays) did not subject the cells to any changes in osmolarity, suggesting that the documented 
osmosensing function of TRPM8 [17] can also not account for the observed TRPM8 activity 
in glioblastoma cells. TRPM8 channel function is reportedly modulated by G-protein coupled 
receptors [36], phosphoinosites [14], serine/threonine [37] and tyrosine kinases/phosphatases 
[38], as well as UBA1-dependent ubiquitination [18]. Moreover, protein-protein interactions 
with the two-transmembrane domain protein Pirt [39] and the TRP channel-associated factors 
(TCAFs) [40] reportedly promote trafficking and/or modulate activity of TRPM8. Finally, 
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picomolar concentrations of testosterone have been shown to stimulate openings of the 
purified TRPM8 channel protein in planar lipid bilayers [15]. Combined, these data suggest a 
highly complex regulation of TRPM8 surface expression and activity which might shift the 
set point of temperature-dependent activation towards body temperature. The exact molecular 
mechanisms leading to activation of TRPM8 in glioblastoma, however, are far from being 
understood. 
 
Upregulation of TRPM8 expression by glioblastoma cells. Reportedly, TRPM8 is a target 
gene of the androgen receptor and p53 [13, 18]. The documented upregulation of the 
androgen receptor in glioblastoma [41] might therefore contribute to TRPM8 overexpression 
in the brain tumor. In U251 glioblastoma cells, downregulation of musashi-1 (MSI1) was 
associated with upregulation of TRPM8 (see Fig. 4A). This might hint to a possible negative 
regulation of TRPM8 by the RNA binding protein musashi-1. Querying the Cancer-Genome-
Atlas for MSI1 and TRPM8 mRNA abundances, however, did not confirm such an 
association in glioblastoma patient specimens (data not shown) suggesting that this 
phenomenon is restricted to U251 cells. In the present study, TRPM8 mRNA abundance 
increased significantly in T98G and U251 glioblastoma cells and not quite significantly in U-
87MG cells during fractionated radiation (see Fig. 6A-D). This suggests either selection of 
TRPM8 overexpressing and resistant glioblastoma cell clones or an adaptative response. The 
latter might in theory result from stabilization of p53. U251, which are p53-mutated, however, 
show similar fractionated radiation-induced increase in TRPM8 as heterogeneous p53 
wildtype/mutated T98G cells and a higher increase than p53 wildtype U-87MG cells, an 
observation which does not support a p53-mediated TRPM8 upregulation. 
 
Possible TRPM8 functions in malignant progression of glioma. TRPM8 knock-down 
radiosensitized the T98G and U251 cells in our colony formation assays which might classify 
TRPM8 as resistance factor. In addition, glioblastoma migration required in the present study 
TRPM8 function. Since the spreading of glioblastoma in the brain contributes to the high 
malignancy of the tumor, TRPM8 might also be thought of a malignancy factor. As a matter 
of fact, high TRPM8 abundance in specimens of low grade glioma associated with bad 
prognosis (see Fig. 1A, B). Although neither subgroup analysis of the patients, nor 
multivariate testing nor validation by a second patient cohort could be performed, these data 
might hint to a possible prognostic value of TRPM8. Such value might be supported by the 
observation that low grade glioma specimens with wildtype IDH1 showed significant higher 
TRPM8 mRNA expression than those with IDH1 mutations (but similar high TRMP8 
abundances as glioblastoma specimens. see Fig. 1C) since IDH1 mutations in low grade 
gliomas are associated with better prognosis than non-IDH1-mutated low grade gliomas [42]. 
 
Association of TRPM8 with CXCR4 chemokine receptor and IK K+ channels. In patient-
derived glioblastoma specimens, TRPM8 mRNA abundance positively correlated with those 
of the IK K+ channel and the CXCR4 chemokine receptor (see Fig. 1D). Reportedly, IK 
confers radioresistance [23] and is required for glioblastoma brain infiltration [34, 43, 44]. 
CXCR4 has been proposed as biomarker of radioresistant cancer stem cells and is associated 
with poor prognosis (for review see [27, 28]). Thus, one might speculate that TRPM8 
expression possibly is associated with a highly migratory and therapy-resistant glioblastoma 
phenotype. In sharp contrast to this assumption, a recent study enrolling 33 glioblastoma 
patients suggests that longer overall survival associates with high TRPM8 mRNA abundance 
in the glioblastoma specimens [2]. In the present study, querying TCGA data from 528 
glioblastoma specimens did not confirm such an association (data not shown).  
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Conclusions 
 
The present in vitro study proposes a possible functional significance of Ca2+-permeable 
TRPM8 nonselective cation channels for glioblastoma brain spreading and radioresistance. 
Targeting TRPM8 alone or in combination with radiotherapy might, therefore, become a 
promising new strategy for future anti-glioblastoma therapy. New and more specific 
pharmacological TRPM8 inhibitors are available [45, 46], antagonizing antibodies binding to 
extracellular TRPM8 protein have been developed [47] suggesting that TRPM8-targeting 
therapy is theoretically feasible. Whether or not TRPM8-targeting alone or in combination 
with radiotherapy has tolerable side effects and does effectively prolong survival has to await 
future preclinical studies in orthotopic glioblastoma animal models. 
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Figures and Figure Legends 
 
 
 
 
Fig. 1. TRPM8 as prognostic marker in glioma. A. Disease-free and B. overall survival of 
patients with low grade glioma with high (n = 15-17, grey) and low (n = 335-352, black) 
expression of TRPM8 mRNA in the tumor (data from TCGA). C. Mean (± SE) TRPM8 
mRNA abundance in human IDH1-mutated low grade glioma (n = 30, left), IDH1 wildtype 
low grade glioma (n = 19, middle) and IDH1 wildtype glioblastoma (n = 48, right) specimens. 
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Log2x+1-transformed RNA sequencing data (Illumina HiSeq 2000 RNA Sequencing platform) 
were received from the The-Cancer-Genome-Atlas (TCGA). D. Association between TRPM8 
and CXCR4 (left), and between TRPM8 and IK mRNA expression (right) by primary 
glioblastoma of patients treated according to [29] (n = 58, closed circles) and of other patients 
(n = 100, open circles, data from TCGA). E. PCR cycle-dependent increase in SYBR green 
fluorescent specific for β-actin, TRPM8, TRPV1, TRPV2, TRPC6 and TRPM1 in WK1 
human glioblastoma cells. F. GAPDH housekeeper-normalized TRPM8 mRNA abundance in 
the human glioma lines WK1, T98G, U373, A172, U-87MG, DBTRG, and U251. *** 
indicates p ≤ 0.001, ANOVA. 
 19 
 
 
Fig. 2. TRPM8 agonist icilin stimulates outward currents in glioblastoma cells. A, B. 
Recording of macroscopic on-cell currents in human T98G glioblastoma cells. Depicted are 
the applied voltage-clamp pulse protocol (A) and (B) tracings recorded with NaCl bath and 
NaCl pipette solution further containing 0 µM (vehicle, left) or 10 µM (right) of the TRPM8 
agonist icilin. In (B) only the currents evoked by voltage sweeps to -50, 0, +50 and +100 mV 
are shown. C. Dependence of the mean macroscopic on-cell currents (± SE, n = 8-10) on the 
voltage recorded as in (A, B) from 0 µM (open circles) or 10 µM icilin-stimulated T98G cells 
(closed triangles). D. Mean (± SE, n = 8-10) macroscopic on-cell conductance as determined 
for the outward currents in (C) of icilin (0, open bar, or 10 µM, closed bar)-stimulated T98G 
cells. Conductances were calculated between +10 and +60 mV voltage as shown by the grey 
lines in (C). * indicates p ≤ 0.05, two-tailed Welch-corrected t-test. 
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Fig. 3. Icilin induces activity of BK K+ channels at physiological membrane potential. A, B. 
Single channel current transitions recorded from T98G glioblastoma cells in on-cell mode at 
different holding potentials (as indicated) with NaCl bath and NaCl pipette solution further 
containing 0 µM (vehicle, A) or 10 µM icilin (B). Note, that the voltage-dependent increase in 
open probability is shifted towards more negative potentials in the icilin-stimulated (B) as 
compared to the vehicle-treated cells (A). C, D. Dependence of the mean (± SE) unitary 
current transition (C, n = 7) and open probability (Po, D, n = 4-7) on the voltage of the 
channels recorded as in (A, B) in the absence (open circles) or presence of icilin (closed 
triangle). E, F. Activation voltage (E) and unitary conductance (F) of channels in vehicle- 
(open circles, n = 4) and icilin-treated (closed triangle, n = 7) T98G cells (given are individual 
recordings and the median values as grey lines). 
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Fig. 4. Transfection with TRPM8- and MSI1-specific siRNA decreases and increases TRPM8 
mRNA abundance and icilin-stimulated Ca2+-entry in glioblastoma cells, respectively. A. 
Silencing of MSI1 mRNA in U251 glioblastoma cells was associated with an increase in 
TRPM8 mRNA abundances (four independent experiments are depicted). MSI1 knock-down, 
therefore, was harnessed to upregulate TRPM8. B, C. TRPM8 mRNA abundance in U251 (B) 
and T98G cells (C) transfected with nontargeting (nt siRNA, open bars) or TRPM8 siRNA 
(closed bars). Shown are means of n = 2 (B) or means (± SE) of n = 3 experiments. D. Mean 
(± SE, n = 16-19) fura-2 340/380 nm fluorescence ratio recorded in nontargeting- (nt siRNA 
open circles), TRPM8 siRNA- (closed triangles) or MSI1 siRNA-transfected (open triangles) 
U251 glioblastoma cells before and during superfusion with the TRPM8 agonist icilin (10 
µM). E. Mean (± SE, n = 16-19) slope of the ratio increase following icilin wash-in as 
calculated for nt siRNA- (open bar), TRPM8 siRNA- (black bar) or MSI1 siRNA-transfected 
(grey bar) U251 cells (data from (D)). ** indicates p ≤ 0.01, ANOVA. Knock-down and fura-
2 Ca2+-imaging experiments were performed as described in the main article. 
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Fig. 5. TRPM8 function is required for cell migration. A. Light Micrographs showing wound 
healing of the human glioblastoma cell line U-87MG at time 0 h (left) and 18 h (right) after 
scratching the monolayer. The white lines indicate the migration routes of 5 selected cells as 
recorded by time lapse microscopy. B-D. Mean (± SE) migration speed during wound healing 
of U-87MG (B, n = 15-15) and T98G glioblastoma cells (C, D, n = 15-45). Wound healing 
was performed either in the absence (open bars) or presence of the TRPM8 agonist icilin (10 
µM, grey bars) or the TRP channel inhibitor BCTC (10 µM, black bars, B, C) as well as upon 
transfecting the cells with nt- (open bar) or TRPM8 siRNA (closed bar, D). E-G. Time 
dependence of the mean impedance (± SE,) as a real-time measure of transfilter migration in 
U-87MG (E, n = 4-15) and T98G cells (F, G, n = 4-7). Transfilter migration was performed 
either in the absence (open circles in E, F, G, closed diamonds in G) or presence of the 
TRPM8 agonist icilin (10 µM, open triangles in E, F, G) or the TRP channel inhibitor 2-APB 
(10 µM, closed diamonds in E, F) as well as upon transfecting the cells with nt- (open 
symbols in G) or TRPM8 siRNA (closed diamonds in G). H. Mean (± SE, n = 4-8) impedance 
increase in T98G cells as a measure of transfilter migration velocity. Transfilter migration 
velocity was calculated for nt- (left) or TRPM8 siRNA-transfected (right) cells in the absence 
(open bars) or presence of icilin (10 µM, grey bars) or BCTC (10 µM, black bars). *, **, and 
*** indicate p ≤ 0.05, p ≤ 0.01, and p ≤ 0.001, ANOVA (B, C and E-H) or two-tailed t-test 
(D), respectively. 
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Fig. 6. Ionizing radiation stimulates TRPM8 mRNA abundance and TRPM8 agonist menthol-
induced Ca2+ entry in glioblastoma cells. A. Dependence of the GAPDH- (circles) and 
TRPM8 (triangles) mRNA-specific SYBR green fluorescence on PCR cycle. mRNAs were 
extracted from cells irradiated with 5 fractions of 0 Gy (open symbols) or 2 Gy (closed 
symbols) B-D. Mean (± SE, n = 3) GAPDH housekeeper-normalized abundance of TRPM8-
specific mRNA in U251 (B), T98G (C), and (D) U-87MG cells fractionated irradiated with 5 
x 0 Gy (open bars) or 5 x 2 Gy (closed bar, mRNA was extracted 24 h after the last IR 
fraction; in (C) mRNA abundances were normalized to those of the respective control (5 x 0 
Gy) cells). E. Mean (± SE, n = 24-32) fura-2 340/380 nm fluorescence ratio as measure of 
cytosolic free Ca2+ concentration (free[Ca2+]i) recorded in 0 Gy- (open circles) or 2 Gy-
irradiated (1.5-3 h after IR, closed triangles) T98G cells. Ratios were measured during 
superfusion with EGTA-buffered Ca2+-free NaCl solution and upon wash-in of Ca2+- and 
menthol (100 µM). F. Mean (± SE, n = 58-72) increase in free[Ca2+]i as determined by the 
slope (grey lines in D) of the rise in the 340/380 nm ratio following Ca2+ wash-in. Slopes 
were determined from 0 Gy- (open bars) or 2 Gy-irradiated T98G cells in the absence 
(control, left) or presence of menthol (right). * indicates p ≤ 0.05, respectively, two-tailed 
(Welch-corrected) t-test in (B, D), one-sample two-tailed t-test (significant difference from 
1.0) in (C), and ANOVA in (F). 
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Fig. 7. MSI1- and TRPM8 RNA interference increase and decrease radioresistance, 
respectively, and diminish clonogenic survival in glioblastoma cells. A, B. Mean survival 
fractions (± SE, n = 24-36) of non targeting siRNA- (nt siRNA, open circles), TRPM8 
siRNA- (closed triangles), or MSI1 siRNA-transfected (open triangles) U251 (A) and T98G 
(D) glioblastoma cells after irradiation with 0, 2, 4, or 6 Gy as determined by delayed plating 
colony formation assay. C-F. Mean (± SE, n = 24-36) survival fractions at 2 Gy (C, D) and 
mean plating efficiencies (± SE, n = 24-36 E, F) of nt- (open bars), TRPM8- (closed bar), or 
MSI1 (grey bar) siRNA-transfected U251 cells (C, E) and T98G cells (D, F). * and *** 
indicate p ≤ 0.05 and p ≤ 0.001, respectively, ANOVA (C, E) or two tailed (Welch-corrected) 
t-test (D, F). 
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Fig. 8. TRPM8 RNA silencing induces caspase activation in glioblastoma cells. A. Dot blots 
recorded by flow cytometry showing the caspACE fluorescence intensity as a measure of 
caspase activity in nt- (top) or TRPM8 (bottom) siRNA-transfected T89G cells 24 h after 
irradiation with 0 Gy (left) or 4 Gy (right). B, C. Mean percentage (± SE, n = 17-18) of nt- 
(left) or TRPM8 (right) siRNA-transfected T98G (B) and U251 cells (B) cells 24 h after 
irradiation with 0 Gy (open bars) or 4 Gy (closed bars). *** indicates p ≤ 0.001, ANOVA. 
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Fig. 9. TRPM8 RNA silencing impairs cell cycle control in irradiated glioblastoma cells. A. 
Histograms showing the cellular DNA content of nt- (left) or TRPM8 (right) siRNA-
transfected U251 cells 48 h after irradiation with 0 Gy (black) or 4 Gy (grey) as determined 
by flow cytometry using propidium iodide as DNA-specific fluorescence dye. B, C. Mean 
percentage (± SE, n = 17-18) of nt- (left) or TRPM8 (right) siRNA-transfected and 0 Gy- 
(open bars) or 4 Gy-irradiated (closed bars) U251 (B) and T98G cells (C) belonging to the G2, 
S, G1, or hyper G population. *, **, and *** indicate p ≤ 0.05, p ≤ 0.01, and p ≤ 0.001, 
respectively, ANOVA. 
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Fig. 10. TRPM8 RNA silencing impairs DNA replication and mitosis in control and irradiated 
glioblastoma cells. A. Dot blots showing 5-ethynyl-2’-deoxyuridine (EdU) incorporation by 
nt- (left) or TRPM8 siRNA-transfected (right) and irradiated (0 or 4 Gy as indicated) U251 
cells. Forty-eight h after irradiation cells were incubated for 6 h with EdU (5 µM) before co-
staining with propidium iodide and analysis by flow cytometry. Gray gates show the different 
cell populations. B, C. Mean percentage (± SE, n = 6) of nt- (left) or TRPM8 siRNA-
transfected (right) and 0 Gy- (open bars) or 4 Gy-irradiated (closed bars) EdU-negative (1st-3rd 
diagram) and EdU-positive (4th-5th diagram) U251 (B) and T98G (C) cells residing in S, G1, 
or G2 phase of cell cycle. D, E. Ratios between EdU-positive and EdU-negative cells in U251 
(D) and T98G (E) cells in dependence on TRPM8 knock-down and irradiation. *, **, and *** 
indicate p ≤ 0.05, p ≤ 0.01, and p ≤ 0.001, respectively, ANOVA. 
